Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.8158750849576472,-2.433475981661965,0.0,0.0,0.0,14/19,12.20%,GRM5;GRIA4;GRM1;GRM8;GRIA1;GRIK1;GRIA2;GRID2;GRIK2;GRM3;GRIK5;GRID1;GRIK3;GRIN2D
prerank,ligand-gated ion channel activity (GO:0015276),-0.7138653958196757,-2.3293156377592736,0.0,0.0,0.0,16/30,12.20%,GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;GRIN3A;GRID2;GRIK2;GRIN1;GABRB1;GRIK5;GRIA3;GRID1;GRIK3;GRIN2D
prerank,ligand-gated channel activity (GO:0022834),-0.7138730101234075,-2.2693768571390738,0.0,0.0,0.0,16/29,12.20%,GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;GRIN3A;GRID2;GRIK2;GRIN1;GABRB1;GRIK5;GRIA3;GRID1;GRIK3;GRIN2D
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6751858248572934,-2.153342244414511,0.0,0.0019090366144995366,0.007,16/29,13.84%,GABRB3;GRIA4;GRIK1;GRIA2;GLRA3;GRID2;GRIK2;GABRA2;GABRB1;GRIK5;GABRA3;GABRG3;GRID1;GRIK3;GRIN2D;GABRA4
prerank,sodium channel activity (GO:0005272),-0.6187482070855465,-2.1345742726456214,0.0,0.0021817561308566137,0.01,18/37,23.27%,HCN1;GRIK1;SCN2A;GRIK2;SCN1B;GRIK5;SCN9A;CACNA1G;HCN2;PKD2;GRIK3;PKD2L1;SCN8A;CACNA1I;KCNK1;SCN4B;SCN1A;HCN3
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.6713971000229034,-2.057328337417237,0.0,0.004545325272617945,0.025,3/21,1.76%,GRM5;GRM1;GRIA1
prerank,voltage-gated cation channel activity (GO:0022843),-0.4800138276038229,-2.0537537669397974,0.0,0.003895993090815381,0.025,35/97,17.76%,KCNMA1;KCND2;CACNA2D3;CACNB2;GRIN2A;HCN1;CACNA1E;GRIN2B;KCNH7;KCNC2;CACNA1C;KCNB2;OPRM1;GRIN3A;CACNB4;KCNH1;KCNC1;GRIN1;CACNG4;KCNC3;CACNA2D2;KCNQ2;HCN2;KCNH8;PKD2;GRIN2D;HVCN1;NCS1;CACNA2D1;CACNG3;CACNB1;CACNG2;KCNG2;CACNA1I;KCNK1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.7126982639410098,-1.9979344263688563,0.0,0.007227067183462533,0.048,13/17,12.20%,GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;GRIN3A;GRIK2;GRIN1;GRIK5;GRIA3;GRIK3;GRIN2D
prerank,sialyltransferase activity (GO:0008373),-0.6767571497721888,-1.9805693096817347,0.0,0.007999772479807581,0.058,13/20,13.96%,ST3GAL6;ST6GALNAC3;ST8SIA6;ST3GAL5;ST3GAL2;ST6GALNAC5;ST6GALNAC4;ST8SIA1;ST8SIA5;ST6GAL2;ST8SIA3;ST6GAL1;ST6GALNAC6
prerank,voltage-gated potassium channel activity (GO:0005249),-0.4815711857596393,-1.9427298474673518,0.0,0.01407232704402516,0.113,18/80,11.82%,KCNMA1;KCND2;HCN1;KCNH7;KCNC2;KCNB2;KCNH1;KCNK2;KCNC1;KCNJ2;KCNK6;KCNJ3;KCNC3;KCNJ9;KCNQ2;HCN2;KCNH8;PKD2
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.6728298557673567,-1.9416964323112098,0.0,0.012892195318698172,0.114,8/18,12.47%,SMAD3;TGFBR2;TGFBR1;ENG;SMAD7;TGFB2;FERMT2;SMAD2
prerank,lipase activity (GO:0016298),0.7143971310796567,1.940644015527225,0.0,0.013603789627110409,0.013,5/43,1.78%,DDHD1;CEL;LIPA;LIPG;MGLL
prerank,ion channel activity (GO:0005216),-0.4681482958491567,-1.917889808459457,0.0,0.016181357970519884,0.149,28/80,12.20%,TRPM3;GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;TRPC1;GRIN3A;GRID2;UNC80;TMEM63B;GRIK2;GRIN1;TRPM4;GABRB1;GRIK5;GRIA3;NALCN;TRPM2;MCOLN1;GRID1;LRRC8A;TMEM120A;TMC4;PKD2;GRIK3;GRIN2D
prerank,ligand-gated cation channel activity (GO:0099094),-0.47191274345774764,-1.9006936216031918,0.0,0.019048409296325047,0.181,20/75,12.20%,GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;GRIN3A;GRIK2;KCNJ2;GRIN1;TRPM4;KCNK6;KCNJ3;GRIK5;GRIA3;TRPM2;KCNJ9;MCOLN1;GRIK3;GRIN2D
prerank,chemoattractant activity (GO:0042056),0.7509426155065321,1.8878866324911272,0.0,0.025264180736062188,0.046,4/26,2.99%,GPNMB;LGALS3;VEGFA;HGF
prerank,monocarboxylic acid binding (GO:0033293),0.7985118473249602,1.8851094606666399,0.0,0.01749058666342767,0.048,5/18,6.22%,PSAP;PYGL;RXRA;RARA;NR1H4
prerank,voltage-gated sodium channel activity (GO:0005248),-0.5966739197497606,-1.8507471886487992,0.007272727272727273,0.033817220028277514,0.311,13/22,25.59%,HCN1;SCN2A;SCN1B;SCN9A;CACNA1G;HCN2;PKD2;SCN8A;CACNA1I;SCN4B;SCN1A;HCN3;SCN2B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.8008302445084501,1.849228325703143,0.0,0.025652860439693913,0.11,10/16,13.32%,ATP6V0D2;ATP6V1A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.8008302445084501,1.849228325703143,0.0,0.025652860439693913,0.11,10/16,13.32%,ATP6V0D2;ATP6V1A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.7532149429499918,1.8456189518681365,0.0,0.023806631847443218,0.122,11/22,13.32%,ATP6V0D2;ATP6V1A;ATP6V1E1;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B
prerank,cholesterol binding (GO:0015485),0.6743416301838066,1.8355868337656174,0.0,0.02581943745553608,0.15,12/47,8.31%,OSBPL8;SOAT1;ABCA1;GRAMD1B;NPC1;ABCG1;OSBPL1A;VDAC2;NR1H3;STARD5;SCARB2;GRAMD1C
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6479889170923987,-1.8233059460463188,0.0,0.039135250597240503,0.393,6/16,4.37%,PTPRD;PTPRM;PTPRT;PTPRG;PTPRO;PTPRN2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6479889170923987,-1.8233059460463188,0.0,0.039135250597240503,0.393,6/16,4.37%,PTPRD;PTPRM;PTPRT;PTPRG;PTPRO;PTPRN2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.8133301682299667,1.8117796206706132,0.0029239766081871343,0.037410421474553625,0.229,3/14,5.07%,DHRS3;AKR1A1;RDH12
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6156494360871311,-1.7964267681971229,0.007142857142857143,0.047870296282912755,0.468,10/19,13.84%,GRIK1;GRID2;GRIK2;GABRA2;GRIK5;GABRA3;GABRG3;GRID1;GRIK3;GABRA4
prerank,GTPase inhibitor activity (GO:0005095),0.8061456800204093,1.7919718841289993,0.002881844380403458,0.04556189859238566,0.301,4/13,1.99%,IQGAP2;IQGAP1;IPO5;GPS1
prerank,cholesterol transfer activity (GO:0120020),0.782396085218201,1.7864064261150046,0.002824858757062147,0.04576703510263573,0.336,6/16,8.31%,ABCA1;GRAMD1B;ABCG1;PLTP;STARD5;GRAMD1C
prerank,sterol transfer activity (GO:0120015),0.7756538931029586,1.7827865897288466,0.004178272980501393,0.0442564844362488,0.349,6/17,8.31%,ABCA1;GRAMD1B;ABCG1;PLTP;STARD5;GRAMD1C
prerank,triglyceride lipase activity (GO:0004806),0.73750453539535,1.7576059098256651,0.00411522633744856,0.06397020122272157,0.487,2/20,1.07%,CEL;LIPG
prerank,amino acid transmembrane transporter activity (GO:0015171),0.6325178797796533,1.7441717074018457,0.0,0.07489558904595951,0.582,11/47,7.51%,SLC6A6;SLC7A2;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC7A4;SLC7A7;SLC38A1;SLC38A7
prerank,cation transmembrane transporter activity (GO:0008324),0.6241885690889474,1.7325064150047553,0.0011806375442739079,0.08495427807950583,0.651,12/48,8.73%,SLC6A6;SLC7A2;ATP1B4;SLC36A2;SLC36A4;SLC38A6;SLC1A5;SLC8B1;SLC38A1;MFSD12;SLC38A7;MMGT1
prerank,serine-type endopeptidase activity (GO:0004252),0.5899146929631469,1.7309728363282957,0.0,0.08078059840479372,0.66,15/80,9.75%,F7;CD5L;PCSK4;KLK3;TMPRSS4;HGF;F11;RHBDF2;HTRA2;F10;PROC;CTSH;HPR;HP;PLAU
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6592693337235482,1.7280508045146192,0.0,0.07852544637434714,0.671,9/32,7.51%,SLC6A6;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC38A1;MFSD12;SLC38A7
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5351192308737452,-1.7140530074077114,0.008771929824561403,0.1004819906933407,0.761,10/28,13.84%,GRIK1;GRID2;GRIK2;GABRA2;GRIK5;GABRA3;GABRG3;GRID1;GRIK3;GABRA4
prerank,water transmembrane transporter activity (GO:0005372),0.7999209010638758,1.683639316718924,0.010218978102189781,0.13855288258872114,0.866,1/11,1.89%,AQP1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.5582099655785507,-1.6758052515444632,0.023715415019762844,0.13245556299700545,0.864,9/19,12.20%,GRIN2A;RYR3;GRIN2B;RYR2;GRIN1;TRPM4;TRPM2;MCOLN1;GRIN2D
prerank,sterol binding (GO:0032934),0.5988852298496083,1.6736362011801835,0.004602991944764097,0.1494257527295302,0.901,15/56,13.38%,OSBPL8;SOAT1;ABCA1;GRAMD1B;NPC1;ABCG1;OSBPL1A;VDAC2;NR1H3;STARD5;SCARB2;GRAMD1C;ERLIN1;RORA;VDAC1
prerank,phospholipase inhibitor activity (GO:0004859),0.7999296998337571,1.6611755851019978,0.009448818897637795,0.16713227256164218,0.931,4/10,5.78%,ANXA4;ANXA1;ANXA5;ANXA2
prerank,serine-type peptidase activity (GO:0008236),0.5533968092767777,1.653925685038248,0.0021321961620469083,0.17437143204178307,0.944,16/96,9.75%,F7;CD5L;PCSK4;TPP1;KLK3;TMPRSS4;HGF;F11;RHBDF2;HTRA2;F10;PROC;CTSH;HPR;HP;PLAU
prerank,ligand-gated anion channel activity (GO:0099095),-0.580116186853189,-1.6343905904578198,0.027972027972027972,0.1760131758568573,0.936,8/17,8.93%,GABRB3;GLRB;GLRA3;GABRA2;GABRB1;GABRA3;GLRA1;GABRG3
prerank,calcium channel activity (GO:0005262),-0.39281712535074587,-1.6337896887943886,0.0,0.16835884809776866,0.937,33/84,17.03%,SLC24A3;CACNA2D3;CACNB2;CACNA1E;SLC24A2;ORAI1;TRPC1;CACNA1C;OPRM1;CACNB4;RYR2;GRIN1;TRPM4;CACNG4;CACNA2D2;TRPC7;TRPM2;TRPC4;MCOLN1;SLC24A4;CUL5;PKD2;NCS1;PKD1;PKD2L1;CACNA2D1;CACNG3;PKD2L2;ORAI2;ANXA9;CACNB1;CACNG2;CACNA1I
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5798853787646939,1.6251114962389577,0.004662004662004662,0.23293019381929866,0.984,20/55,19.68%,SLC6A6;SLC7A2;SLC36A2;SLC36A4;SLC38A6;SLC7A4;SLC16A1;SLC38A1;SLC38A7;SLC25A32;SLC23A2;SLC23A1;SLC38A9;SLC7A1;SLC36A1;SLC16A9;ABCC1;SLC19A1;SLC19A2;SLC7A8
prerank,mannose binding (GO:0005537),0.7574461694734391,1.6250417277136555,0.014619883040935672,0.22247496218102317,0.984,2/12,4.35%,CLEC4D;CLN5
prerank,ferrous iron binding (GO:0008198),0.6785101435498998,1.6222092807091446,0.014666666666666666,0.22049123622325845,0.985,10/21,17.17%,CDO1;FTL;ACP5;HEPH;TET2;EGLN3;FTO;FECH;ALKBH1;FTH1
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.4220868779526276,-1.620159789408511,0.0078125,0.17964778322939798,0.952,15/60,9.09%,ERBB4;EPHA5;ACVR1;CSF1R;NTRK3;EPHA6;TGFBR2;RYK;EPHA3;FGFR2;NTRK2;FLT3;EGFR;IGF1R;EPHA7
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5573699507448336,-1.6159671822046922,0.041379310344827586,0.16981335218500643,0.956,5/17,9.64%,EPHA5;EPHA6;EPHA3;EPHA7;EFNB3
prerank,ephrin receptor activity (GO:0005003),-0.5573699507448336,-1.6159671822046922,0.041379310344827586,0.16981335218500643,0.956,5/17,9.64%,EPHA5;EPHA6;EPHA3;EPHA7;EFNB3
prerank,inward rectifier potassium channel activity (GO:0005242),-0.523614655299447,-1.6108887656576056,0.01639344262295082,0.16974062698064454,0.961,16/24,37.96%,KCNJ2;KCNK6;KCNJ3;KCNJ9;KCNN2;KCNK1;ABCC9;KCNJ6;KCNJ13;ABCC8;KCNJ12;KCNJ16;KCNJ10;KCNN1;KCNN3;KCNJ15
prerank,phosphatase inhibitor activity (GO:0019212),0.6721900852631585,1.6002644231669192,0.016238159675236806,0.2715494554435402,0.994,7/20,11.61%,LGALS3;MGAT5;ENSA;PPP1R9B;STYXL1;BOD1;STYX
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.6659386848219084,-1.5984507687583196,0.04154302670623145,0.1782746500001875,0.974,3/10,3.24%,CACNB2;CACNA1C;CACNB4
prerank,chemorepellent activity (GO:0045499),-0.49795158673316164,-1.5969088067276154,0.021739130434782608,0.17324759794653996,0.975,8/25,11.92%,NRG3;SEMA5A;SEMA4G;SEMA3E;SEMA3A;EPHA7;SEMA6A;DPP4
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6688945342470662,1.5891689548160026,0.025899280575539568,0.29438600753066924,0.999,7/18,14.04%,TRIM29;ANXA1;BAIAP2;ANXA2;PDLIM5;RAB10;PPP1CA
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.7390033960635477,1.5867378622853523,0.015895953757225433,0.29061282456156745,0.999,4/13,3.72%,ERN1;VEGFA;ITGA5;PDGFA
prerank,alkali metal ion binding (GO:0031420),-0.6125695700159335,-1.5843075694395228,0.036065573770491806,0.181864957479262,0.985,3/13,4.59%,CAPN3;ATP1A2;IMPA1
prerank,alpha-actinin binding (GO:0051393),0.628234265626852,1.5717344472382677,0.025032938076416336,0.3294780265507825,1.0,5/24,6.79%,PPARG;PALLD;RARA;DAG1;PDLIM5
prerank,low-density lipoprotein particle binding (GO:0030169),0.6860088710828057,1.571183040275797,0.024531024531024532,0.3196196491471604,1.0,5/16,5.58%,CD36;STAB2;SORL1;PLTP;THBS1
prerank,alanine transmembrane transporter activity (GO:0022858),0.7416087690963011,1.5690830644079383,0.013657056145675266,0.31473003932868987,1.0,4/12,7.51%,SLC6A6;SLC36A2;SLC36A4;SLC38A7
prerank,sulfotransferase activity (GO:0008146),-0.45884653561302347,-1.5658007933777076,0.014925373134328358,0.1989535892431143,0.992,15/33,22.99%,UST;TPST1;CHST11;GAL3ST1;CHST1;CHST7;CHST2;GAL3ST4;CHST9;CHST8;TPST2;SULT1A1;HS3ST3A1;CHST12;SULT4A1
prerank,voltage-gated calcium channel activity (GO:0005245),-0.454763027907554,-1.5609777751562326,0.017241379310344827,0.19883070872539937,0.993,16/37,17.03%,CACNA2D3;CACNB2;CACNA1E;CACNA1C;OPRM1;CACNB4;CACNG4;CACNA2D2;CACNA1G;PKD2;NCS1;CACNA2D1;CACNG3;CACNB1;CACNG2;CACNA1I
prerank,semaphorin receptor activity (GO:0017154),0.7454950451404438,1.5603817498470625,0.027314112291350532,0.3329689461111786,1.0,4/11,5.49%,PLXNA1;PLXNC1;PLXND1;NRP2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.7035969758998976,1.560118572155386,0.04538799414348463,0.3230743310751774,1.0,4/13,7.51%,SLC7A2;SLC7A4;SLC7A7;SLC38A7
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.5996324683482025,1.556248412953906,0.02349869451697128,0.3248512085509535,1.0,12/29,18.27%,HPSE;GALC;GLA;IDUA;ABHD10;HEXD;MOGS;CTBS;GUSB;NEU1;ACER2;GANC
prerank,carboxylic ester hydrolase activity (GO:0052689),0.526878833040109,1.5548473903959468,0.004371584699453552,0.3193651564840682,1.0,19/85,14.93%,CEL;LIPA;PLA2G7;LIPG;MGLL;PLA2G2D;PNPLA7;AOAH;PON3;PGAP1;ABHD4;PLAAT1;PAFAH1B2;PLA2G4F;ESD;PLAAT3;TARS2;GDE1;PRDX6
prerank,potassium channel activity (GO:0005267),-0.37261428086020276,-1.5543375735113134,0.0,0.20029928865864263,0.995,21/89,13.99%,KCNMA1;KCND2;HCN1;KCNH7;GRIK1;KCNC2;KCNB2;KCNH1;GRIK2;KCNK2;KCNC1;KCNK6;GRIK5;KCNC3;KCNQ2;HCN2;KCNH8;PKD2;GRIK3;PKD2L1;KCNN2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.613331913862791,1.5446590198874994,0.03363518758085381,0.3431813147948357,1.0,6/26,9.37%,LGALS3;MGAT5;ENSA;PPP1R9B;STYXL1;BOD1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.7334948014097408,1.542371354405764,0.03245749613601236,0.34112196560878694,1.0,5/10,16.77%,CYBB;CYBA;NCF2;NCF4;NCF1
prerank,histone acetyltransferase binding (GO:0035035),0.6410570567822179,1.5415510669733508,0.036885245901639344,0.3337247122015736,1.0,5/21,5.07%,EPAS1;FOXP3;KANSL1;CITED2;TAF7
prerank,actin monomer binding (GO:0003785),0.640989060607418,1.5336273862713914,0.026027397260273973,0.3494440632786315,1.0,5/22,4.40%,MTSS1;LIMA1;MRTFA;ABL2;MYL2
prerank,heme binding (GO:0020037),0.5337544701754053,1.5299800297579804,0.008928571428571428,0.3519341290186477,1.0,19/65,19.28%,FLVCR1;PGRMC1;BACH1;CYBB;PTGES2;HMOX1;CAT;CYB5A;CYCS;FLVCR2;HEBP1;CYB5R4;HMOX2;CYP46A1;HCCS;COX15;RSAD1;CYP27A1;PXDNL
prerank,N-acyltransferase activity (GO:0016410),0.5909283743955542,1.5295340759128175,0.029639175257731958,0.3441808606390169,1.0,17/32,20.94%,BAAT;TGM2;NAT8;SAT1;CERS6;GLYAT;PLAAT1;NAT10;SIRT1;PLAAT3;SIRT7;NAA10;NAT14;TLCD3B;NMT2;CERS1;NAA80
prerank,calcium-release channel activity (GO:0015278),0.6613427698670454,1.527010717096073,0.03012912482065997,0.34359285801044576,1.0,4/17,3.43%,MCOLN3;TPCN2;MCOLN2;RASA3
prerank,acetylcholine receptor activity (GO:0015464),-0.5007804525601718,-1.5070486759340007,0.024896265560165973,0.2607880375164546,0.998,12/22,47.96%,CHRM3;CHRM2;ANXA9;CHRFAM7A;CHRNA7;CHRNB2;CHRNA5;HRH3;CHRNA3;CHRNB4;CHRM1;CHRNB3
prerank,ADP binding (GO:0043531),0.5990824073621422,1.496669650792932,0.03790849673202614,0.43652996714590003,1.0,9/25,12.31%,ERN1;ABCG1;PRKAG2;ABCD1;MYO9B;LONP1;ATP5F1A;ATP5F1D;MYH9
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6020937893621421,-1.4945035547953922,0.06285714285714286,0.27281868709029744,0.999,4/10,18.70%,SLCO2B1;SLCO1B1;SLCO5A1;SLCO4A1
prerank,cyclic nucleotide binding (GO:0030551),-0.49975239356964873,-1.4839595170630762,0.046511627906976744,0.2811898636886377,0.999,8/21,14.84%,HCN1;KCNH1;RAPGEF4;PDE11A;PDE4B;PDE4A;PDE5A;RAPGEF2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.530047469943142,1.4816629525575533,0.038506417736289385,0.4813844400872216,1.0,17/49,16.28%,OPTN;MINDY1;IKBKE;TNIP1;ZRANB3;BABAM2;PRPF8;RAD23A;TAB2;ZFAND6;EPS15;TNFAIP3;ZFAND2B;SQSTM1;UBQLN2;BRCC3;RNF169
prerank,MAP kinase kinase kinase activity (GO:0004709),0.7148626522366988,1.481263336814608,0.05426356589147287,0.47170349614003765,1.0,2/11,1.49%,MAP3K20;MAP3K1
prerank,neuropeptide receptor activity (GO:0008188),-0.44558690137886225,-1.4782424335492677,0.05217391304347826,0.28284909839319666,0.999,16/29,38.88%,SORCS3;OPRM1;SORCS1;HCRTR2;GPR37;TACR3;SORCS2;GALR1;NPY1R;NPSR1;SSTR2;NMUR2;NPY2R;KISS1R;NTSR1;GAL
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.5113586014813155,1.4769741503570646,0.018867924528301886,0.4782968762077228,1.0,14/75,8.59%,CBR3;SORD;DHRS3;PHGDH;PGD;AKR1A1;UGDH;HADHA;IMPDH2;RDH12;ABCC4;KCNAB2;SDR42E1;GRHPR
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5729355667867566,-1.4755337167056812,0.0914826498422713,0.2792647847496465,0.999,6/12,10.22%,ACVR1;BMPR1A;TGFBR2;TGFBR1;ENG;LTBP1
prerank,transferrin receptor binding (GO:1990459),-0.6156961082296961,-1.4750960889901652,0.08211143695014662,0.2725721004022891,0.999,4/10,18.57%,SNX2;RGMA;HFE;CHUK
prerank,growth factor receptor binding (GO:0070851),0.49019809878939274,1.4740749568964944,0.015086206896551725,0.4795227876972077,1.0,10/95,4.67%,CD300LF;SDCBP;GRB2;ERN1;VEGFA;PIBF1;IL6;ITGA5;PDGFA;ATXN2
prerank,aminopeptidase activity (GO:0004177),0.5868371531961785,1.4736127277644242,0.05154639175257732,0.4711262733749122,1.0,10/26,19.67%,ANPEP;NPEPPS;MMP14;CTSH;LTA4H;METAP1D;LNPEP;BLMH;RNPEPL1;LAP3
prerank,lipoprotein particle binding (GO:0071813),0.6023587970031873,1.4596887115457204,0.055020632737276476,0.5149799328597161,1.0,5/20,5.58%,CD36;STAB2;SORL1;PLTP;THBS1
prerank,galactosyltransferase activity (GO:0008378),0.6875291873267578,1.455415375428059,0.09370199692780339,0.5216810397182072,1.0,6/11,14.18%,B4GALT5;B4GALT7;B4GALT6;A4GALT;B4GALT3;B4GALT2
prerank,metalloaminopeptidase activity (GO:0070006),0.6362524975715235,1.4515123166461845,0.05113636363636364,0.5278508342484328,1.0,4/16,10.31%,ANPEP;NPEPPS;MMP14;LTA4H
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5748589812292176,-1.4465175319407209,0.06722689075630252,0.3143738340659312,1.0,3/11,11.82%,KCND2;KCNK2;PKD2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.5495174731270005,1.4441066550141528,0.05583126550868486,0.5464059273654803,1.0,11/35,13.44%,SYK;FRK;TEC;ABL2;MELK;DYRK1A;PKDCC;PTK2B;FES;BTK;FGR
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5511195236429367,1.4433068734872863,0.04539877300613497,0.5391978241557768,1.0,7/34,6.79%,IQGAP2;IQGAP1;GAB2;KIF16B;ARAP2;ARHGAP9;ARAP1
prerank,manganese ion binding (GO:0030145),0.5230916630483748,1.4401752625352264,0.035842293906810034,0.5409935624924086,1.0,14/48,13.27%,GALNT3;ARG1;GYG1;MGAT5;ABL2;FAM20C;B4GALT7;PIM1;ARG2;ADPRM;HMGCL;TDP2;WRN;DYRK2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.5911315313440242,1.4397196188031873,0.07228915662650602,0.5324178581823266,1.0,8/22,16.28%,OPTN;IKBKE;ZRANB3;PRPF8;TAB2;TNFAIP3;SQSTM1;RNF169
prerank,MAP kinase kinase activity (GO:0004708),0.6259381727677858,1.438599997838131,0.08172362555720654,0.5269309148818441,1.0,4/15,9.07%,SBK2;MAPKAPK3;MAP2K5;MAP2K4
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5124758089927577,1.4342357866168212,0.03096330275229358,0.5345582633084152,1.0,14/53,17.24%,SLC7A2;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC7A7;SLC38A1;SLC38A7;SLC7A11;SLC38A9;SLC25A15;SLC7A1;SLC36A1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.6364712409876264,1.4301038632934457,0.07851239669421488,0.5410803213548264,1.0,1/16,0.17%,CDO1
prerank,vinculin binding (GO:0017166),0.6955988130111338,1.4290782631025827,0.07389937106918239,0.5357472388611515,1.0,6/11,15.78%,SORBS3;ACTN1;DAG1;TLN1;CTNNA1;UTRN
prerank,retinoid binding (GO:0005501),0.5798727619771661,1.4262795616184427,0.07549668874172186,0.5364114978827846,1.0,3/22,4.62%,RBP1;RXRA;RARA
prerank,glutathione transferase activity (GO:0004364),0.5643206664959687,1.424705302895158,0.07723577235772358,0.5338416912507952,1.0,7/23,22.47%,MGST2;GSTM1;HPGDS;MGST1;GSTA4;GSTO1;GSTM5
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6349878105421856,1.4208140793138853,0.08393632416787265,0.5396169885420463,1.0,8/14,23.28%,CYBB;CYBA;NCF2;CYB5R4;NCF4;NCF1;MICAL1;AIFM1
prerank,histone methyltransferase binding (GO:1990226),0.6596321640557445,1.4188123708613554,0.08615384615384615,0.5381143060812842,1.0,5/11,11.69%,CTNNB1;LCOR;LCORL;CBX3;CBX1
prerank,endopeptidase activity (GO:0004175),0.45449732399495846,1.4179648245468035,0.0030211480362537764,0.532553884250244,1.0,87/257,25.37%,F7;MMP12;CTSB;CD5L;ADAM33;ADAMTS8;CTSL;PCSK4;TPP1;KLK3;TMPRSS4;MMP27;ADAM9;HGF;NLN;F11;RHBDF2;MMP14;HTRA2;F10;PITRM1;PROC;USP42;CTSS;CTSZ;USP12;CTSH;HPR;HP;BACE1;PLAU;ADAM17;USP40;USP26;USP48;CTSW;RHBDD1;OMA1;ATG4B;USP16;CAPN7;ADAM19;USP36;CASP6;USP8;PMPCB;PARL;ADAMTSL4;ACE;PSMB10;MASP1;SENP1;CASP2;CASP3;PSMA3;APEH;USP30;DDI2;PSMA2;AFG3L2;TYSND1;PSMA6;ADAMTS10;LGMN;ADAM10;MMP19;USP9X;ADAMTS2;USP2;PSMB3;FURIN;MALT1;PSEN2;PCSK7;SPRTN;MMP11;KLK1;USP47;CASP8;MMP28;USP46;ZMPSTE24;ADAMTSL3;CTSK;CTSO;RCE1;CELA1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5940837591895545,1.4175695202006406,0.07152875175315568,0.5256121801730935,1.0,3/18,5.68%,PIK3R5;WDR91;SOCS6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6589550069886182,1.4087162252166787,0.10461538461538461,0.5514241467265881,1.0,2/11,6.12%,ARG1;ARG2
prerank,solute:anion antiporter activity (GO:0140323),0.6358424834049301,1.4070170775420001,0.08394698085419734,0.5498920853226695,1.0,3/14,12.04%,SLC26A11;SLC26A1;SLC7A11
prerank,phosphatidylinositol binding (GO:0035091),0.47604052264336566,1.4031354301931989,0.028692879914984058,0.5559297579217414,1.0,35/91,20.32%,MTM1;SNX8;MREG;SNX10;SNX27;DENND1A;MYO1E;EEA1;SNX9;ESYT1;SNX5;SNX24;APPL2;AIDA;PLEKHF2;SESTD1;DENND1B;PICALM;SNX16;PITPNA;FES;BCAS3;APPL1;PITPNC1;RNF34;WDFY3;ESYT2;SNX17;RUBCN;NCF1;PITPNM1;FCHO2;PIGU;GAP43;FRMPD2
prerank,neuropeptide hormone activity (GO:0005184),-0.46396140305067807,-1.402005934721879,0.10108303249097472,0.3889679584063086,1.0,17/22,49.42%,PPY;ADCYAP1;AGRP;CCK;PNOC;GRP;NPFF;NPY;CRH;GAL;NMB;VIP;SPX;CORT;NPPA;GHRH;CALCB
prerank,semaphorin receptor binding (GO:0030215),-0.4438748895046255,-1.3963472369885093,0.08433734939759036,0.3908070669396909,1.0,7/23,11.90%,RIT2;SEMA5A;SEMA4G;SEMA3E;SH3BP1;SEMA3A;SEMA6A
prerank,protease binding (GO:0002020),0.4662980048696204,1.396084219255467,0.032908704883227176,0.5737231491032629,1.0,27/99,16.52%,CCBE1;PSAP;VWF;TIMP1;FLOT1;CD28;PTEN;COL1A1;ANXA2;UBC;NLRC4;BFAR;TIMP2;LCOR;RAD23A;ITGB1;GSK3B;LONP2;ITGA3;COL3A1;TNFAIP3;PRKN;DERL2;SERPINC1;TWNK;NFRKB;ADAMTSL4
prerank,phosphatidylcholine transporter activity (GO:0008525),0.6051163264614088,1.3956202340239166,0.08275862068965517,0.5671294146226449,1.0,7/17,13.46%,ABCA1;ABCG1;PLTP;ABCA3;PITPNA;PITPNC1;ATP8B1
prerank,sulfate transmembrane transporter activity (GO:0015116),0.6233942948394264,1.3953281765551968,0.1,0.5602057467561615,1.0,2/14,5.29%,SLC26A11;SLC26A1
prerank,retinoic acid binding (GO:0001972),0.6298339503413067,1.394579466294203,0.11504424778761062,0.5551595495479863,1.0,2/12,4.62%,RXRA;RARA
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.36448920685086283,-1.3939210592989815,0.006993006993006993,0.3863038690720387,1.0,20/55,15.91%,SLC24A3;CACNB2;SLC24A2;ORAI1;ITPR2;TRPC1;RYR2;ATP2C1;GRIN1;ATP2B3;TRPM2;SLC24A4;CUL5;PKD2;ATP2B2;ATP2B4;PKD1;PKD2L1;PKD2L2;ANXA9
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5733808723630279,1.3925296830534037,0.1,0.5401982333043265,1.0,3/22,3.05%,HTR2B;HRH1;HTR6
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5733808723630279,1.3925296830534037,0.1,0.5401982333043265,1.0,3/22,3.05%,HTR2B;HRH1;HTR6
prerank,serotonin receptor activity (GO:0099589),0.5733808723630279,1.3925296830534037,0.1,0.5401982333043265,1.0,3/22,3.05%,HTR2B;HRH1;HTR6
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6245114333930659,1.392149475677012,0.11287988422575977,0.5342638885697308,1.0,1/13,0.34%,GDF15
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.4708229376678718,-1.390624837691071,0.09854014598540146,0.3838851858816756,1.0,7/18,10.22%,ACVR1;BMPR1A;TGFBR2;ACVR2B;TGFBR1;ENG;LTBP1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.5456116006445823,1.386668836676901,0.07621550591327202,0.5470796388517754,1.0,5/28,4.62%,SBK2;SGK1;RPS6KA2;MAPKAPK3;MAP2K5
prerank,GABA receptor activity (GO:0016917),-0.4546104997640963,-1.385008887462683,0.09558823529411764,0.38594251184560074,1.0,7/21,13.84%,GABRB3;GABRA2;GABRB1;GABBR1;GABRA3;GABRG3;GABRA4
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.6244506798147671,1.3835468831667828,0.10401188707280833,0.5519763212233183,1.0,2/12,3.01%,VEGFA;ITGA5
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.5495842353127005,1.3831987387196816,0.08125819134993446,0.545804735771941,1.0,6/27,11.35%,SLC26A11;SLC26A1;SLC5A5;GET3;SLC39A14;XPR1
prerank,thyroid hormone receptor binding (GO:0046966),0.5421862092290717,1.3785421653828351,0.08333333333333333,0.5560860452151598,1.0,11/28,18.52%,TRIP12;MED12;NCOR1;GTF2B;TAF7;JMJD1C;NCOA3;MED16;GAS2L1;THRAP3;NCOA6
prerank,cGMP binding (GO:0030553),-0.5528925884647478,-1.3756639397464023,0.08414239482200647,0.39442679870224845,1.0,4/11,24.50%,PDE11A;PDE5A;RAPGEF2;PDE2A
prerank,potassium ion antiporter activity (GO:0022821),-0.5104426420471999,-1.3698987838623218,0.11182108626198083,0.39693416540717985,1.0,3/15,2.00%,SLC24A3;SLC9A9;SLC24A2
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5466700144372606,-1.3678375196071975,0.1295774647887324,0.39290582147861275,1.0,11/11,45.38%,KCNMA1;PKD2L1;KCNN2;KCNMB4;KCNU1;KCNN1;KCNMB2;KCNN3;KCNMB3;KCNMB1;KCNN4
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.6397192323586318,1.3672849133917822,0.12710566615620214,0.5883946513490783,1.0,3/11,12.18%,SASH1;PPEF2;STK38
prerank,Toll-like receptor binding (GO:0035325),0.639678690070423,1.3667754074269312,0.12480739599383667,0.5827766306328191,1.0,4/11,16.53%,CD36;UNC93B1;MYD88;TLR1
prerank,wide pore channel activity (GO:0022829),-0.4378941376458834,-1.3641625190259532,0.09386281588447654,0.3908824999974067,1.0,12/23,47.47%,GJB1;GJB6;GJC1;GJD3;PANX1;PANX2;GJB2;GJD2;PRF1;GJA5;GJA4;PANX3
prerank,aspartic-type peptidase activity (GO:0070001),0.6481313636017612,1.3640507959690644,0.13186813186813187,0.5859466495119761,1.0,2/10,9.35%,CTSD;BACE1
prerank,exoribonuclease activity (GO:0004532),0.633176584000878,1.362801896035529,0.11861861861861862,0.5834580051132711,1.0,8/12,21.01%,EXOSC3;EXOSC9;CNOT7;EXOSC8;CNOT6;EXOSC10;EXOSC1;EXOSC7
prerank,hexose transmembrane transporter activity (GO:0015149),-0.5242238382882456,-1.3627589228790344,0.10062893081761007,0.385261770107097,1.0,5/12,16.88%,SLC2A3;MFSD4A;SLC2A5;SLC2A8;SLC2A6
prerank,phospholipase binding (GO:0043274),0.6223794483030194,1.3613936820975363,0.13656387665198239,0.5812049363493083,1.0,6/13,13.63%,SYK;PDPK1;BLNK;BTK;DGKQ;PRKN
prerank,3'-5' DNA helicase activity (GO:0043138),-0.4898989634514675,-1.3608272466164328,0.11960132890365449,0.38162922035861296,1.0,5/16,17.67%,NAV2;FBH1;HELQ;MCM6;RECQL
prerank,BMP receptor binding (GO:0070700),0.6245116422609088,1.3562736646292757,0.1346153846153846,0.5923316733470991,1.0,1/12,0.34%,GDF15
prerank,actinin binding (GO:0042805),0.562833561208311,1.355065355268316,0.1078167115902965,0.5893298847536099,1.0,4/21,6.79%,PPARG;RARA;DAG1;PDLIM5
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.5564707664229387,-1.3528002514846524,0.1359773371104816,0.389268928867437,1.0,9/11,30.07%,DCPS;NUDT3;NUDT5;NUDT4;NUDT16L1;NUDT16;NUDT1;NUDT11;DCP2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.45840196831379876,1.3510374642697867,0.05307855626326964,0.5973464701047119,1.0,26/100,16.11%,OSBPL8;IQGAP2;IQGAP1;GAB2;SNX27;DENND1A;CERT1;LANCL2;KIF16B;ARAP2;ARHGAP9;TECPR1;SNX24;ARAP1;SESTD1;DENND1B;ZFYVE19;BTK;RNF34;NCF4;CLVS2;SH3PXD2B;GOLPH3;GOLPH3L;MAPKAP1;RUBCN
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.5969014283489168,1.3478142358674945,0.13872832369942195,0.6024423716721743,1.0,3/14,4.72%,MTM1;MTMR3;PTEN
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5173004126588123,-1.3471639808257574,0.13496932515337423,0.39241664683034744,1.0,7/13,13.84%,GLRB;GLRA3;GABRA2;GABRA3;GLRA1;GABRG3;GABRA4
prerank,GABA-A receptor activity (GO:0004890),-0.46569477854574326,-1.3468612479714235,0.11262798634812286,0.3854156118855548,1.0,6/18,13.84%,GABRB3;GABRA2;GABRB1;GABRA3;GABRG3;GABRA4
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5241170119145453,-1.344983881526074,0.11940298507462686,0.3817044098748669,1.0,6/12,13.84%,GABRB3;GABRA2;GABRB1;GABRA3;GABRG3;GABRA4
prerank,glucose transmembrane transporter activity (GO:0005355),-0.4599936584808267,-1.3399718099345426,0.10738255033557047,0.3840698848133883,1.0,5/17,16.88%,SLC2A3;MFSD4A;SLC2A5;SLC2A8;SLC2A6
prerank,flavin adenine dinucleotide binding (GO:0050660),0.48632522665086664,1.3388848700081524,0.08235294117647059,0.6289985976612965,1.0,22/53,20.77%,XDH;POR;CYB5R3;AIFM2;NQO2;ACADL;ACADVL;CYBB;PRODH;GSR;QSOX1;SDHA;MICAL2;KDM1B;GCDH;CRY1;MTRR;CYB5R2;CYB5R1;MICAL1;ETFA;FOXRED2
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.3999050578401605,-1.3362238913657312,0.08173076923076923,0.3839295765908315,1.0,6/32,10.90%,KCNC2;KCNB2;KCNH1;KCNC1;KCNC3;KCNQ2
prerank,gap junction channel activity (GO:0005243),-0.43282212262415365,-1.3341801024066424,0.10526315789473684,0.38061904500720867,1.0,11/22,47.47%,GJB1;GJB6;GJC1;GJD3;PANX1;PANX2;GJB2;GJD2;GJA5;GJA4;PANX3
prerank,organic anion transmembrane transporter activity (GO:0008514),0.4347508106578735,1.3337645166776761,0.03941908713692946,0.6414743625611918,1.0,35/134,19.80%,CD36;SLC6A6;SLC7A2;SLC35D3;SLC36A2;SLC36A4;SLC38A6;SLC1A5;SLC25A1;SLC16A1;SLC38A1;SLC26A1;MFSD12;ABCC4;SLC38A7;SLC27A1;SLC35B3;SLC25A32;SLC35D1;SLC6A8;SLC23A2;SLC23A1;SLC38A9;SLC52A1;SLC25A42;SLC17A9;SLC25A15;SLC7A1;SLCO3A1;SLC36A1;ABCC1;SLC19A1;SLC19A2;SLC7A8;SLC25A17
prerank,retinoid X receptor binding (GO:0046965),0.6229012977248156,1.332842835235796,0.1476923076923077,0.6374779005897675,1.0,1/11,0.13%,PPARG
prerank,phospholipase C activity (GO:0004629),-0.41535363143483484,-1.3319406090265125,0.10852713178294573,0.37788398950670027,1.0,5/25,4.93%,PLCL1;CCR5;PLCB1;CHRM3;PLCH1
prerank,small GTPase binding (GO:0031267),0.42677532141396535,1.330542896701985,0.027439024390243903,0.6390791280867802,1.0,47/169,18.80%,IQGAP2;IQGAP1;MYO5A;DMXL2;ABCA1;OPTN;FGD6;RIC1;RANGRF;MYO9B;RAF1;SORL1;GCC1;SIKE1;SPHK2;TRIOBP;RAB3GAP2;KIF3A;MICALL1;HPS6;AKAP13;PICALM;RIN3;PAK2;ARHGEF2;STRN3;LZTR1;TRIP11;AP1G1;FGD5;OCRL;WHAMM;PARD6A;RABGEF1;FGD3;EXOC4;GOLGA4;MAPKAP1;RABGAP1;RANBP1;RAB29;GGA2;ERC1;MYCBP2;RANBP9;TNFAIP1;ANKRD27
prerank,SUMO transferase activity (GO:0019789),0.5843491008428237,1.329768198273513,0.1172106824925816,0.6351216472414831,1.0,7/16,23.69%,NSMCE2;PIAS4;TOPORS;PIAS2;PIAS1;RANBP2;EGR2
prerank,signal sequence binding (GO:0005048),0.509258341098842,1.329143290977143,0.1051980198019802,0.6307164061755145,1.0,11/35,13.51%,IPO5;KPNA4;TIMM22;KPNA2;BRAP;BABAM2;TOMM20;CAT;KDELR2;TNPO1;AP2B1
prerank,glycine binding (GO:0016594),-0.509880532168353,-1.325201131140579,0.1419939577039275,0.3829358174503505,1.0,6/11,8.54%,GRIN2B;GLRB;GRIN3A;GLRA3;GRIN1;GLRA1
prerank,MAP-kinase scaffold activity (GO:0005078),0.6175403426965699,1.322998200169971,0.15877862595419848,0.646686531369605,1.0,4/11,12.45%,IQGAP1;SH3RF1;AKAP13;SPAG9
prerank,E-box binding (GO:0070888),0.5050775000167922,1.3226235596736367,0.11925465838509317,0.6412294552730666,1.0,4/34,7.95%,PPARG;MITF;BHLHE40;SNAI2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5504885192740733,-1.3224949529828467,0.14127423822714683,0.3810492550917284,1.0,6/10,24.00%,NAALAD2;DPP10;DPP6;DPP4;FAP;DPP8
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.6361543979639986,1.3215820679207233,0.15582450832072617,0.6383861694805458,1.0,3/10,5.76%,DSE;RENBP;GALE
prerank,neurexin family protein binding (GO:0042043),0.6245695166621607,1.3204041345500754,0.1523809523809524,0.6359921913446139,1.0,2/10,2.32%,CEL;SYTL3
prerank,Tat protein binding (GO:0030957),0.6377839586885183,1.31586461695511,0.14683153013910355,0.6466063651259119,1.0,4/10,19.26%,MDFIC;CTDP1;SMARCB1;DNAJA1
prerank,phospholipase A2 activity (GO:0004623),0.5251920043047169,1.3150643701817324,0.145478374836173,0.6431471277821332,1.0,6/26,14.93%,PLA2G7;PLA2G2D;PLAAT1;PLA2G4F;PLAAT3;PRDX6
prerank,metallopeptidase activity (GO:0008237),0.43898192699032784,1.314571666472179,0.06512605042016807,0.6384452811854731,1.0,30/113,21.57%,ANPEP;MMP12;ADAM33;ADAMTS8;MMP27;ADAM9;NLN;MMP14;ADAM8;PITRM1;PRPF8;COPS5;ADAM18;ADAM17;PSMD14;METAP1D;OMA1;ADAM19;BRCC3;LNPEP;PMPCB;ADAMTSL4;ACE;EIF3H;LAP3;AFG3L2;ADAMTS10;ADAM10;MMP19;ADAMTS2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.6134489371290215,1.3143146233765235,0.15315315315315314,0.6330476361130586,1.0,7/12,15.76%,GAB2;TRAT1;STAP1;BLNK;SH2B2;SHC1;FRS2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.33724799714914205,-1.3111933611323219,0.07692307692307693,0.39504331009377086,1.0,13/60,9.09%,ERBB4;EPHA5;CSF1R;NTRK3;EPHA6;RYK;EPHA3;FGFR2;NTRK2;FLT3;EGFR;IGF1R;EPHA7
prerank,platelet-derived growth factor binding (GO:0048407),0.6177618202007384,1.3110697497658492,0.1555891238670695,0.6383397279718398,1.0,4/11,12.97%,PDGFA;COL1A1;COL4A1;COL3A1
prerank,GDP binding (GO:0019003),0.4572796873203441,1.307263507835385,0.10985277463193659,0.6464724604628072,1.0,20/63,16.85%,RASEF;RAP2A;RAB8B;RAB7A;RAB21;NRAS;RAB31;RAB28;ARL8B;RAB12;RAP2B;RAB10;RAB18;RAB11B;RIT1;ARL3;RRAS;RAB2A;RAB29;RAB22A
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.4659019036632604,-1.306771963492744,0.16842105263157894,0.3968829000991871,1.0,6/15,6.20%,HS6ST3;NDST3;HS3ST4;HS6ST2;HS3ST3B1;HS3ST5
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6019181857969174,1.303628086547965,0.1661676646706587,0.6536452737108635,1.0,6/12,12.73%,GALNS;GNS;ARSA;SULF2;SULF1;SGSH
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4796712435310162,1.3033304794908747,0.13151658767772512,0.6486138825747717,1.0,22/44,26.71%,SMYD3;CXXC1;SMYD5;EED;NSD3;DOT1L;N6AMT1;SETD7;KMT2E;KMT5B;SUV39H2;SMYD2;KMT2A;PRDM16;ASH1L;EHMT2;SETD3;SETD5;MEN1;KMT2D;SETD1B;KMT2C
prerank,5'-3' RNA polymerase activity (GO:0034062),0.5146647204440936,1.3029345461915491,0.1363040629095675,0.6438790967780378,1.0,8/27,14.11%,POLR2A;POLR2L;TENT2;POLR1A;POLR2G;POLR2I;POLRMT;POLR1D
prerank,GTPase binding (GO:0051020),0.4154211181312365,1.3025513649895673,0.028282828282828285,0.6391601612385079,1.0,53/194,18.80%,IQGAP2;IQGAP1;MYO5A;DMXL2;ABCA1;OPTN;FGD6;RIC1;LCP1;RANGRF;MYO9B;RAF1;SORL1;GCC1;SIKE1;SPHK2;TRIOBP;RAB3GAP2;AMBRA1;KIF3A;MICALL1;HPS6;AKAP13;PICALM;LAMTOR1;RIN3;PAK2;ARHGEF2;STRN3;LZTR1;TRIP11;EPRS1;AP1G1;FGD5;OCRL;WHAMM;PARD6A;RABGEF1;FGD3;EXOC4;GOLGA4;MAPKAP1;BNIP3;RABGAP1;RANBP1;AIMP1;RAB29;GGA2;ERC1;MYCBP2;RANBP9;TNFAIP1;ANKRD27
prerank,CoA hydrolase activity (GO:0016289),0.5649201354948952,1.3016150130076376,0.16170212765957448,0.6363910369740565,1.0,9/16,23.87%,BAAT;ABCD1;ACOT9;ACAA2;NUDT7;ACOT2;ACOT6;ACOT13;ACOT8
prerank,phosphatidate phosphatase activity (GO:0008195),0.5966893180483613,1.3004677494346761,0.16231884057971013,0.6345196161787926,1.0,3/13,8.17%,PLPP3;LPIN3;PLPP5
prerank,chloride channel activity (GO:0005254),-0.3446354778962792,-1.2997495103921164,0.07086614173228346,0.40329058286584224,1.0,17/59,14.95%,GABRB3;ANO4;GLRB;ANO3;GLRA3;GABRA2;GABRB1;TTYH1;GABRA3;CLCC1;GLRA1;GABRG3;CLCN3;CLCN6;GABRA4;CLCN2;SLC1A4
prerank,filamin binding (GO:0031005),0.6121763589683907,1.2977407989185368,0.19242424242424241,0.6383975795854819,1.0,2/11,1.74%,FBLIM1;MICALL2
prerank,leucine zipper domain binding (GO:0043522),0.6127399327044499,1.296766854038311,0.1752738654147105,0.6362266554177157,1.0,5/10,20.70%,MRTFA;ATF4;DDIT3;ERC1;PAWR
prerank,protein phosphorylated amino acid binding (GO:0045309),0.47781858974920566,1.2958702264792674,0.1366906474820144,0.6338081935069668,1.0,11/42,14.50%,SYK;GRB2;NCK2;FBXW7;ABL2;SH3BP2;STAP1;VAV1;PFN1;FGR;SHC1
prerank,nuclear receptor binding (GO:0016922),0.42595182711795254,1.2934361524106084,0.09978991596638656,0.6364286182630016,1.0,36/111,19.08%,TRIP12;CTNNB1;KDM4C;RXRA;MED12;NCOR1;GTF2B;TAF7;STAT5B;NR1H4;DCAF13;DDX5;KDM3A;JMJD1C;LCOR;FOXP1;NCOA3;STRN;NCOA1;ESR1;MED16;SIRT1;PRPF6;BCAS3;PRKCB;GAS2L1;BUD31;DCAF1;LATS1;ASXL1;PPARGC1B;THRAP3;CRY1;ZBTB7A;NCOA6;NCOA2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.5667324579811746,1.29335999144453,0.17945007235890015,0.6310760503834589,1.0,2/15,5.68%,PIK3R5;SOCS6
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.44561353087673317,1.293285399860356,0.11383928571428571,0.6258588184348248,1.0,16/74,9.21%,HK3;PAPSS2;FCSK;FAM20C;SHPK;DGKZ;NMRK1;COASY;DGKA;SPHK2;PIK3CA;PIK3C2G;IPPK;TKFC;PAPSS1;GALK2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4150256599345936,1.2930540775294312,0.050204918032786885,0.6211671280842027,1.0,28/173,11.10%,PPARG;TFEC;IRX3;TRPS1;ZNF3;MITF;CEBPB;ZEB2;FOXP3;ATF3;FOXO3;ZNF692;JUN;MZF1;BACH1;NR3C1;BHLHE40;TGIF1;ZBTB20;ETV6;ZNF177;SNAI2;ZNF148;FOXP1;DACH1;FOXK1;NFATC3;PPARD
prerank,metalloexopeptidase activity (GO:0008235),0.468736485618717,1.2924440194277913,0.125,0.6177183546307803,1.0,16/51,22.48%,ANPEP;CPQ;NPEPPS;CPXM1;MMP14;VASH2;LTA4H;METAP1D;CPM;LNPEP;ACE;RNPEPL1;LAP3;AGBL3;PEPD;XPNPEP3
prerank,5'-nucleotidase activity (GO:0008253),0.5855700329645109,1.2913028348032936,0.16172106824925817,0.6164937714489229,1.0,4/13,12.87%,NT5C2;NT5E;NT5DC1;NT5C3B
prerank,amino acid:sodium symporter activity (GO:0005283),-0.5251046432355685,-1.2875330269629512,0.20923076923076922,0.418689390826293,1.0,5/11,10.13%,SLC1A3;SLC6A15;SLC1A2;SLC6A1;SLC1A1
prerank,phospholipase activity (GO:0004620),0.4512616816882732,1.2847433208902819,0.109375,0.6333356128799146,1.0,15/67,14.93%,DDHD1;LIPG;MGLL;PLD3;PLA2G2D;PNPLA7;ABHD4;PLAAT1;PLCB4;PLA2G4F;PLBD2;PLAAT3;GPLD1;GDE1;PRDX6
prerank,transition metal ion binding (GO:0046914),0.4049842817386509,1.2804217428062714,0.013013013013013013,0.6427790598809668,1.0,112/397,21.33%,ANPEP;PPARG;MMP12;CBLB;ADAM33;SORD;GALNT3;LITAF;FTL;TIMP1;ARG1;AOC3;ZNF3;GYG1;NPEPPS;KDM4C;SLC11A2;DCT;RNF26;MGAT5;MSRB1;ABL2;EEA1;RXRA;FAM20C;P2RX4;ENPP1;B4GALT7;GTF2B;PIM1;ZMYND8;ADAM8;PITRM1;SIRT6;NQO2;ARG2;TET3;KDM3A;POLR2L;PIAS4;TES;TIMP2;RBAK;CALB1;PTGR2;CHD3;MEFV;HEPH;TET2;ARIH2;DOHH;LTA4H;ZFPL1;KDM2A;ADPRM;ARHGEF2;MT3;TAB2;EPRS1;HMGCL;LACTB2;TDP2;WRN;UBA5;ATAD3A;DYRK2;USP16;KDM1B;PRKN;SUV39H2;ZKSCAN5;KDM7A;PRDM2;TNKS;MNAT1;ATP7A;LNPEP;ALKBH8;SCD;RNF7;MYT1;MELTF;SIRT3;PGGT1B;PTPN1;CA2;ACE;RABIF;BAZ1B;TK1;FTH1;BIRC2;MYCBP2;PAM;ENPP5;GCH1;ALAD;KMT2A;SAP30L;PHF2;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;JMJD6;SEC24C;RPS27;SEC24B
prerank,amino acid binding (GO:0016597),-0.3678520206370196,-1.2788217602898746,0.10945273631840796,0.42839122528765056,1.0,15/31,27.15%,GRIN2B;GLRB;GRIN3A;GLRA3;AARS1;GRIN1;GLRA1;AGXT;GRM7;SHMT1;GLRA2;NOS1;AARS2;DDAH1;CAD
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.5188462258385861,1.2768267134666766,0.1607843137254902,0.6502916603509561,1.0,4/24,6.82%,OSBPL8;CERT1;LANCL2;SESTD1
prerank,zinc ion binding (GO:0008270),0.4055858295468107,1.275312901224658,0.024096385542168676,0.6503455705049451,1.0,85/293,21.33%,ANPEP;PPARG;MMP12;CBLB;ADAM33;SORD;LITAF;TIMP1;ZNF3;NPEPPS;KDM4C;RNF26;MSRB1;EEA1;RXRA;P2RX4;ENPP1;GTF2B;ZMYND8;ADAM8;PITRM1;SIRT6;NQO2;TET3;POLR2L;PIAS4;TES;TIMP2;RBAK;CALB1;PTGR2;CHD3;MEFV;TET2;ARIH2;LTA4H;ZFPL1;KDM2A;ARHGEF2;MT3;TAB2;EPRS1;LACTB2;UBA5;ATAD3A;USP16;KDM1B;PRKN;SUV39H2;ZKSCAN5;KDM7A;PRDM2;TNKS;MNAT1;LNPEP;ALKBH8;MYT1;SIRT3;PGGT1B;PTPN1;CA2;ACE;RABIF;BAZ1B;TK1;BIRC2;MYCBP2;PAM;ENPP5;GCH1;ALAD;KMT2A;SAP30L;PHF2;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;SEC24C;RPS27;SEC24B
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.2978007410543532,-1.2748502327740985,0.011494252873563218,0.42945352024992217,1.0,34/91,17.94%,FRMPD4;TWF2;KRIT1;PLEKHA5;PLCB1;MYO1B;SNAP91;ADAP2;MAPT;STXBP6;KCNH1;PARD3;KCNJ2;SYT7;SYTL2;MARK1;WIPI1;GSDME;WDR45B;AMER1;SNX21;ACTN2;SNX20;CGAS;SNX18;HIP1R;PLA2G4E;CLVS1;RPH3A;ANXA9;OSBPL2;GSN;TTPAL;SLC9A1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.4420745191333916,1.2744415330752803,0.1289237668161435,0.6480128058902355,1.0,14/69,12.97%,SOAT1;BAAT;ZDHHC14;ZDHHC16;GTF2B;CERS6;CREBBP;GLYAT;ZDHHC12;ZDHHC18;PLAAT1;PLAAT3;LPCAT3;NAA10
prerank,NF-kappaB binding (GO:0051059),0.5108759078020244,1.2725331698484568,0.167989417989418,0.6493615387327945,1.0,10/24,25.84%,ANXA4;FOXP3;GSK3B;RELA;PSMA6;FAF1;BCL10;SETD6;HDAC1;COMMD7
prerank,iron ion binding (GO:0005506),0.46088218223833877,1.271422815903323,0.13625866050808313,0.6476414429733998,1.0,16/48,17.17%,CDO1;FTL;KDM3A;ACP5;HEPH;TET2;EGLN3;DOHH;FTO;KDM7A;FECH;ALKBH8;SCD;MELTF;ALKBH1;FTH1
prerank,channel activity (GO:0015267),0.47281873330439395,1.271279171708872,0.13934426229508196,0.6428561788697827,1.0,5/41,14.42%,AQP1;MPV17;TMEM266;TRPV2;BAX
prerank,metalloendopeptidase activity (GO:0004222),0.4411562666548804,1.2703525939982738,0.13082039911308205,0.641030766332151,1.0,8/76,5.83%,MMP12;ADAM33;ADAMTS8;MMP27;ADAM9;NLN;MMP14;PITRM1
prerank,cytokine receptor binding (GO:0005126),0.4269513318728876,1.2683812371917667,0.10457516339869281,0.6429005222883517,1.0,6/83,2.98%,CD300LF;SDCBP;SYK;VEGFA;PIBF1;IL6
prerank,UDP-galactosyltransferase activity (GO:0035250),0.6160021025764053,1.2681248410961639,0.20186335403726707,0.6387529106253242,1.0,3/10,5.70%,B4GALT5;B4GALT7;B4GALT6
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5622484516631736,1.2671139725720595,0.19186046511627908,0.6373749170785489,1.0,2/14,1.89%,MINDY1;MINDY4
prerank,anion:anion antiporter activity (GO:0015301),0.5478055357565826,1.2642432167321485,0.20056899004267426,0.6421374416679106,1.0,2/17,5.29%,SLC26A11;SLC26A1
prerank,GTPase regulator activity (GO:0030695),0.4073069875019121,1.263515707661404,0.046511627906976744,0.6395915918568658,1.0,41/212,11.46%,ARHGAP24;HTR2B;IQGAP2;ARHGAP10;IQGAP1;ABR;ARHGAP19;ARHGAP15;VAV3;IPO5;GPS1;TBC1D22A;TBC1D25;GNAQ;TBC1D1;SOS1;TBC1D2;ARHGAP9;JUN;TBC1D12;ARHGAP31;MYO9B;RALGAPA2;ASAP1;ADAP1;TBC1D10A;RASA4;RAB3GAP2;FLCN;ARAP1;TBC1D2B;STXBP5;SIRPA;DLC1;ARHGAP18;EIF5;ARHGAP17;TBC1D22B;SEC23B;ELMOD3;TBC1D15
prerank,protein heterodimerization activity (GO:0046982),0.4102509474383612,1.2607984635603569,0.06945863125638406,0.6442877508358532,1.0,37/178,14.87%,EPAS1;SDCBP;AOC3;SLC51A;ADRA1A;ABCG1;IRAK2;ATF3;TFAP2B;EXT1;PDGFA;MICU2;MICU1;RALGAPA2;TAF7;GADD45A;HEXA;IRAK3;BHLHE40;CYBB;ATF4;CYBA;PAFAH1B2;SMC1A;VAPA;DDIT3;ITGB1;TPM4;PSMF1;ITGA3;UBA3;TENM1;GTF2A1;BAX;ADCY8;MCL1;SMC3
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.5610077591932321,1.2606176032548253,0.2177650429799427,0.6400815067139705,1.0,1/14,0.68%,AK8
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5092602887674673,1.2601148501839448,0.19146183699870634,0.6369812543017936,1.0,9/27,13.66%,AQP1;SLC11A2;ATP2B1;TMEM165;SLC12A3;MMGT1;MAGT1;SLC23A1;SLC11A1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5926824581311707,1.257844729688975,0.20245398773006135,0.6395138645765606,1.0,2/11,5.07%,AKR1A1;RDH12
prerank,peptidase inhibitor activity (GO:0030414),0.4849539595414655,1.2577890731508776,0.18125,0.6350657537185672,1.0,7/33,14.36%,TIMP1;ITIH2;RENBP;TIMP2;ITIH3;PSMF1;SLPI
prerank,double-stranded RNA binding (GO:0003725),0.42915919929409024,1.2553951199715665,0.13590033975084936,0.6378290266988453,1.0,17/70,15.88%,RFTN1;TLR8;TFRC;VIM;MBNL1;ACTN1;AGO2;HNRNPU;MSN;EIF4A1;AGO3;DROSHA;DUS2;SIDT2;MRPL44;ADARB1;HSPD1
prerank,DNA polymerase binding (GO:0070182),0.5273688111583098,1.2499382880282168,0.19827586206896552,0.6506679995491036,1.0,7/18,17.33%,ACD;LONP1;POLG2;RTEL1;NAT10;CDK2AP1;CDT1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5776260429030744,1.2487633958938842,0.21633888048411498,0.6499904565251341,1.0,4/12,14.00%,TENT4B;TENT5A;TENT2;TENT5D
prerank,hyaluronic acid binding (GO:0005540),0.6112121151817285,1.246950248571335,0.20884146341463414,0.6512176821699216,1.0,2/10,3.07%,CD44;STAB2
prerank,phosphotyrosine residue binding (GO:0001784),0.46525466164771145,1.245460389086806,0.17503059975520197,0.6514832954975083,1.0,10/37,14.50%,SYK;GRB2;NCK2;ABL2;SH3BP2;STAP1;VAV1;PFN1;FGR;SHC1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.5379904651233216,1.2443744788315256,0.22946175637393768,0.6505492564037444,1.0,3/16,4.72%,MTM1;MTMR3;PTEN
prerank,lysine-acetylated histone binding (GO:0070577),0.5182340208592893,1.2394225439586417,0.20026702269692923,0.6576393571706798,1.0,12/20,28.53%,ZMYND8;BRD2;BRD7;BRD3;PHIP;MLLT3;ATAD2B;KMT2A;TAF1;CARM1;BAZ2A;SMARCA4
prerank,acetylation-dependent protein binding (GO:0140033),0.5182340208592893,1.2394225439586417,0.20026702269692923,0.6576393571706798,1.0,12/20,28.53%,ZMYND8;BRD2;BRD7;BRD3;PHIP;MLLT3;ATAD2B;KMT2A;TAF1;CARM1;BAZ2A;SMARCA4
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5019816424265164,-1.2387366662672143,0.20298507462686566,0.4968288449804466,1.0,4/11,11.89%,ATP8A2;ATP8A1;ABCB4;ATP10B
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.5203350144570729,-1.2378181247262177,0.20943952802359883,0.49112307411312606,1.0,4/11,9.53%,RYR3;RYR2;TRPM2;MCOLN1
prerank,exopeptidase activity (GO:0008238),0.4441285076369812,1.2376278569968442,0.1699421965317919,0.6589518626176979,1.0,17/50,22.48%,ANPEP;NPEPPS;CTSA;CNDP2;CTSZ;CTSH;LTA4H;METAP1D;CPM;LNPEP;BLMH;ACE;PRCP;LAP3;DPEP2;DPP3;XPNPEP3
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4776163307263438,1.2364157066206232,0.21820448877805487,0.658375824519046,1.0,10/34,15.37%,SMYD3;NSD3;DOT1L;ETFBKMT;N6AMT1;CAMKMT;SETD7;KMT2E;KMT5B;SMYD2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4048653594682856,-1.2358768205358759,0.17490494296577946,0.4879593840607766,1.0,8/21,14.11%,PDE3B;PDE8B;PDE11A;PDE4B;PDE1C;PDE4A;PDE5A;PDE1A
prerank,GTPase activator activity (GO:0005096),0.391507248269205,1.2301162347120844,0.04417670682730924,0.6740244434887943,1.0,86/313,17.22%,ARHGAP24;HTR2B;IQGAP2;ARHGAP10;IQGAP1;DENND4C;ABR;ARHGAP19;DENND2D;ARHGAP15;FGD6;VAV3;CYTH1;FNIP1;TBC1D22A;RIC1;TBC1D25;DENND1A;GNAQ;SERGEF;TBC1D1;SOS1;TBC1D2;RANGRF;ARHGAP9;RGL1;JUN;TBC1D12;RGL2;ARHGAP31;MYO9B;RALGAPA2;DOCK5;ASAP1;ADAP1;TBC1D10A;RASA4;RAB3GAP2;FLCN;DOCK10;ARAP1;DNMBP;TBC1D2B;STXBP5;AKAP13;DENND1B;VAV1;DLC1;ARHGAP18;LAMTOR1;ARHGAP17;RCBTB2;RIN3;TBC1D22B;SEC23B;DENND2A;ARHGEF2;ELMOD3;TBC1D15;DOCK2;FGD5;ARFGEF2;DOCK1;RAPGEF1;RASGEF1A;LAMTOR3;NPRL3;RAP1GAP2;OCRL;RGS11;RASGEF1B;RABGEF1;NUCB1;FGD3;ARRB1;TBC1D9;RABGAP1;RANBP1;GAPVD1;NRP1;CCDC88C;ARHGAP25;NPRL2;RABIF;SH3BP5;RIC8B
prerank,phosphatidic acid binding (GO:0070300),0.5149662232485142,1.2273283460055238,0.20488466757123475,0.6794721194864015,1.0,10/19,24.59%,GRAMD1B;PLTP;SESTD1;MICALL1;PITPNC1;MAPKAP1;PITPNM1;PLEKHN1;GSDMD;ATP13A2
prerank,palmitoyltransferase activity (GO:0016409),0.4836372441689341,1.227256490769871,0.21583652618135377,0.6751172112231264,1.0,8/28,17.11%,ZDHHC14;ZDHHC19;ZDHHC16;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC17;ZDHHC4
prerank,thioesterase binding (GO:0031996),0.5753009358076012,1.2253160572048805,0.23708206686930092,0.6771006360286459,1.0,5/11,16.25%,TRAF1;TRAF3;TRAF5;TRAF2;HAUS7
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5038199422430342,-1.2251020315145578,0.2247191011235955,0.5034955615897868,1.0,7/11,25.35%,ITPR2;TRPC1;TRPC7;TRPC4;RPH3A;CYTH2;TRPC5
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.39168038585411974,1.224174262205443,0.07684529828109202,0.6763218625940535,1.0,80/232,24.75%,CBLB;NSMCE2;RNF149;TRIP12;ZNRF1;WWP1;RNF26;RNF19A;RNF130;TRIM17;BRAP;TRIM25;UHRF2;ZNRF3;CUL3;RNF10;RNF135;RNF128;NHLRC1;BFAR;PIAS4;SH3RF1;XIAP;NEDD4L;WWP2;RNF115;MEFV;TOPORS;HUWE1;TRIM7;ARIH2;RLIM;RNFT2;BIRC3;NHLRC3;STUB1;TRIM41;RNF34;FBXO6;PRKN;HECTD1;TRAF3IP2;VPS11;CBL;NEURL1B;RNF7;TMEM129;UBE2O;KCMF1;TRIM14;BIRC2;MYLIP;MYCBP2;AMFR;NFX1;RNF43;CBLL1;PIAS2;PELI2;DTX1;RNF19B;MKRN1;NEURL4;DTX2;PIAS1;NEURL2;UBR3;RNF125;IRF2BP1;SIAH2;RNF138;ARIH1;UBE2D3;EGR2;TRAF6;RNF150;RNF180;RNF2;PRPF19;RNF145
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5208206948731987,1.220089728681037,0.2184873949579832,0.684882852286629,1.0,9/17,23.87%,BAAT;ABCD1;PPT1;ACOT9;ACAA2;ACOT2;ACOT6;ACOT13;ACOT8
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.29902892205397974,-1.218955871881574,0.10091743119266056,0.5083491784895909,1.0,27/72,17.94%,FRMPD4;TWF2;KRIT1;PLCB1;MYO1B;SNAP91;ADAP2;STXBP6;PARD3;KCNJ2;SYT7;SYTL2;MARK1;GSDME;AMER1;SNX21;ACTN2;SNX20;CGAS;SNX18;HIP1R;PLA2G4E;RPH3A;ANXA9;OSBPL2;GSN;SLC9A1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.48364823300483334,-1.2165337778299177,0.22070844686648503,0.5061366933991448,1.0,7/11,51.65%,CHRNA7;CHRNB2;CHRNA5;CHRNA3;CHRNA9;CHRNB4;CHRNA4
prerank,clathrin adaptor activity (GO:0035615),0.5503348141364839,1.216427573139701,0.23120567375886525,0.6925881115119547,1.0,11/15,27.02%,AP1G2;AP1G1;AP2B1;STON1;AP1M1;LDLRAP1;STON2;HIP1;AP2S1;AP2A2;AP2A1
prerank,proton transmembrane transporter activity (GO:0015078),0.4524410425205904,1.2129262024252354,0.193390452876377,0.6998178063889227,1.0,11/39,17.01%,SLC11A2;UQCRFS1;ATP6V1B2;COX6A1;CYB5A;COX8A;MFSD3;NNT;ATP6V1F;COX15;CLCN4
prerank,carbohydrate:cation symporter activity (GO:0005402),0.5728723030812816,1.209161596465457,0.24036979969183359,0.708094690847029,1.0,3/11,12.74%,SLC17A5;SLC23A2;SLC23A1
prerank,transcription cis-regulatory region binding (GO:0000976),0.37934762862403354,1.2091160657856095,0.044,0.70375164109638,1.0,69/406,14.68%,EPAS1;PPARG;MMP12;TFEB;TRPS1;NFE2L2;ZNF3;CEBPB;TIPARP;GRHL1;ATF3;VEZF1;ARID4A;NR1H3;E2F3;FOXO3;TFAP2B;RUNX3;RXRA;JUN;NCOR1;RARA;MZF1;E2F1;LONP1;TAF7;RNF10;AGO2;NR3C1;NR1H4;ATF4;ZBTB20;ETV6;ZNF177;RREB1;SOX9;BRCA1;SNAI2;RB1;RBAK;FOXP1;GABPB1;GABPB2;IRF2;CHD3;BRD7;TBL1XR1;DACH1;ARID5B;NR5A1;DDIT3;XRCC5;PAX8;PSPC1;FOXK1;SALL2;CUX1;SP3;RORA;POLRMT;RFX5;SOX2;RELA;BBX;SUV39H2;ATF1;PRDM2;ZNF513;PER3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.4290841693308474,-1.2074003552161265,0.23972602739726026,0.5180458724045092,1.0,2/15,1.66%,CX3CR1;CCR5
prerank,ubiquitin protein ligase activity (GO:0061630),0.38610395535803455,1.2053576361225615,0.08493427704752275,0.7115544574397262,1.0,78/228,24.75%,CBLB;RNF149;TRIP12;ZNRF1;WWP1;RNF26;RNF19A;RNF130;TRIM17;BRAP;TRIM25;UHRF2;ZNRF3;CUL3;RNF10;UBE2K;RNF135;RNF128;NHLRC1;BFAR;SH3RF1;XIAP;NEDD4L;WWP2;RNF115;MEFV;TOPORS;HUWE1;TRIM7;ARIH2;RLIM;RNFT2;BIRC3;NHLRC3;STUB1;TRIM41;RNF34;FBXO6;PRKN;HECTD1;TRAF3IP2;VPS11;CBL;NEURL1B;RNF7;TMEM129;UBE2O;KCMF1;TRIM14;BIRC2;MYLIP;MYCBP2;AMFR;NFX1;RNF43;CBLL1;PELI2;DTX1;RNF19B;MKRN1;NEURL4;DTX2;NEURL2;UBR3;RNF125;IRF2BP1;UBE4A;SIAH2;RNF138;ARIH1;UBE2D3;UBE4B;TRAF6;RNF150;RNF180;RNF2;PRPF19;RNF145
prerank,RNA methyltransferase activity (GO:0008173),0.516283415856512,1.205099210551818,0.22777777777777777,0.7079226337938974,1.0,11/19,26.81%,TRMT12;LCMT2;TRDMT1;MEPCE;MRM2;FBL;TRMT13;METTL8;TGS1;FTSJ1;METTL4
prerank,cation channel activity (GO:0005261),-0.2903784230969806,-1.2017749418247505,0.13043478260869565,0.5222616097075875,1.0,27/94,16.10%,SLC24A3;TRPM3;CACNB2;HCN1;CACNA1E;SLC24A2;ORAI1;TRPC1;UNC80;TMEM63B;RYR2;GRIN1;TRPM4;NALCN;TRPM2;MCOLN1;SLC24A4;CUL5;PKD2;HVCN1;PKD1;PKD2L1;TRPM6;PKD2L2;KCNK9;ANXA9;CALHM2
prerank,solute:proton symporter activity (GO:0015295),0.5216732896292198,1.2012707156143845,0.24823695345557123,0.7160208915340702,1.0,4/16,11.23%,SLC36A2;SLC11A2;SLC17A5;MFSD3
prerank,ribonuclease activity (GO:0004540),0.4215656311462446,1.2010516054670333,0.2063854047890536,0.712189167514766,1.0,18/56,16.75%,ERN1;RNASE3;AGO2;RNASEL;EXOSC3;EXOSC9;NOB1;CNOT7;AGO3;EXOSC8;SND1;LACTB2;N4BP1;RNASEH2A;RNASEH1;CNOT6;EXOSC10;EXOSC1
prerank,store-operated calcium channel activity (GO:0015279),-0.5030404074994467,-1.1974121196429202,0.2514124293785311,0.5240637192699501,1.0,7/10,25.35%,ORAI1;TRPC1;TRPC7;TRPC4;ORAI2;ORAI3;TRPC5
prerank,nucleotidase activity (GO:0008252),0.5310361747374956,1.1955086251486737,0.2616279069767442,0.7258173595272263,1.0,5/15,17.09%,NT5C2;NT5E;NT5DC1;NT5C3B;BPNT2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.5663144385398966,1.1937127581771052,0.2662440570522979,0.7273079534031457,1.0,6/11,23.03%,SAMD8;SGMS2;PTDSS1;SGMS1;DPAGT1;AASDHPPT
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.38369411365386075,1.193080505309189,0.14566115702479338,0.7249942971918484,1.0,31/181,13.49%,PPARG;MDFIC;ANXA4;NFE2L2;CTNNB1;FOXP3;ID2;RXRA;JUN;NCOR1;TCERG1;NR1H4;CREBBP;BHLHE40;ATF4;PIAS4;RB1;WWP2;NCOA3;HIPK2;NCOA1;GSK3B;SIRT1;RERE;PPARD;BCAS3;TBX6;HCLS1;BUD31;RELA;CTDP1
prerank,voltage-gated anion channel activity (GO:0008308),0.5308364367121519,1.1925044328092287,0.27046783625730997,0.722443676409424,1.0,6/15,17.01%,ANO6;VDAC2;VDAC1;GPR89A;GPR89B;CLCN4
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.5465943337598478,1.191984418209189,0.2632331902718169,0.7197306168680553,1.0,10/13,32.67%,TRMT1L;TRMT10C;TARBP1;TRMT10A;FTSJ1;THUMPD3;METTL1;TRMT1;WDR4;TRMT5
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5065277429073562,-1.1910180500809904,0.24404761904761904,0.5296140282450068,1.0,8/10,49.37%,SLC6A1;SLC10A1;SLC10A6;SLC6A11;SLC10A3;SLC6A12;SLC6A13;SLC10A2
prerank,actin binding (GO:0003779),0.384415447769317,1.1901965087849895,0.14784394250513347,0.7210764914965405,1.0,35/170,14.81%,IQGAP2;MTSS1;CXCR4;LIMA1;MRTFA;SYNPO2L;GAS2L3;SPEF1;LCP1;MSRB1;ABL2;MYO9B;MYL2;DAG1;PARVB;MYO19;PDLIM5;HNRNPU;MEFV;VASH2;CAPZB;MYO1F;ITGB1;COTL1;RUSC1;PFN1;MYH9;MICAL2;MACF1;CAP1;SYNPO;PRKN;PHACTR4;ADCY8;PFN2
prerank,chloride channel regulator activity (GO:0017081),0.5386518395704176,1.1900366676770806,0.27412587412587414,0.717316490546176,1.0,3/14,5.61%,SGK1;STX8;VTI1B
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4300570210207876,1.1893359185117467,0.22195985832349469,0.7155788833651843,1.0,8/49,9.97%,ANXA4;CPNE2;ANXA1;ESYT1;ANXA5;ANXA2;PLA2G4F;SYT17
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.4812668463776058,-1.186487069556664,0.2849002849002849,0.5319896544601228,1.0,4/10,14.15%,PML;ANKRD13B;IDE;ANKRD13A
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.37857055959966956,1.1841199306739536,0.16938775510204082,0.7281514136080766,1.0,29/188,10.34%,PPARG;TFEB;NFE2L2;CEBPB;GRHL1;ATF3;ARID4A;NR1H3;FOXO3;RXRA;JUN;NCOR1;MZF1;TAF7;RNF10;ATF4;ZBTB20;BRCA1;GABPB1;GABPB2;CHD3;BRD7;TBL1XR1;ARID5B;DDIT3;XRCC5;PAX8;PSPC1;FOXK1
prerank,fatty acid synthase activity (GO:0004312),-0.4723116641426947,-1.1836609430841492,0.2818991097922849,0.5310167746543349,1.0,5/10,15.80%,ELOVL7;ELOVL4;ELOVL6;OXSM;MCAT
prerank,copper ion binding (GO:0005507),0.4419171212954247,1.182925204141686,0.23649459783913565,0.7278595695684817,1.0,10/42,18.11%,AOC3;DCT;P2RX4;HEPH;SNCG;MT3;ATP7A;SUMF1;RNF7;PAM
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.48543579753054067,-1.1816426708478722,0.25977653631284914,0.5282926672242162,1.0,8/10,32.56%,IGSF11;SHISA6;SHISA7;SHANK2;NSF;GNAS;SHANK1;SHANK3
prerank,I-SMAD binding (GO:0070411),-0.4467176197377525,-1.1807934628269734,0.25609756097560976,0.5233729169096669,1.0,6/13,12.47%,SMAD3;SMURF1;TGFBR1;SMAD1;SMAD7;SMAD2
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.44161651136363234,-1.1784030203530216,0.25,0.5219987902832627,1.0,5/13,12.71%,ARHGDIA;ITGB1BP1;GDI2;GPSM2;GDI1
prerank,ATP binding (GO:0005524),0.37348347476551325,1.178156295008258,0.11670020120724346,0.7387004652292674,1.0,63/266,18.32%,ABCA1;MAP3K20;TLK1;ERN1;ERCC6;PDK4;ABCG1;PRKAG2;MTHFS;LANCL2;PYGL;ABCD1;RUNX3;SIK3;P2RX4;SRPK2;DAPK1;ENPP1;MYO9B;LONP1;PIM1;SIK1;OLA1;IRAK3;STK3;HSPA1B;HNRNPU;P2RX3;NLRC4;TOP1;ABCA2;MAP4K3;ACVRL1;RTEL1;MYO1F;VPS4A;ATP5F1A;ATP5F1D;PI4K2A;ACVR1B;SARS2;STK38;MYH9;MTHFD1L;BTK;SYN1;DYRK2;HSPA1A;UHMK1;LATS1;MTREX;ATP7A;HSPA13;PMVK;EIF4A3;CARS2;HSPA4;SRPK1;RRM1;PFKP;EIF2B2;HSPA4L;STK4
prerank,receptor antagonist activity (GO:0048019),-0.40641308623447675,-1.1772555766799289,0.24110671936758893,0.5176283758609502,1.0,8/17,43.53%,CCL5;DKK2;ESR2;DKK3;FST;IGSF1;WFIKKN1;AGTR2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.4756377354581013,1.1769962505807658,0.27212681638044917,0.7381825151705143,1.0,7/24,17.11%,ZDHHC14;ZDHHC19;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC17;ZDHHC4
prerank,cAMP binding (GO:0030552),-0.47978541932862206,-1.175882551796087,0.30177514792899407,0.5142292773300703,1.0,5/11,14.84%,HCN1;RAPGEF4;PDE4B;PDE4A;RAPGEF2
prerank,ATP hydrolysis activity (GO:0140603),0.43509676355811316,1.1737792244405616,0.24484848484848484,0.7445059202452704,1.0,15/41,22.16%,KIF20B;MYO1E;ATP2B1;ABCD1;MYO19;HSPA1B;ABCA3;CHD3;HSPA1A;ABCG4;VWA8;TOR1A;CLPX;VCP;RUVBL2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.456943571438597,1.1713529550306176,0.2696629213483146,0.7480529576096199,1.0,9/30,19.26%,SLC11A2;TMEM165;SLC39A14;SLC11A1;SLC39A12;ATP7A;SLC39A3;SLC39A11;SLC30A1
prerank,neuropeptide receptor binding (GO:0071855),-0.43799882653995875,-1.1698926412574833,0.2435064935064935,0.5195339644375366,1.0,7/14,38.88%,PPY;NMU;AGRP;SHANK1;NPY;APLN;GAL
prerank,cell-cell adhesion mediator activity (GO:0098632),0.42896385288286354,1.1692574110809408,0.26322115384615385,0.7506708037498758,1.0,9/42,10.39%,TRIM29;PALLD;ANXA1;BAIAP2;ANXA2;PDLIM5;SIRPA;DSCAM;RAB10
prerank,1-phosphatidylinositol binding (GO:0005545),0.5227476531763168,1.1674907158798042,0.28983516483516486,0.7522105128801619,1.0,6/15,13.34%,SNX10;EEA1;SNX9;SESTD1;PICALM;WDFY3
prerank,cysteine-type peptidase activity (GO:0008234),0.4106327000119158,1.1673616807821927,0.24392935982339956,0.7484267888751354,1.0,32/73,25.10%,CTSB;TINAGL1;CTSL;CAPN2;USP42;CTSS;CTSZ;USP12;CTSH;USP40;USP26;USP48;CTSW;ATG4B;USP21;USP16;USP36;CASP6;USP8;BLMH;CASP2;CASP3;USP30;LGMN;USP9X;USP2;MALT1;USP47;CASP8;USP46;CTSK;CTSO
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.429863778307644,1.1667340005889693,0.2384887839433294,0.7464441710597833,1.0,14/48,14.16%,ATP1B4;CALHM5;AQP1;CALHM6;RHD;TMEM165;GRIN3B;ATP6V1B2;MMGT1;TRPV2;PIEZO1;PIEZO2;TRPM7;SLC12A7
prerank,nuclear import signal receptor activity (GO:0061608),0.5195694850957043,1.1651428344416463,0.3121301775147929,0.7469074321497496,1.0,5/15,16.85%,IPO5;KPNA4;KPNA2;TNPO1;KPNA3
prerank,FMN binding (GO:0010181),0.5623627195034354,1.1634761379120075,0.296583850931677,0.7482460090204291,1.0,3/11,17.70%,POR;DUS2;MTRR
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4394055387104366,1.1617262302465796,0.2884371029224905,0.7497834365318878,1.0,9/35,14.20%,MMP12;GTF2B;AGO2;NR3C1;FOXP1;TAF1B;RELA;POU2F1;GTF2A1
prerank,lipid phosphatase activity (GO:0042577),0.5146902285274592,1.1610476768431208,0.30725462304409673,0.7478526707459451,1.0,2/14,7.12%,PLPP3;PLPP6
prerank,retinoic acid receptor binding (GO:0042974),0.4982863103583048,1.1608064466421464,0.2843273231622746,0.744643771883037,1.0,1/17,0.13%,PPARG
prerank,nuclear localization sequence binding (GO:0008139),0.4987141727613733,1.1606978345406984,0.30286493860845837,0.7409810879748934,1.0,4/18,4.69%,IPO5;KPNA4;KPNA2;BRAP
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.45404482642035715,1.1605297935749168,0.2910737386804657,0.7374936166933753,1.0,7/27,14.11%,POLR2A;POLR2L;POLR1A;POLR2G;POLR2I;POLRMT;POLR1D
prerank,LRR domain binding (GO:0030275),0.5162014082045704,1.1569401384187175,0.2964071856287425,0.7448516502324348,1.0,4/14,9.53%,MRTFA;LRRFIP2;ATF4;DDIT3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5701540927702473,1.1543539569371641,0.314785373608903,0.7491336112324299,1.0,1/10,0.51%,APOBEC1
prerank,peptidoglycan binding (GO:0042834),-0.476668012415314,-1.1543159327678956,0.2909604519774011,0.5464390042741294,1.0,6/10,34.37%,NLRP3;RNASE7;TLR2;NOD1;PGLYRP1;JCHAIN
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.37853505638148555,1.1539946046028464,0.2182952182952183,0.7461622056544928,1.0,46/147,18.13%,DENND4C;ABR;DENND2D;FGD6;VAV3;CYTH1;FNIP1;RIC1;DENND1A;SERGEF;SOS1;RANGRF;RGL1;RGL2;DOCK5;RAB3GAP2;DOCK10;DNMBP;AKAP13;DENND1B;VAV1;LAMTOR1;RCBTB2;RIN3;DENND2A;ARHGEF2;DOCK2;FGD5;ARFGEF2;DOCK1;RAPGEF1;RASGEF1A;LAMTOR3;RASGEF1B;RABGEF1;NUCB1;FGD3;GAPVD1;CCDC88C;RABIF;SH3BP5;RIC8B;ARHGEF10;EIF2B2;MYCBP2;ITSN1
prerank,protein homodimerization activity (GO:0042803),0.3607498900943274,1.1500883552906094,0.079,0.7547494997666643,1.0,110/589,14.85%,PSAP;GDF15;IDH1;XDH;APOE;PHETA2;SLC51A;LILRB1;CPQ;ERN1;ATG7;VEGFA;MGLL;GYG1;TXN;ABCB7;CEBPB;ABCG1;GRHL1;KIF20B;FOXP3;TBC1D22A;TPI1;GSTM1;IRAK2;ATF3;TFRC;KYNU;TPD52;GLA;TMEM266;ABCD1;EEA1;TFAP2B;EXT1;PDGFA;PGRMC1;SNX9;SLC8B1;RIPK1;ENPP1;MYO9B;APPL2;SH3GLB1;MZF1;PEX11A;PON3;ACTN1;MVD;GADD45A;GALE;NQO2;PEX7;IRAK3;BHLHE40;HMOX1;SCARB2;RABEP1;NLRC4;CAT;RBPMS;SMIM1;PDCD6IP;GRHPR;PAFAH1B2;TYROBP;HPGDS;PAPSS1;LHPP;S100A16;TERF1;TPR;DDIT3;IL6R;DNTTIP1;MTCL1;TMEM192;POU3F3;RBPMS2;TPM4;PSMF1;HM13;CCDC66;STUB1;DROSHA;BST2;ALDH3A2;EPRS1;S100A1;DCLRE1B;SARS1;APPL1;MYH9;MTHFD1L;S100A6;WRN;UBA5;RELA;SSBP1;TARS2;SLC11A1;TENM1;INPP5F;GDNF;BAX;ADCY8;LRP6;FECH;MCL1;SNF8
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.4592675713039638,1.1492280826344472,0.2795838751625488,0.7536112808687806,1.0,10/25,18.05%,TIPARP;PARP4;PARP2;SIRT6;PARP3;ZC3HAV1;SIRT1;TNKS;SIRT3;TNKS2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.44994200308026955,1.1478962632792624,0.2846054333764554,0.7540335641119075,1.0,13/32,20.10%,KDM4C;TMLHE;TET3;HSPBAP1;TET2;EGLN3;KDM2A;FTO;KDM7A;RIOX2;ALKBH1;ALKBH5;JMJD4
prerank,WW domain binding (GO:0050699),0.4502303390001893,1.1445350201571867,0.2897800776196636,0.7607901727472342,1.0,6/26,14.23%,LITAF;KIF20B;PRRG4;TCEAL6;WBP11;DAZAP2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.528420162391219,1.1442912178499582,0.31825037707390647,0.757569800188079,1.0,3/13,15.54%,DCT;IDI1;EHHADH
prerank,ATPase regulator activity (GO:0060590),0.42869351038810577,1.1423468360604496,0.28162291169451076,0.7596993961138259,1.0,7/38,12.08%,FNIP2;FNIP1;DNAJB6;MYBPC3;SIL1;BAG4;PFN1
prerank,gamma-tubulin binding (GO:0043015),-0.3909485580806442,-1.1417205560410317,0.25,0.5669614152520741,1.0,8/21,19.74%,TUBGCP5;PAK1;MARK4;RAB11FIP5;RACGAP1;GIT1;BRSK1;TUBGCP6
prerank,magnesium ion binding (GO:0000287),0.3716634966578676,1.1410166752133348,0.24539877300613497,0.7599580582870825,1.0,22/135,13.27%,IDH1;MAP3K20;CERK;ERN1;RAP2A;ABL2;SIK3;SRPK2;SIK1;IRAK3;STK3;NLRC4;ENDOV;HPGDS;PGM1;PI4K2A;STK38;HMGCL;PGP;TDP2;WRN;DYRK2
prerank,protein phosphatase regulator activity (GO:0019888),0.40994415254596256,1.13585084836633,0.2862108922363847,0.7720717848993249,1.0,17/53,22.46%,LGALS3;MGAT5;PPP4R1;ENSA;PPP4R2;PPP1R9B;STYXL1;BOD1;PPP2R2A;PHACTR4;PPP2R2B;PPP2R5C;CALM2;CABIN1;PPP2R1A;PPP6R1;PPP1R15B
prerank,single-stranded RNA binding (GO:0003727),0.41270441035405686,1.1357306481166143,0.31212484993997597,0.7686337442198002,1.0,11/43,18.38%,TLR8;LONP1;AGO2;HNRNPU;ENDOV;POLR2G;AGO3;LACTB2;EXOSC10;RBM7;AGO4
prerank,frizzled binding (GO:0005109),0.435970428212474,1.1338393753678844,0.32112332112332115,0.7707039997753861,1.0,7/34,19.02%,SDCBP;ZNRF3;DVL1;FZD7;LRP6;CCDC88C;RNF43
prerank,phosphatidylinositol kinase activity (GO:0052742),0.5039510087414357,1.1336330843362472,0.3047337278106509,0.7674820842949107,1.0,4/15,11.88%,PIKFYVE;PIK3CA;PIK3C2G;PI4K2A
prerank,mannosyltransferase activity (GO:0000030),-0.3822314021861042,-1.133576189399389,0.2644927536231884,0.5778355743316405,1.0,10/21,23.96%,DPY19L1;TMTC2;PIGZ;DPY19L4;DPY19L3;DPM1;TMTC1;POMT1;POMT2;ALG8
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5025925540078917,1.1327387977314407,0.3194444444444444,0.7663129753878488,1.0,5/15,7.20%,P2RY14;P2RX4;GPR171;PTAFR;P2RX3
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.5243051845655066,1.1323471215959544,0.3318903318903319,0.7638325839142884,1.0,5/12,16.80%,TOE1;CNOT6L;CNOT7;CNOT6;PAN3
prerank,mRNA 3'-UTR binding (GO:0003730),0.38272457045709624,1.130684086954256,0.29577464788732394,0.7650719589971633,1.0,15/79,11.99%,RBMS1;CPEB4;CPSF1;UTP23;CELF1;IGF2BP3;DDX5;HNRNPU;ZFP36L2;LARP4B;HNRNPA0;EXOSC9;SERBP1;PUM2;EXOSC8
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3983375904026474,1.1285314672173086,0.3064699205448354,0.7679710776573474,1.0,17/60,19.70%,MTMR3;PPM1H;PPEF1;PTEN;PPEF2;PDP1;RPAP2;PPP3CA;PPP3R1;ILKAP;CTDP1;PPP6C;PPP1CA;SSU72;CTDSPL2;PPP2CA;CDC14B
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4847153412731852,1.1280556237177406,0.3267605633802817,0.7657511561147434,1.0,6/18,17.90%,TNFAIP8;XIAP;BIRC3;MT3;GAS6;BIRC2
prerank,endoribonuclease activity (GO:0004521),0.4377941005225407,1.1279033952892017,0.3235668789808917,0.7624584462953375,1.0,8/32,12.39%,ERN1;AGO2;RNASEL;ENDOV;NOB1;AGO3;SND1;LACTB2
prerank,androgen receptor binding (GO:0050681),0.4522053291803436,1.1271524078128017,0.31333333333333335,0.7610564530277879,1.0,6/25,11.91%,KDM4C;DDX5;KDM3A;FOXP1;PRPF6;PRKCB
prerank,pre-mRNA binding (GO:0036002),0.43937188401090416,1.1247500987772714,0.3193384223918575,0.7647927197301665,1.0,10/28,17.72%,CELF1;RNPC3;RBM41;DDX5;HNRNPU;PRPF8;ERI1;ZRSR2;RBM7;RBM22
prerank,ubiquitin protein ligase binding (GO:0031625),0.3586663817151222,1.1228102164365328,0.2209889001009082,0.7671356432887371,1.0,84/254,23.92%,CXCR4;GGN;POLR2A;TPI1;IKBKE;FBXW7;CDKN1A;PSMD1;TANK;WASHC1;SNX9;JUN;RIPK1;TNFRSF1B;UBE2L3;CUL3;NPLOC4;UBE2K;TRIOBP;APC;SUMO2;HSPA1B;DET1;AMBRA1;RPS27A;UBC;MFHAS1;RPL23;PIAS4;BRCA1;RB1;XRCC5;FAF2;GSK3B;FOXO1;BAG4;ASB4;HM13;STUB1;TRAF1;FZD5;ACVR1B;CUL4A;RNF34;TRAF3;ATP6V0C;RELA;PRKN;HSPA1A;SQSTM1;CUL1;PRDX6;ARRB1;TRAF5;RTN4;HSPD1;TRAF2;LTBR;TNFRSF14;PSMA3;CCT2;BAG1;FBXO7;DNAJA1;ATXN3;WFS1;DTX1;ACTG1;SPOP;CUL4B;JKAMP;USP2;HSPBP1;VCP;FAF1;MFN2;SLF1;HSPA9;ARIH1;BCL10;EGR2;ISG15;PA2G4;TRAF6
prerank,histone methyltransferase activity (GO:0042054),0.4303697675011434,1.1215192028202052,0.31069182389937106,0.7675544990254087,1.0,9/32,15.37%,SMYD3;EED;NSD3;DOT1L;N6AMT1;SETD7;KMT2E;KMT5B;SMYD2
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3545393726461636,1.1194435788227206,0.17185929648241205,0.7701890956692031,1.0,119/346,24.75%,CBLB;RNF149;TRIP12;ZNRF1;WWP1;RNF26;BIRC6;UBE2Q2;RNF19A;RNF130;TRIM17;BRAP;TRIM25;UHRF2;UBE2L3;TSPAN17;ZNRF3;CUL3;RNF10;UBE2K;FBXL3;RNF135;RNF128;CNOT4;NHLRC1;BFAR;SH3RF1;XIAP;BRCA1;NEDD4L;KLHL20;WWP2;FBXO11;RNF115;RNF146;MEFV;TOPORS;HUWE1;TRIM7;RSPRY1;ARIH2;RLIM;RNFT2;MIB2;FBXO9;BIRC3;NHLRC3;ASB4;STUB1;TRAF1;TRIM41;CUL4A;RNF34;CHFR;FBXO6;FBXW2;TRAF3;TNFAIP3;PRKN;RNF123;HECTD1;TRAF3IP2;VPS11;CUL1;TRAF5;CBL;NEURL1B;CDC34;RNF7;TRAF2;TMEM129;UBE2O;UBE2M;KCMF1;TRIM14;BIRC2;MYLIP;MYCBP2;AMFR;TNFAIP1;NFX1;RNF43;UBE2S;FBXO7;CBLL1;PELI2;UBE2R2;DTX1;RNF19B;CUL4B;MKRN1;NEURL4;DTX2;TAF1;NEURL2;UBE2H;UBR3;KCTD10;RNF141;RNF125;IRF2BP1;MALT1;RNF168;OBI1;SIAH2;RNF138;ARIH1;UBE2D3;MIB1;TRAF6;FBXO4;RNF150;RNF180;RNF2;TTC3;UBE2J2;PRPF19;UBE2E1;RNF145
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3512107770303858,1.1190581354943265,0.165,0.7677615853365082,1.0,110/431,20.47%,ABCA1;MAP3K20;TLK1;RASEF;ERN1;RAP2A;ERCC6;PDK4;ABCG1;TGM2;PRKAG2;RAB7A;MTHFS;LANCL2;PYGL;ABCD1;RUNX3;RHOJ;SIK3;P2RX4;SRPK2;DAPK1;ENPP1;MYO9B;LONP1;PIM1;EEF1A1;RAB21;NRAS;SIK1;OLA1;IRAK3;STK3;HSPA1B;HNRNPU;GBP6;P2RX3;MFHAS1;NLRC4;RAB31;TOP1;RAB1B;ABCA2;MAP4K3;RAB28;ACVRL1;RTEL1;RRAD;MYO1F;ARL8B;VPS4A;RAP2B;RHOD;RAB10;ATP5F1A;ATP5F1D;PI4K2A;ACVR1B;SARS2;STK38;MYH9;MTHFD1L;BTK;SYN1;RAB11B;ATL2;DYRK2;RIT1;TUBA1A;HSPA1A;ARL3;ARL8A;ARL4C;RRAS;ATL1;UHMK1;LATS1;MTREX;TUBA1C;ATP7A;RND2;HSPA13;PMVK;EIF4A3;CARS2;RAB2A;RAB29;RAB22A;HSPA4;RABL6;ARF4;SRPK1;RRM1;PFKP;EIF2B2;ADSS1;HSPA4L;STK4;ARF5;RHEB;GCH1;ARL5B;TLK2;MKNK2;PFKM;RAB13;BRSK2;GCK;TUBE1;PSMA6
prerank,calcium activated cation channel activity (GO:0005227),-0.39234539991507733,-1.1187591823899607,0.31448763250883394,0.6044843753590028,1.0,5/17,13.99%,KCNMA1;TMEM63B;TRPM4;PKD2L1;KCNN2
prerank,cadherin binding (GO:0045296),0.3511958831699813,1.118155881875894,0.20841683366733466,0.766976367293196,1.0,80/315,17.90%,IQGAP1;TRIM29;IDH1;LIMA1;MRTFB;PRDX1;ANXA1;CTNNB1;AHNAK;PLIN3;BAIAP2;CD46;TBC1D2;NIBAN2;FASN;CLINT1;P2RX4;SNX9;CEMIP2;SNX5;DDX6;SH3GLB1;ABI1;TRIM25;ASAP1;ANXA2;CAPG;TBC1D10A;OLA1;STK24;STX5;APC;PDLIM5;TLN1;MICALL1;TES;ZC3HAV1;VAPA;ARHGAP18;PICALM;BMPR2;CAPZB;EIF5;SERBP1;ITGB1;RAB10;PAK2;PKN2;OLFM4;SND1;PFN1;STK38;MYH9;RAB11B;MACF1;EPS15;RPS26;HSPA1A;PPP1CA;RPL15;PRDX6;RTN4;CBL;PCBP1;CLIC1;ESYT2;CTNNA1;USP8;PUF60;RANBP1;GAPVD1;MB21D2;PTPN1;LRRC59;CAPZA1;CHMP5;ERC1;PFKP;KIF5B;LYPLA2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.41776367256692426,1.1170727100730535,0.3275217932752179,0.7667479064762166,1.0,10/38,15.76%,NCK2;GAB2;TRAT1;STAP1;BLNK;SH2B2;DEDD2;SPAG9;SHC1;FRS2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.4599405263358884,1.1135669803098225,0.32526881720430106,0.7738160946163907,1.0,10/20,24.09%,SENP3;COPS5;SENP5;USP21;OTUD5;EIF3H;SENP1;UFSP2;USP9X;USP47
prerank,protein kinase activator activity (GO:0030295),0.40216769555521614,1.1134992784972915,0.3275462962962963,0.7703910639657026,1.0,13/60,13.37%,IQGAP1;GPRC5D;ERCC6;PRKAG2;CDKN1A;ABI1;STK3;INCENP;PAK2;DBF4;MT3;AFAP1L2;GAS6
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.4197472557890791,1.1129319358071497,0.3229426433915212,0.7685872466711184,1.0,16/34,25.99%,BIRC6;UBE2Q2;UBE2L3;UBE2K;UBE2F;CDC34;UBE2O;UBE2S;UBE2R2;TAF1;UBE2H;UBE2D3;UBE2J2;UBE2E1;UFC1;UBE2G1
prerank,FAD binding (GO:0071949),0.4552687321956063,1.11167549209361,0.34076015727391873,0.7686542299561956,1.0,11/24,19.63%,CYB5R3;NQO2;PRODH;QSOX1;MICAL2;KDM1B;CRY1;MTRR;CYB5R2;CYB5R1;MICAL1
prerank,acetyltransferase activity (GO:0016407),0.42783839852556926,1.1100103925169593,0.34944237918215615,0.7701448730385069,1.0,16/31,27.27%,NAT8;GTF2B;SAT1;CREBBP;PAFAH1B2;NAT10;NAA10;NAT14;NAA80;NAA15;KAT6B;SMARCE1;KAT6A;KAT2B;PAFAH1B3;ELP3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.35731480465410237,-1.1094651605122563,0.32098765432098764,0.6188253752975122,1.0,8/23,14.11%,PDE3B;PDE8B;PDE11A;PDE4B;PDE1C;PDE4A;PDE5A;PDE1A
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.4309896041685786,-1.1085929233903917,0.3285302593659942,0.6138824385270935,1.0,8/12,47.45%,ELOVL4;GPR88;RRH;GPR52;OPN1MW;OPN1MW3;OPN5;OPN4
prerank,protein kinase inhibitor activity (GO:0004860),-0.3162433272874208,-1.1081482242823804,0.2857142857142857,0.6077645328522907,1.0,13/42,13.62%,RPTOR;SPRED1;CIT;NCK1;RACK1;CAMK2N1;QARS1;PARVA;MAPK8IP1;SPRED2;SMCR8;PRKRIP1;SH3BP5L
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.4934545365930218,1.1071818998353842,0.34820143884892085,0.7751819175601515,1.0,2/16,7.21%,CD38;NEIL1
prerank,NADPH binding (GO:0070402),0.5018595267347685,1.1040942064312589,0.38830584707646176,0.7811450772275574,1.0,6/13,19.05%,CBR3;GRHPR;DUS2;MTRR;CBR4;HMGCR
prerank,tRNA methyltransferase activity (GO:0008175),0.4877326507746501,1.1040135544329257,0.36149584487534625,0.7778496339166812,1.0,9/16,26.64%,TRMT12;LCMT2;TRDMT1;TRMT44;ALKBH8;TARBP1;TRMT13;FTSJ1;THUMPD3
prerank,deoxyribonuclease activity (GO:0004536),0.5052265007096332,1.1038841274298683,0.3580060422960725,0.774771114169761,1.0,4/14,11.06%,ZRANB3;DFFB;DNASE1L1;MBD4
prerank,acid-thiol ligase activity (GO:0016878),0.5070231763320888,1.1017849457558335,0.3672566371681416,0.7776240217938263,1.0,3/13,10.78%,ACSS3;ACSM3;AACS
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.513491482949876,1.1017566043004954,0.34662576687116564,0.7742499696343982,1.0,2/12,10.17%,XDH;SDHB
prerank,receptor ligand activity (GO:0048018),0.3517393699071135,1.1009274097985005,0.229607250755287,0.7732490334064616,1.0,12/245,5.08%,GPNMB;LGALS3;GDF15;TIMP1;VEGFA;IL36G;IL6;HGF;PDGFA;SEMA4B;OSGIN1;IGF1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.47199958002238984,1.100575437147225,0.36856745479833103,0.7708828390740818,1.0,1/17,0.68%,AK8
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.4090788235946807,-1.0991674958971007,0.3035143769968051,0.6209134096365339,1.0,2/14,5.80%,KCNJ2;KCNJ3
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3495651654716769,1.0973764649434414,0.26538849646821394,0.7767755353402332,1.0,86/269,23.92%,CXCR4;GGN;POLR2A;TPI1;IKBKE;FBXW7;CDKN1A;PSMD1;TANK;WASHC1;SNX9;JUN;RIPK1;TNFRSF1B;UBE2L3;CUL3;NPLOC4;STAM;UBE2K;TRIOBP;APC;SUMO2;HSPA1B;DET1;AMBRA1;RPS27A;UBC;MFHAS1;RPL23;PIAS4;BRCA1;RB1;XRCC5;FAF2;GSK3B;FOXO1;BAG4;ASB4;HM13;STUB1;TRAF1;FZD5;ACVR1B;CUL4A;RNF34;TRAF3;ATP6V0C;RELA;PRKN;HSPA1A;SQSTM1;CUL1;PRDX6;ARRB1;TRAF5;RTN4;HSPD1;TRAF2;LTBR;TNFRSF14;PRR7;PSMA3;CCT2;BAG1;FBXO7;DNAJA1;ATXN3;WFS1;DTX1;ACTG1;SPOP;CUL4B;JKAMP;USP2;HSPBP1;VCP;FAF1;MFN2;SLF1;HSPA9;ARIH1;BCL10;EGR2;ISG15;PA2G4;TRAF6
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.43513541451287924,1.0945080018137363,0.3525641025641026,0.7818105536511122,1.0,10/28,16.07%,AGO2;ENDOV;POP4;AGO3;DROSHA;RNASEH2A;MRPL44;RNASEH1;PRORP;EDC3
prerank,poly-purine tract binding (GO:0070717),0.432614753318487,1.0926689334328672,0.3722721437740693,0.7840345586953882,1.0,9/27,17.10%,RBMS1;ATXN1;HNRNPU;RBPMS;PATL1;PPIE;MCRS1;EIF4A3;HNRNPDL
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.41017357085121053,1.0925840758594145,0.35758323057953145,0.7809054785855467,1.0,15/37,24.23%,FARS2;DARS1;TARS3;NARS2;EPRS1;SARS2;SARS1;TARS2;IARS2;PARS2;CARS2;IARS1;FARSA;WARS2;LARS1
prerank,antiporter activity (GO:0015297),0.4584093262865072,1.091435804577176,0.3697705802968961,0.7809781493317473,1.0,7/20,18.85%,SLC35D3;SLC35E3;SLC35D1;SLC35E2B;SLC35E2A;CLCN4;SLC35C2
prerank,NAD binding (GO:0051287),0.43709354612315493,1.0895840049029315,0.3681462140992167,0.7833522477582888,1.0,9/26,16.36%,SORD;SIRT6;NUDT6;GRHPR;ZC3HAV1;SIRT1;NNT;ALDH2;SIRT3
prerank,O-acyltransferase activity (GO:0008374),0.42888792885189875,1.088585094425836,0.36222509702457956,0.7830068901367335,1.0,6/30,16.16%,SOAT1;GPAT2;PLAAT1;LPCAT3;PRDX6;GPAT3
prerank,cysteine-type endopeptidase activity (GO:0004197),0.38043362594803354,1.0884278337179978,0.34945054945054943,0.7800843000793383,1.0,30/78,25.10%,CTSB;CAPN15;CTSL;CAPN2;USP42;CTSS;CTSZ;USP12;CTSH;USP40;USP26;USP48;CTSW;USP16;CASP12;USP36;CASP6;USP8;CASP2;CASP3;USP30;LGMN;USP9X;USP2;MALT1;USP47;CASP8;USP46;CTSK;CTSO
prerank,adenyl ribonucleotide binding (GO:0032559),0.34386737823341784,1.0884103570090202,0.281563126252505,0.7768406186759774,1.0,71/291,20.34%,ABCA1;MAP3K20;TLK1;ERN1;ERCC6;PDK4;ABCG1;PRKAG2;MTHFS;LANCL2;PYGL;ABCD1;RUNX3;SIK3;P2RX4;SRPK2;DAPK1;ENPP1;MYO9B;LONP1;PIM1;SIK1;OLA1;IRAK3;STK3;HSPA1B;HNRNPU;P2RX3;NLRC4;TOP1;CNBD2;ABCA2;MAP4K3;ACVRL1;RTEL1;MYO1F;VPS4A;ATP5F1A;ATP5F1D;PI4K2A;ACVR1B;SARS2;STK38;MYH9;MTHFD1L;BTK;SYN1;DYRK2;HSPA1A;UHMK1;LATS1;MTREX;ATP7A;HSPA13;PMVK;EIF4A3;CARS2;HSPA4;SRPK1;RRM1;PFKP;EIF2B2;HSPA4L;STK4;SLC19A1;HMGCR;TLK2;MKNK2;PFKM;BRSK2;GCK
prerank,protein serine/threonine kinase activity (GO:0004674),0.34317633394542935,1.087795603189222,0.2778335005015045,0.7753586087890607,1.0,59/334,12.20%,SGK1;MAP3K20;MAK;SYK;TLK1;PIKFYVE;PRKCH;MAP3K1;RPS6KA2;ERN1;MAPKAPK3;IRAK2;IKBKE;PLK2;TAOK3;PDPK1;PRKCD;SIK3;FAM20C;SRPK2;DAPK1;RIPK1;MAPK6;RAF1;PIM1;MAPK7;PKN3;STK35;GAK;MELK;SIK1;IRAK3;STK24;STK3;DYRK1A;EIF2AK4;TOP1;BRD2;ACVR2A;MAP3K8;HIPK1;MAP4K3;ACVRL1;CSNK2A2;HIPK2;BMPR2;TNIK;PIM3;ROCK1;GSK3B;PTK2B;PAK2;PKN2;CDK7;MOK;PRKCB;ACVR1B;STK38;MYLK
prerank,methylated histone binding (GO:0035064),0.38226570180682173,1.0868655550531405,0.34812286689419797,0.7746443652160244,1.0,20/62,22.24%,NCAPG2;CXXC1;CBX8;TAF7;ZMYND8;ING3;CDYL;KMT2E;ING4;TDRD3;KDM7A;MPHOSPH8;RRP8;PHF13;SGF29;PHF1;PHF2;TAF1;CBX5;MTF2
prerank,NADP binding (GO:0050661),0.4185555682186942,1.0859139905317017,0.3704630788485607,0.7741393829404779,1.0,9/32,19.05%,CBR3;PGD;CAT;GRHPR;NNT;DUS2;MTRR;CBR4;HMGCR
prerank,PDZ domain binding (GO:0030165),-0.2887453741857134,-1.0858199604461578,0.29464285714285715,0.6455626673280297,1.0,18/61,14.90%,CADM1;NLGN1;F11R;GRIA1;DOCK4;FZD3;CIT;GRID2;ACOX1;CXXC4;ATP2B3;ADRB1;CLCN3;SNTG2;ATP2B2;ATP2B4;RAPGEF2;CRIM1
prerank,protein phosphatase binding (GO:0019903),0.3624566894101469,1.08556980231581,0.31518324607329845,0.7719097939187821,1.0,22/117,14.70%,LGALS3;IQGAP1;MTMR3;LILRB1;CTNNB1;IKBKE;ENSA;MFHAS1;KIF3A;PPP1R9B;SIRPA;CD22;STRN;STYXL1;BOD1;FOXO1;STRN3;TRAF3;PHACTR4;ADCY8;JAK3;AP3B1
prerank,endopeptidase regulator activity (GO:0061135),0.40408451981121213,1.0844732607701493,0.3780487804878049,0.7718920869509559,1.0,9/40,14.51%,ITIH2;RENBP;NLRC4;ABCA2;ITIH3;PSMF1;PSMD14;SLPI;PSME2
prerank,glucuronosyltransferase activity (GO:0015020),-0.3744901088112199,-1.0843238104482418,0.3494809688581315,0.6419876064403942,1.0,6/19,16.20%,B3GAT3;CSGALNACT1;B3GAT1;B3GAT2;EXT2;CHSY1
prerank,kinase activity (GO:0016301),0.35945873206496265,1.0841569250026688,0.34182590233545646,0.7696460424837356,1.0,32/109,21.62%,CERK;PAPSS2;FCSK;ITPKB;SHPK;DGKZ;NMRK1;COASY;DGKA;SPHK2;PIK3CA;PIK3C2G;SEPHS2;IPPK;TKFC;PAPSS1;GSK3B;PKN2;DGKQ;PANK2;PRKD3;PMVK;DGKG;CSNK2A1;GK5;CERKL;PIK3CB;GK;COQ8B;TAF1;CDKL5;EPHA4
prerank,RNA binding (GO:0003723),0.33548494554996405,1.0824872157862455,0.121,0.7711373329954379,1.0,375/1321,22.67%,LGALS3;MYO5A;RFTN1;APOBEC1;MAP3K20;RBMS1;HNRNPLL;TLR8;GRB2;RPL3L;PRDX1;DHX34;DHX8;SAMD4A;FNDC3B;DIAPH1;AHNAK;RBM47;TXN;POLR2A;FAM120A;IPO5;EIF1;EIF1AX;CPEB4;TFRC;VIM;C1D;LRP1;ALYREF;MRPS26;FARS2;ANKRD17;MRPL20;HNRNPH2;DYNC1H1;FASN;MBNL1;SNTB2;UBAP2L;EBNA1BP2;UTP23;JUN;SRPK2;MPHOSPH10;BYSL;RBM28;DDX6;SCAF4;RPP25L;HNRNPAB;SCAF11;CELF1;KPNA2;RBM39;ATXN2;IGF2BP3;TEP1;TENT4B;YTHDF3;CLNS1A;TRIM25;CHTOP;LONP1;DDX59;UBE2L3;EEF1A1;PCID2;ACTN1;AGO2;NUFIP1;TENT5A;MRPL39;ANXA2;TCERG1;RNASEL;TOE1;FNDC3A;RPL18A;ANKHD1;MRPL40;EIF3A;HNRNPUL1;DCAF13;DDX5;RPS14;MRPL11;RPS11;HELB;SUMO2;CSTF3;HSPA1B;CFAP20;HNRNPU;EIF2AK4;CNOT4;PRPF8;RPS27A;UBC;ZFP36L2;SNRNP200;MRPL23;RPL17;RPL23;LARP4B;DARS1;RBPMS;TOP1;MSN;TCF20;ENDOV;TES;BRCA1;WDR33;JAKMIP1;AKAP1;ISY1;CHD3;PUM3;MRPS23;RPL36A;ZC3HAV1;ETF1;XPOT;SMC1A;NOP14;EXOSC3;S100A16;HUWE1;SART1;MRPS7;CHD2;NAT10;HNRNPA0;TNRC6B;TPR;SF1;EXOSC9;POP4;EIF3B;NOSIP;EIF4A1;EIF5;SERBP1;XRCC5;RPL22;GLRX3;RPS21;MTCL1;PSPC1;RRBP1;POLR2G;PATL1;ALG13;GRSF1;LTA4H;DKC1;AGO3;MRPL14;MRPL32;PKN2;RBPMS2;MRPL1;PRPF6;DDX23;DDX55;BAG4;ATP5F1A;PTBP3;NUFIP2;LARP7;ERI1;NCBP2;SREK1;DROSHA;SRSF3;ELP1;SYF2;BST2;RBM42;THOC2;HNRNPM;TNPO1;TDRD3;EPRS1;MRPS35;MRPS28;PUM2;SF3A3;SND1;MEPCE;PTBP2;PFN1;NOL8;SARS2;SARS1;RPL10A;DQX1;MYH9;SNRNP35;DDX20;LACTB2;MRPL28;SPOUT1;EIF3G;POLRMT;MAZ;DUS2;PPRC1;MACF1;NPM2;KRR1;BCLAF1;RBM34;SUGP1;SSBP1;RBM10;N4BP1;RPS26;PPIE;WBP11;PRRC2B;HSPA1A;TBCA;LLPH;SIDT2;SNRPF;MRPS21;MRPL44;SRBD1;SLPI;HNRNPD;RNASEH1;MCRS1;NOC3L;ATP5F1C;RPL15;RPL10;YTHDC2;RPL7L1;MTREX;ALDH18A1;USP36;ADARB1;ISG20L2;RTN4;PCBP1;FAM133B;RPSA;DDX39A;DNAJC21;PPARGC1B;CTNNA1;PRRC2C;GRN;ACAA2;CFAP65;EXOSC10;MBNL2;NUP98;HSPD1;ALKBH8;EIF4A3;PUF60;EDC3;THRAP3;ANXA11;AIMP1;IFIT2;RRP8;SYNCRIP;CCAR1;PTPN1;LUC7L;LRRC59;UTP11;EXOSC1;DHX38;MRPL43;HSPE1;ALKBH1;RPL7;HNRNPDL;TAF15;NELFE;RBM7;UBE2O;CAPRIN1;RPL26;TFB2M;ACIN1;TRMT1L;EIF3H;SRPK1;ZCCHC7;RBM22;HMGN5;SEC63;RADX;C1QBP;PWP2;PLEC;ALKBH5;CLK3;AGO4;NUDT7;EIF2S2;NOC2L;UTP15;APEH;GNL3L;EIF4G3;CDK13;EIF4G2;NFX1;NGDN;DHX37;FUBP1;RBM18;SECISBP2L;CPEB2;RBM27;PURB;TRMT10C;NCL;RAMAC;AGFG1;PPAN;MRPS31;EIF3C;LARP4;RBM15;SPEN;PSMA6;MKRN1;SNRNP40;RALY;JMJD6;PIN4;IMMT;EXOSC7;SAFB;RTCA;FUBP3;EIF2S1;CMSS1;CCDC86;RPS27;MTIF2;WDR43;SNRPB;ABT1;GTPBP4;RPGR;PEF1;PCDHGA9;PPP1R10;NOL12;SLC4A1AP;FBL;PKM;ACO1;VCP;PRKDC;RCC2;KTN1;NAA15;FARSA;TSNAX;HEATR6;TPD52L2;HNRNPR;DIMT1;MTERF4;STAT3
prerank,sequence-specific mRNA binding (GO:1990825),-0.45260109736323406,-1.0819799721955137,0.36666666666666664,0.6404614752644403,1.0,3/10,5.88%,SSB;FMR1;SHFL
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.48611058757381576,1.0808680343362491,0.3799705449189985,0.7726084350663961,1.0,3/13,6.61%,PIKFYVE;PIK3CA;PIK3C2G
prerank,Hsp70 protein binding (GO:0030544),0.42170835633553144,1.0807341997716018,0.38316582914572866,0.7698634415505544,1.0,9/31,19.36%,ERN1;MVD;PPEF2;STUB1;DNAJB14;PRKN;DNAJC18;DNAJA1;HDAC8
prerank,translation initiation factor activity (GO:0003743),0.40943802561281006,1.0794600246415387,0.37192118226600984,0.7702968126486803,1.0,16/36,22.34%,EIF1;AGO2;EIF3A;COPS5;EIF3B;EIF4A1;EIF5;EIF3G;EIF3H;EIF2B2;EIF2S2;EIF4G3;EIF4G2;EIF3C;EIF2S1;MTIF3
prerank,sequence-specific DNA binding (GO:0043565),0.3375808382228699,1.0787538977886468,0.246,0.7691412706148014,1.0,111/590,20.06%,EPAS1;PPARG;MMP12;TFEC;ELF2;IRX3;TFEB;NFE2L2;ACD;CEBPB;ZEB2;GRHL1;FOXP3;EN2;ATF3;CXXC1;RUNX2;E2F3;FOXO3;TFAP2B;RUNX3;RXRA;JUN;RARA;FOXO4;E2F1;CHTOP;LONP1;NR3C1;NR1H4;BHLHE40;HNRNPU;KLF5;TET3;ATF4;TGIF1;ZBTB20;ZNF177;POU3F1;SOX9;SNAI2;ZNF148;FOXP1;IRF2;CBFB;SNAPC1;TERF1;NR5A1;XRCC5;PAX8;NR2C1;WDR77;ESR1;FOXK1;KDM2A;POU3F3;MAFB;FOXO1;MAFG;NFATC3;PPARD;CUX1;MYRFL;SP3;RORA;TBX6;POLRMT;RFX1;RFX5;SOX2;BBX;BCL11B;POU2F1;TEN1;ZKSCAN3;FOXJ3;UPF2;JUNB;PRDM2;HNRNPD;STN1;ETV3;MBNL2;KLF6;NHLH2;ZNF32;MTF1;SIRT3;TCF12;CREB3L4;CREB3;PLAGL2;ZBTB7A;GABPA;ZNF23;CREB1;ZBTB7B;E2F2;HOXD8;FLI1;SOX8;CLOCK;KMT2A;NFIC;CREB3L1;NR2F1;NCL;PRDM16;TCF4;TCF7L2;HSF2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.40845229661643684,1.078199129548213,0.3645083932853717,0.7676149876774429,1.0,9/38,13.34%,SNX27;DENND1A;LANCL2;KIF16B;TECPR1;SESTD1;ZFYVE19;NCF4;SH3PXD2B
prerank,metal ion binding (GO:0046872),0.340277078061743,1.077218330155083,0.253,0.7672170523463951,1.0,69/477,13.51%,IQGAP1;MMP12;ANXA4;IDH1;APOE;MAP3K20;GALNT3;AOC3;PLSCR4;CERK;ANXA1;ERN1;RAP2A;MAN1C1;TGM2;TPD52;LRP1;LCP1;ABL2;SIK3;ESYT1;CEMIP2;SRPK2;MICU2;PLA2G2D;ENPP1;EFCAB11;MYL2;MICU1;ANXA5;AOAH;SLC8A1;THBS1;ADAM8;ANXA2;MELK;SIK1;IRAK3;STK3;TESMIN;ARSA;NLRC4;ENDOV;CALB1;NUDT22;HPGDS;LETM1;S100A16;NDUFAB1;PLA2G4F;PPP3CA;SYT17;PPP3R1;TPM4;MT3;FBLN1;PGM1;PI4K2A;S100A1;STK38;HMGCL;PGP;S100A6;TDP2;WRN;MCTP1;CRACR2A;DYRK2;PVALB
prerank,R-SMAD binding (GO:0070412),-0.3747777584692243,-1.0766183397164597,0.3233333333333333,0.6457653659525441,1.0,4/18,4.01%,LDLRAD4;SMAD3;TRIM33;SMURF1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.4915193675863394,1.0731529138874847,0.36764705882352944,0.7753110652253128,1.0,2/13,2.57%,GPAT2;AGPAT4
prerank,carbohydrate kinase activity (GO:0019200),0.505721364634148,1.066968508432732,0.40088757396449703,0.7896817926883501,1.0,6/11,24.43%,HK3;GALK2;NAGK;XYLB;HK1;FGGY
prerank,pentosyltransferase activity (GO:0016763),0.40303918939749034,1.0661325094710727,0.39631901840490796,0.7889195436869432,1.0,9/36,10.59%,TIPARP;PARP4;PPAT;PARP2;SIRT6;UMPS;PARP3;ZC3HAV1;SIRT1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.297234898563298,-1.0653814709062546,0.3090909090909091,0.66501517732355,1.0,13/42,22.04%,CCND3;CCNC;CCNG2;CDK5R1;CCNL2;CCNI;INCA1;CKS2;CCNJ;CCNF;CCNJL;CCNQ;CDK5R2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.40676056705739777,1.0649482999611384,0.3811944091486658,0.78883928507131,1.0,14/31,25.99%,BIRC6;UBE2Q2;UBE2L3;UBE2K;CDC34;UBE2O;UBE2S;UBE2R2;TAF1;UBE2H;UBE2D3;UBE2J2;UBE2E1;UBE2G1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.5148811741928998,1.0649337355821842,0.4213938411669368,0.785794827996798,1.0,7/11,25.28%,UBE2K;STUB1;AMFR;UBE4A;UBE4B;PRPF19;UBR5
prerank,transcription corepressor binding (GO:0001222),0.4212970961088682,1.0647534405755807,0.39180537772087065,0.7832353298418845,1.0,11/27,22.85%,EED;LCOR;ESR1;RORA;PER3;ZBTB7A;PHF1;ZBTB16;EHMT2;MTF2;CTBP1
prerank,protein tyrosine kinase binding (GO:1990782),-0.2621084646324287,-1.0641357189713179,0.32558139534883723,0.661004630655816,1.0,11/71,6.12%,NRG3;GRM5;ACVR1;GRB14;DOCK4;SH2B3;BANK1;NCK1;HSP90AA1;KHDRBS1;RACK1
prerank,amyloid-beta binding (GO:0001540),0.36456778298482956,1.0634234594528713,0.3822562979189485,0.7838880116603911,1.0,14/79,12.53%,CD36;APOE;LILRB1;LILRB3;LRP1;PGRMC1;SORL1;APBB2;PICALM;BACE1;FZD5;TREM2;APBB3;ITM2C
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.46768536341746175,1.0620665528926483,0.3802008608321377,0.7847397845152917,1.0,3/15,8.06%,GPAT2;AGPAT4;ABHD4
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.4724267945166727,1.0616180983012147,0.40611353711790393,0.7828242740267236,1.0,2/14,6.93%,CAPN15;CAPN2
prerank,nucleotidyltransferase activity (GO:0016779),0.44387930776467915,1.0581468886755032,0.40540540540540543,0.7892899232629585,1.0,4/19,8.98%,PAPSS2;TENT4B;PAPSS1;TENT2
prerank,chemokine receptor binding (GO:0042379),-0.31119420442360074,-1.0560642860460598,0.3446601941747573,0.6741515130258627,1.0,3/35,7.38%,CX3CR1;CCL4;CXCL16
prerank,N-acetyltransferase activity (GO:0008080),0.4461008245687244,1.0524224719989177,0.4154057771664374,0.8018948135552046,1.0,5/19,14.32%,NAT8;SAT1;NAT10;NAA10;NAT14
prerank,adrenergic receptor binding (GO:0031690),-0.37820866391411134,-1.0524192090988087,0.3938356164383562,0.6759146607215936,1.0,7/16,24.88%,MAGI2;ADRB1;GRK2;RAPGEF2;AKAP5;ADRA2A;GNAS
prerank,hexosyltransferase activity (GO:0016758),0.3494428252890345,1.0510564126614037,0.39655172413793105,0.8024858375298362,1.0,15/101,10.88%,B4GALT5;B3GNT8;GCNT2;GYG1;EXT1;B4GALT7;HAS3;B4GALT6;HEXA;B3GALNT2;GBE1;LFNG;A4GALT;ALG12;B4GALT3
prerank,lipoprotein particle receptor binding (GO:0070325),0.4128622260710419,1.0490185479320788,0.4098360655737705,0.804915611442686,1.0,5/27,15.76%,APOE;LRP1;PICALM;APBB3;SNX17
prerank,cell adhesion mediator activity (GO:0098631),-0.3349824270762723,-1.048205272593528,0.384297520661157,0.6799224806201551,1.0,8/24,11.62%,LRRC4C;NTNG1;CNTN6;CNTN2;CNTN4;BSG;IGSF9;NEXN
prerank,histone acetyltransferase activity (GO:0004402),0.40392217979304207,1.048117491860524,0.41035353535353536,0.8043637794482836,1.0,12/30,25.86%,BAZ1A;CREBBP;EPC1;NCOA3;ARRB1;CLOCK;TAF1;KAT2A;KAT6B;KAT6A;BRCA2;KAT2B
prerank,pyrophosphatase activity (GO:0016462),0.3771155265936462,1.0477727489231516,0.4090368608799049,0.8023033689254994,1.0,10/50,10.47%,NUDT14;ENPP1;ENTPD1;ITPA;NUDT6;PLPP5;BNIPL;NUDT22;LHPP;ADPRM
prerank,methylation-dependent protein binding (GO:0140034),0.37483141523489866,1.0476958678177541,0.40835266821345706,0.7995031500014896,1.0,18/57,22.24%,NCAPG2;CXXC1;CBX8;ZMYND8;ING3;CDYL;KMT2E;ING4;TDRD3;KDM7A;MPHOSPH8;RRP8;PHF13;SGF29;PHF1;PHF2;CBX5;MTF2
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.3947167210904507,1.047429987831608,0.39644218551461247,0.7972354060177774,1.0,10/35,18.91%,TRMT12;DTWD1;LCMT2;TRDMT1;FTO;DUS2;TARS2;QRSL1;ALKBH1;MTFMT
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.28531848049252184,-1.0473447215571612,0.31543624161073824,0.6752103194084217,1.0,20/49,25.04%,PPP1CB;PTPRO;ATP1A2;PPP5C;ACP2;MPPED2;ACP6;DUSP15;ARMT1;GDPD3;PLCXD3;PTPRJ;SMPDL3B;SBF1;SACM1L;SMPD1;ENPP6;SAMHD1;ACP3;DUSP18
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.42538917271891424,-1.0442603443814027,0.39344262295081966,0.6758310461818192,1.0,2/10,3.22%,EXD2;DCLRE1C
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.3843463456932031,1.0421641673647393,0.42284325637910086,0.8086503069996465,1.0,17/40,23.79%,DNMT3A;GNMT;COMTD1;N6AMT1;MEPCE;PCMTD2;DNMT1;RRP8;ICMT;DPH5;AS3MT;CARNMT1;TARBP1;FBL;COMT;SETD3;METTL8
prerank,transaminase activity (GO:0008483),-0.42215735375919405,-1.0411688751539734,0.38285714285714284,0.6762173079754031,1.0,3/11,13.88%,BCAT1;AGXT;ABAT
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.25824874983424073,-1.0410375754681345,0.4,0.6699984272041642,1.0,16/71,11.34%,PTPRD;PTPRM;PTPRT;PTPRG;HACD2;UBASH3B;PTPRO;PTP4A3;PTPRN2;PTPN21;PALD1;PTPDC1;PTPN3;PTPN4;PTPN5;DUSP15
prerank,vitamin D receptor binding (GO:0042809),0.4646910097236474,1.0396957668331652,0.4382183908045977,0.8121012815190415,1.0,5/14,16.38%,RXRA;MED12;TAF7;MED16;THRAP3
prerank,transforming growth factor beta binding (GO:0050431),0.42643832167576123,1.0370811032146006,0.4392523364485981,0.8161515200636481,1.0,3/23,8.84%,CD36;THBS1;ACVRL1
prerank,snRNA binding (GO:0017069),0.3831559441103297,1.0367188143549635,0.4133811230585424,0.8141688147518343,1.0,11/42,17.72%,RNPC3;TOE1;RBM41;HNRNPU;PRPF8;LARP7;NCBP2;MEPCE;SNRNP35;RBM7;RBM22
prerank,RNA cap binding (GO:0000339),-0.3826765370657783,-1.0364708881333438,0.41423948220064727,0.6740587512856051,1.0,10/16,18.20%,SNUPN;EIF4E2;GEMIN5;DCPS;NCBP3;LSM1;LARP1;CYFIP1;EIF3D;EIF4E3
prerank,calcium ion binding (GO:0005509),0.32973746537975474,1.0348384096988297,0.41365461847389556,0.8161018814123523,1.0,43/323,13.05%,IQGAP1;MMP12;ANXA4;GALNT3;AOC3;PLSCR4;ANXA1;MAN1C1;TGM2;TPD52;LRP1;LCP1;ESYT1;CEMIP2;MICU2;PLA2G2D;ENPP1;EFCAB11;MYL2;MICU1;ANXA5;AOAH;SLC8A1;THBS1;ADAM8;ANXA2;MELK;ARSA;CALB1;HPGDS;LETM1;S100A16;NDUFAB1;PLA2G4F;PPP3CA;SYT17;PPP3R1;TPM4;FBLN1;S100A1;S100A6;MCTP1;CRACR2A
prerank,estrogen receptor binding (GO:0030331),0.39742708879896244,1.0339206165584611,0.4338896020539153,0.8156200655897,1.0,10/32,18.52%,CTNNB1;DCAF13;LCOR;STRN;NCOA1;ESR1;DCAF1;LATS1;PPARGC1B;NCOA6
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.49227213575977863,1.0323774338044078,0.4341317365269461,0.816779075008153,1.0,7/11,26.50%,SLC35B3;SLC25A42;SLC17A9;SLC19A1;SLC25A17;SLC25A24;SLC25A23
prerank,carboxypeptidase activity (GO:0004180),0.3864653111359136,1.0311437696367458,0.41890166028097064,0.8172948282725474,1.0,5/35,9.13%,MINDY1;CTSA;CPXM1;CTSZ;VASH2
prerank,DNA binding (GO:0003677),0.3212838312645428,1.0287153221542633,0.399,0.8209622031072292,1.0,163/694,22.00%,EPAS1;PPARG;MMP12;RBMS1;TLR8;NFE2L2;ZNF3;POLR2A;CEBPB;ERCC6;ZEB2;GRHL1;FOXP3;DNMT3A;ZMYM6;C1D;ARID4A;NR1H3;E2F3;FOXO3;APLP2;TFAP2B;MCM9;RXRA;MSH4;RFC3;JUN;PARP4;FOXO4;BRIP1;E2F1;LONP1;FAM111A;PCID2;NUFIP1;AIFM2;NR1H4;CREBBP;POLG2;HNRNPU;PMS1;ATF4;TOP1;POU3F1;ENDOV;SOX9;BRCA1;SNAI2;ZNF148;RAD23A;IRF2;CHD3;CBFB;SMC1A;TOPORS;HUWE1;CARF;ARID5B;SNAPC1;TERF1;CHD2;NR5A1;DDIT3;DNTTIP1;XRCC4;XRCC5;PAX8;NR2C1;DDB1;POLR2G;ZFPL1;POU3F3;MAFB;FOXO1;POLL;DNASE1L1;GTF3C4;MBD4;PPARD;CUX1;NBN;APP;MYRFL;RORA;TBX6;DCLRE1B;PQBP1;DEDD2;CAMTA2;POLRMT;TDP2;WRN;RFX5;BCLAF1;JRKL;SOX2;RELA;SSBP1;POU2F1;POLA1;ZKSCAN3;WBP11;FOXJ3;JUNB;GTF2A1;SLPI;PRDM2;ZNF513;STN1;INO80;ORC1;QRICH1;PCBP1;TWNK;DNMT1;DNASE2;HSPD1;CENPX;MTF1;SIRT3;THRAP3;TIGD2;ATAD5;PLAGL2;RPL7;CRY1;CDT1;NKX2-1;SMARCB1;ZBTB7A;NFYC;RADX;E2F2;FLI1;SOX8;CLOCK;FUBP1;NR2F1;PURB;PRDM16;SAP30L;TCF4;TCF7L2;PHF1;TOP3A;POLR3C;SREBF1;MRE11;CUL4B;ZBTB16;SAFB;FUBP3;NPAS2;RPS27;RAD51B;CEBPA;TAF1;XPC;NR1H2;RARB;SNAPC4;CCNT1;RTF2
prerank,muscle alpha-actinin binding (GO:0051371),0.44725934876391693,1.0261308026487694,0.4484304932735426,0.8246628538032696,1.0,2/15,6.79%,PALLD;PDLIM5
prerank,protein kinase C activity (GO:0004697),0.45660437537431636,1.0259228209354447,0.4321167883211679,0.8222680495549082,1.0,5/14,15.61%,PRKCH;PRKCD;PRKCB;PRKCG;PRKD3
prerank,AMP binding (GO:0016208),0.49685625979067793,1.0258853455227064,0.445635528330781,0.8193801572370186,1.0,2/11,3.39%,PRKAG2;PYGL
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.34337635071475503,-1.0258085385345779,0.3920863309352518,0.6921312586067484,1.0,13/21,47.99%,FGF2;FGF10;FRS3;FGF7;NPTN;FGF18;FGF5;FGF22;KL;FGF20;FGF16;FGF23;KLB
prerank,adenylyltransferase activity (GO:0070566),0.4275935588200741,1.0229018135028973,0.4577181208053691,0.8243039746940258,1.0,4/21,8.98%,TENT4B;COASY;NMNAT1;TENT2
prerank,ubiquitin binding (GO:0043130),0.36088140276152625,1.0228261497404063,0.45414364640883975,0.8215404903610904,1.0,24/73,23.36%,CXCR4;FBXW7;NPLOC4;ASCC2;MVB12B;RAD23A;FAF2;UBAP1;USP16;N4BP1;TNFAIP3;PRKN;USPL1;SQSTM1;BIRC2;FBXO7;DDI2;PLAA;RNF19B;VPS36;GGA3;FAF1;RNF168;SPRTN
prerank,CoA-ligase activity (GO:0016405),0.463880544924386,1.0218786768579904,0.44005847953216376,0.8210305458503298,1.0,3/14,10.78%,ACSS3;ACSM3;AACS
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.4329839128485634,-1.021257897164292,0.43956043956043955,0.6959598154990462,1.0,5/10,31.22%,KAT8;NAA60;MSL3;NAA40;HAT1
prerank,G protein-coupled receptor activity (GO:0004930),0.32262006551537015,1.020762042863094,0.46130653266331656,0.8211099941163954,1.0,25/239,11.35%,ADGRE5;APLNR;CXCR4;TAS1R3;HRH1;GPR15;ADGRG3;ADRA1D;ADRA1A;P2RY14;GPR157;C3AR1;LPAR2;GPR83;GPR171;CNR2;ADGRE1;PTAFR;GPR176;VIPR1;PAX8;PTH2R;GPR173;GRPR;XPR1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4256683107543251,1.0205608423945394,0.4438430311231394,0.8186720768226121,1.0,9/20,29.02%,SLC39A14;SLC39A12;SLC39A3;SLC39A11;SLC30A1;SLC39A10;SLC39A1;SLC39A13;SLC30A5
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4041386552586599,1.0199177501748076,0.4640102827763496,0.8175549104171977,1.0,4/27,6.03%,SLC9A3;SLC8B1;SLC8A1;SLC12A3
prerank,intracellular chloride channel activity (GO:0061778),0.4499729298521665,1.0190251481517532,0.4700854700854701,0.8140053800201984,1.0,2/16,2.68%,ANO6;TTYH2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.4499729298521665,1.0190251481517532,0.4700854700854701,0.8140053800201984,1.0,2/16,2.68%,ANO6;TTYH2
prerank,poly-pyrimidine tract binding (GO:0008187),0.41989203559263827,1.0174715223678577,0.4562091503267974,0.8152184355388,1.0,5/23,14.50%,RBMS1;ATXN1;HNRNPU;PATL1;MCRS1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.496084956928309,1.0094641001325495,0.46656760772659733,0.8331983751029056,1.0,1/10,3.13%,CDKN1A
prerank,myosin II binding (GO:0045159),0.48813859166115026,1.0082484786052048,0.4603174603174603,0.8336305449795468,1.0,2/10,7.75%,TRIOBP;STXBP5
prerank,carboxylic acid binding (GO:0031406),0.37873290902124157,1.007597750100077,0.4630541871921182,0.8323408318918398,1.0,4/38,5.19%,PSAP;SESN2;GNMT;GRIN3B
prerank,tau protein binding (GO:0048156),-0.2833603821912437,-1.0066188707454056,0.378698224852071,0.7252622012217472,1.0,12/40,12.47%,BIN1;MARK3;PPP5C;MAP2;HSP90AA1;PPP2CB;MARK1;CLU;MARK2;MARK4;HDAC6;SMAD2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.4724326626159786,1.005149718789945,0.4773371104815864,0.8358283214437915,1.0,2/12,6.00%,AIFM2;NQO2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.4183631066330499,-1.0048762292898459,0.45454545454545453,0.7163895426400911,1.0,2/10,6.52%,DUSP6;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.4183631066330499,-1.0048762292898459,0.45454545454545453,0.7163895426400911,1.0,2/10,6.52%,DUSP6;DUSP7
prerank,phosphatidylglycerol binding (GO:1901611),0.45906880356809027,1.0045118168951774,0.46458923512747874,0.8345532263243978,1.0,5/13,23.79%,PLTP;PITPNA;PITPNC1;PLEKHN1;GSDMD
prerank,phospholipid transfer activity (GO:0120014),0.4196925758781482,1.0045099022944897,0.47003994673768307,0.8317082381774171,1.0,7/21,18.20%,CERT1;PLTP;ABCA3;PITPNA;PITPNC1;PRELID3A;PITPNM1
prerank,glutamate receptor binding (GO:0035254),-0.34830087176317354,-1.0044005451542983,0.4387755102040816,0.7113311205018095,1.0,10/17,24.88%,IGSF11;HOMER1;SHISA6;SYNDIG1;CAMK2A;AKAP5;SHISA7;SHANK2;NSF;GNAS
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4702298161934487,1.0038123125102048,0.46944858420268254,0.8306276962382184,1.0,5/12,16.20%,BABAM2;TRAF1;TRAF3;TRAF5;TRAF2
prerank,motor activity (GO:0003774),0.34906628614232804,1.0015213306204058,0.4872389791183295,0.8337245520816392,1.0,14/60,18.29%,KIF13B;KIF20B;MYO1E;KIF9;KIF16B;KIF27;KIF3A;DYNLRB1;KIF6;MYH9;SMC3;KIF5B;KIF5C;DNAH3
prerank,deubiquitinase activity (GO:0101005),0.34124757706716724,1.0013439061434755,0.4956803455723542,0.8313510887299299,1.0,26/88,21.90%,MINDY1;MINDY4;TANK;USP42;USP12;VCPIP1;COPS5;USP40;USP26;USP48;PSMD14;USP21;USP16;TNFAIP3;USP36;BRCC3;USP8;OTUD5;EIF3H;USP32;USP30;STAMBP;ATXN3;USP3;USP9X;USP2
prerank,ubiquitin-specific protease binding (GO:1990381),0.4263465475560737,0.997501984185268,0.4913678618857902,0.8380857033838937,1.0,8/19,25.11%,PTEN;LCOR;RAD23A;PRKN;DERL2;AMFR;VCP;CLTC
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.3925466468790202,-0.9960428491187964,0.4415954415954416,0.7243040755134875,1.0,1/11,0.85%,SRRM2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.46717326318600494,0.9957166952918808,0.4903129657228018,0.839714457368733,1.0,7/12,26.50%,SLC35B3;SLC25A42;SLC17A9;SLC19A1;SLC25A17;SLC25A24;SLC25A23
prerank,GTP binding (GO:0005525),0.3188366268115143,0.9951568261479566,0.5005107252298263,0.8383327233131045,1.0,43/172,20.46%,RASEF;RAP2A;TGM2;RAB7A;LANCL2;RHOJ;EEF1A1;RAB21;NRAS;GBP6;MFHAS1;RAB31;RAB1B;RAB28;RRAD;ARL8B;RAP2B;RHOD;RAB10;RAB11B;ATL2;RIT1;TUBA1A;ARL3;ARL8A;ARL4C;RRAS;ATL1;TUBA1C;RND2;RAB2A;RAB29;RAB22A;RABL6;ARF4;EIF2B2;ADSS1;ARF5;RHEB;GCH1;ARL5B;RAB13;TUBE1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3952322537181967,0.9934130060291202,0.4819759679572764,0.8399465565407507,1.0,14/27,24.93%,RNF19A;ARIH2;DCUN1D5;DCUN1D3;DCUN1D4;PRKN;DCUN1D1;RNF19B;RNF125;SIAH2;ARIH1;TRAF6;RNF180;DCUN1D2
prerank,MAP kinase activity (GO:0004707),0.44051550456155286,0.9908138290747329,0.4698972099853157,0.8435285757463381,1.0,2/14,5.24%,MAPK6;MAPK7
prerank,aspartic-type endopeptidase activity (GO:0004190),0.45078470639030505,0.989813679945435,0.4791666666666667,0.8433126900866567,1.0,7/12,30.15%,BACE1;HM13;DDI2;SPPL3;SPPL2A;PSEN1;NAPSA
prerank,peptidase activator activity (GO:0016504),0.41027836996119915,0.9894691288806163,0.4946236559139785,0.8414466613672177,1.0,9/22,22.88%,TANK;PCOLCE2;NLRC4;PSMD14;PSME2;CLPX;VCP;APH1B;PSME3
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.3910061776152093,0.9866772509501833,0.49605263157894736,0.8455733345266483,1.0,3/26,8.02%,SLC6A6;SLC16A1;SLC27A1
prerank,carboxy-lyase activity (GO:0016831),0.3981532121587346,0.986415682144062,0.49868073878627966,0.8434253991832151,1.0,7/23,21.64%,MVD;UMPS;ACOD1;AZIN1;ECHDC1;AZIN2;UXS1
prerank,guanyl ribonucleotide binding (GO:0032561),0.3140618794682175,0.9847927854183226,0.5273279352226721,0.8446257647963838,1.0,45/196,19.36%,RASEF;RAP2A;RAB8B;TGM2;RAB7A;LANCL2;RHOJ;EEF1A1;RAB21;NRAS;GBP6;MFHAS1;RAB31;RAB1B;RAB28;RRAD;ARL8B;RAB12;RAP2B;RHOD;RAB10;RAB18;RAB11B;ATL2;RIT1;TUBA1A;ARL3;ARL8A;ARL4C;RRAS;ATL1;TUBA1C;RND2;RAB2A;RAB29;RAB22A;RABL6;ARF4;EIF2B2;ADSS1;ARF5;RHEB;SLC19A1;GCH1;ARL5B
prerank,ribosomal large subunit binding (GO:0043023),0.46497715329969086,0.9841143732700461,0.47619047619047616,0.843514085485005,1.0,8/11,31.37%,EIF6;MALSU1;CPEB2;NMD3;CPSF6;NEMF;MRRF;DHX33
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.28429175296260506,-0.9834596004344767,0.4385026737967914,0.7488829650224379,1.0,18/35,24.46%,PLCL1;ENPP2;PLD4;PDE11A;MPPED2;SMPD3;GDPD3;PDIA3;PLCXD3;SMPDL3B;SMPD1;SMPD4;SMPD2;PLCB3;ENPP3;FAM83B;ENPP6;MPPE1
prerank,P-type ion transporter activity (GO:0015662),0.45914390558266677,0.9830868847017583,0.5099846390168971,0.843274058626907,1.0,2/12,3.32%,ATP6V1E1;ATP2B1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4686939581671066,0.9824372813355722,0.5060975609756098,0.8422525655494091,1.0,5/10,22.29%,NAA10;NAA30;NAA25;NAA80;NAA15
prerank,solute:sodium symporter activity (GO:0015370),-0.30042467083310864,-0.9820223012896403,0.48292682926829267,0.745749125201967,1.0,3/27,9.72%,SLC4A7;SLC4A10;SLC4A8
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3742657974286353,0.9785978438073263,0.5114503816793893,0.8489517010614247,1.0,15/33,24.93%,RNF19A;TCERG1;ARIH2;DCUN1D5;DCUN1D3;DCUN1D4;PRKN;DCUN1D1;RNF19B;RNF125;SIAH2;ARIH1;TRAF6;RNF180;DCUN1D2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.4588624638883943,0.9763167863773305,0.502283105022831,0.849050257406871,1.0,8/11,30.75%,SIL1;BAG4;PFN1;BAG1;HSPBP1;BAG3;GRPEL2;HSPH1
prerank,adenyl nucleotide binding (GO:0030554),0.4588624638883943,0.9763167863773305,0.502283105022831,0.849050257406871,1.0,8/11,30.75%,SIL1;BAG4;PFN1;BAG1;HSPBP1;BAG3;GRPEL2;HSPH1
prerank,DNA-binding transcription factor binding (GO:0140297),0.31315486397851555,0.9757274330211103,0.5477903391572456,0.8478402004867035,1.0,49/189,21.97%,PPARG;NFE2L2;CTNNB1;ID2;JUN;NCOR1;FOXO4;ZMYND8;TCERG1;CRTC1;SIK1;CREBBP;BHLHE40;ATF4;PIAS4;RB1;WWP2;HIPK2;DDIT3;GSK3B;SIRT1;RERE;PPARD;NBN;TBX6;DDX20;HCLS1;DGKQ;RELA;NHLH2;TCF12;ZBTB7A;GABPA;CREB1;BBS7;NOC2L;CRTC3;PURB;PIAS2;PRDM16;TCF7L2;BBS1;SPEN;SIN3A;PIAS1;TAF1;DMAP1;CBX5;TLE3
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.47728359281091964,0.9749616155162186,0.5399361022364217,0.8469039851274311,1.0,5/10,23.59%,NSD3;SMYD2;ASH1L;SETD3;SETD5
prerank,hexosaminidase activity (GO:0015929),0.44937634041228536,0.9737872129925339,0.5152439024390244,0.8469454132517414,1.0,4/12,12.25%,CEMIP2;HEXA;OGA;HEXD
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.39812284517808716,0.9699946186655092,0.5133333333333333,0.8533610493122,1.0,2/24,3.19%,AK8;ITPKB
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3026763636896574,0.9688173112575541,0.602,0.8535933522896431,1.0,106/597,20.06%,PPARG;TFEC;ELF2;IRX3;TFEB;NFE2L2;CEBPB;GRHL1;FOXP3;EN2;ATF3;RUNX2;ARID4A;NR1H3;E2F3;FOXO3;TFAP2B;RUNX3;MCM9;RXRA;JUN;NCOR1;RARA;MZF1;FOXO4;E2F1;TAF7;RNF10;NR3C1;BHLHE40;HNRNPU;KLF5;ATF4;TGIF1;ZBTB20;ZNF177;POU3F1;SOX9;BRCA1;SNAI2;FOXP1;GABPB1;GABPB2;IRF2;CHD3;BRD7;TBL1XR1;ARID5B;NR5A1;DDIT3;XRCC5;PAX8;NR2C1;ESR1;PSPC1;FOXK1;MAFG;NFATC3;MBD4;PPARD;CUX1;SP3;TBX6;RFX1;RFX5;SOX2;RELA;BBX;BCL11B;POLA1;FOXJ3;JUNB;SUV39H2;ZNF513;PER3;ETV3;ORC1;MBNL2;HSPD1;KLF6;NHLH2;ZNF32;MTF1;ORC4;TCF12;CREB3L4;CREB3;NKX2-1;ZBTB7A;GABPA;NFYC;ZNF23;CREB1;ZBTB7B;E2F2;HOXD8;FLI1;SOX8;CLOCK;NFIC;CREB3L1;NR2F1;PRDM16;TCF4;TCF7L2;HSF2
prerank,5'-3' exonuclease activity (GO:0008409),-0.3600191267731468,-0.9677302117427914,0.49221183800623053,0.7741250188128108,1.0,8/14,30.07%,DCLRE1C;TRIR;XRN1;CPSF3;DCLRE1A;EXO1;FEN1;DCP2
prerank,epidermal growth factor receptor binding (GO:0005154),-0.3038205694291383,-0.9670247423863899,0.5064935064935064,0.7692289061882691,1.0,6/25,11.70%,ERBB4;TGFA;FER;SNX2;TNK2;LINGO1
prerank,calcium channel regulator activity (GO:0005246),0.36779896013993013,0.9666189039388293,0.528395061728395,0.8563084442346227,1.0,8/37,19.26%,SGK1;RRAD;NRXN2;CACNB3;STIMATE;SRI;CALM2;SLC30A1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.3954236362737315,0.9629127665437136,0.5382585751978892,0.8622566801468362,1.0,8/22,27.02%,APOE;PICALM;APBB3;SNX17;DNAJA1;LDLRAP1;CLTC;AP2A1
prerank,diacylglycerol kinase activity (GO:0004143),0.45258367864808685,0.9620928441157152,0.5197568389057751,0.8615844771043362,1.0,4/11,17.19%,DGKZ;DGKA;DGKQ;DGKG
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.440996047389082,0.9605703136627749,0.5144157814871017,0.8625843946158478,1.0,1/12,0.65%,B3GNT8
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.3694980360360388,-0.9596995247487085,0.4956521739130435,0.7803880615237936,1.0,4/12,11.62%,PDE3B;PDE8B;PDE4B;PDE4A
prerank,syntaxin binding (GO:0019905),0.33586123215006974,0.9574200907106938,0.55125284738041,0.8671208807457943,1.0,18/61,20.45%,ABCA1;SNAP29;DAPK1;STX8;VPS54;STXBP5;SYT17;VPS52;STXBP3;VAMP3;SYPL1;STX6;VPS11;SNAP47;BAIAP3;STXBP2;VAMP2;SNAP23
prerank,nuclear receptor coactivator activity (GO:0030374),0.3392534287700349,0.9564711877007627,0.528554070473876,0.866803872808177,1.0,15/52,19.08%,ZMIZ1;MED12;ACTN1;NCOA3;NCOA1;WDR77;PRKCB;PPRC1;BUD31;CNOT6;PPARGC1B;THRAP3;CCAR1;NCOA6;NCOA2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.39110500949756244,-0.9542106006698573,0.5096952908587258,0.7871055031239954,1.0,4/10,13.84%,GABRA2;GABRA3;GABRG3;GABRA4
prerank,dynactin binding (GO:0034452),0.4428591145394185,0.9541575664294938,0.5479876160990712,0.8694938916405373,1.0,5/12,18.60%,HOOK3;SNX5;GSK3B;PAFAH1B1;HTT
prerank,peptide hormone receptor binding (GO:0051428),-0.37553353760118663,-0.9523971684946471,0.5260115606936416,0.78489135159695,1.0,5/11,40.12%,ADCYAP1;CCK;PTHLH;GNRH1;VIP
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.44931482291276553,0.9520843720200483,0.5418641390205371,0.8715693877360342,1.0,1/11,1.89%,AQP1
prerank,endopeptidase inhibitor activity (GO:0004866),0.3253024061529843,0.9505906912993568,0.5718990120746432,0.872386229590776,1.0,14/82,14.37%,TIMP1;ITIH2;BIRC6;RENBP;ANXA2;TIMP2;ITIH3;ROCK1;PSMF1;APP;BST2;SERPINB8;SLPI;SERPINC1
prerank,SH2 domain binding (GO:0042169),-0.29354058554587803,-0.9505057304853796,0.53,0.7830959099182554,1.0,5/31,6.12%,PAG1;ARHGAP5;IRS1;KHDRBS1;RACK1
prerank,ephrin receptor binding (GO:0046875),0.3933732319713828,0.949767327048227,0.5184174624829468,0.8717479554756702,1.0,5/21,16.55%,GRB2;ANKS1B;SHC1;CBL;PTPN1
prerank,voltage-gated ion channel activity (GO:0005244),-0.3529691007756552,-0.9481714802129055,0.5331230283911672,0.7823128367725279,1.0,3/14,1.15%,KCND2;HCN1;CACNA1E
prerank,endonuclease activity (GO:0004519),0.34402562616677007,0.9480962647996992,0.578125,0.8729384718844152,1.0,9/49,12.39%,ERN1;ZRANB3;AGO2;RNASEL;NOB1;AGO3;MBD4;SND1;LACTB2
prerank,sodium channel regulator activity (GO:0017080),0.3511985708802965,0.9474272653777046,0.551094890510949,0.8717943984786556,1.0,7/37,13.14%,SGK1;RANGRF;FGF11;GPD1L;NEDD4L;GPLD1;PRSS8
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.43815865409050525,0.9468952806677229,0.555895865237366,0.8702244109993411,1.0,8/12,28.30%,GTF2B;RELA;POU2F1;GTF2A1;TAF1;RUVBL2;HDAC1;FOS
prerank,acylglycerol lipase activity (GO:0047372),0.45311783364243735,0.9463331970052006,0.5503875968992248,0.8688958259865702,1.0,1/11,1.78%,MGLL
prerank,microtubule motor activity (GO:0003777),0.3376562951278701,0.9453860028175141,0.5612366230677764,0.868447432387146,1.0,12/51,18.29%,KIF13B;KIF20B;KIF9;KIF16B;KIF27;KIF3A;DYNLRB1;KIF6;SMC3;KIF5B;KIF5C;DNAH3
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.4139690566052666,0.9450855051178765,0.5305832147937412,0.8664960356931691,1.0,5/15,17.34%,ALDH3A2;ALDH2;ALDH1A2;ALDH7A1;ALDH9A1
prerank,telomeric DNA binding (GO:0042162),0.3674333385661046,0.9447778878549412,0.5549872122762148,0.8645970539183991,1.0,8/32,14.75%,ACD;TERF1;XRCC5;WRN;TEN1;UPF2;HNRNPD;STN1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.4235686805459317,0.9443728536233302,0.5424929178470255,0.8628776438468413,1.0,2/15,9.25%,PLA2G2D;PLA2G4F
prerank,myosin V binding (GO:0031489),-0.33679476724483964,-0.9434670818607644,0.5032258064516129,0.7869969912186264,1.0,5/15,19.60%,RAB6B;RAB8A;RAB11A;RAB3B;RAB39B
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.34736030291127146,-0.9426799402457208,0.5324232081911263,0.7821329661300124,1.0,4/14,10.13%,SLC1A3;SLC17A6;SLC1A2;SLC1A1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.386109751771345,0.9410128807168526,0.5739014647137151,0.8677621419027953,1.0,2/20,2.05%,AK8;MPP1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.43778108952811134,0.9401942922941748,0.5520361990950227,0.8670844444860933,1.0,4/12,14.31%,KDM4C;KDM3A;JMJD1C;KDM7A
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4464477175512258,0.9359233881933174,0.5579598145285936,0.8738997410478972,1.0,4/10,19.38%,TNFAIP3;OTUD5;STAMBP;ATXN3
prerank,nucleoside-triphosphatase activity (GO:0017111),0.2958133814501906,0.9345314709291039,0.65625,0.8743974801745762,1.0,47/248,17.06%,RAP2A;RAB8B;KIF20B;MYO1E;GNAQ;RAB20;RAB7A;ATP2B1;ABCD1;RHOJ;RAB33B;GNA13;EEF1A1;RAB21;NRAS;GNA12;MYO19;HSPA1B;GBP6;RAB31;RAB1B;ABCA3;CHD3;RAB28;ARL8B;GNG11;RAP2B;RHOD;RAB18;TBC1D24;GNGT2;RAB24;MYH9;RAB43;RAB11B;ATL2;RIT1;HSPA1A;ARL8A;RRAS;ATL1;RND2;RAB2A;RAB29;ABCG4;RAB22A;MTG1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.37869519222360376,0.9339418994505577,0.5762273901808785,0.8729660405398647,1.0,6/25,16.77%,GAB2;KIF16B;SESTD1;PLEKHA1;MAPKAP1;NCF1
prerank,protein tyrosine kinase activity (GO:0004713),0.30846876388681804,0.9316034242720911,0.6136606189967982,0.8756235634220768,1.0,18/108,13.44%,SYK;WEE2;FRK;TEC;ABL2;FGFR4;MERTK;MELK;DYRK1A;PKDCC;HIPK1;HIPK2;PTK2B;FES;ROR1;BTK;DYRK2;FGR
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3526029176674038,0.9315481068377819,0.5682102628285357,0.8731825920930104,1.0,9/33,16.82%,WAC;GTF2B;AGO2;HNRNPU;NCOA3;LLPH;SMYD2;CDC73;ELP4
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.35348284708395195,0.9306191385656972,0.5801242236024845,0.8727360806028786,1.0,9/34,16.80%,TOE1;EXOSC3;CNOT6L;EXOSC9;CNOT7;ERI1;CNOT6;EXOSC10;PAN3
prerank,kinesin binding (GO:0019894),0.37379448065550497,0.9302168012523389,0.5659411011523687,0.8709758515785875,1.0,11/27,25.60%,PLEKHM2;AP1G1;SPAG9;RAB29;ARHGEF10;IFT88;TOR1A;CROCC;SPTBN5;ACTB;MAPK8IP3
prerank,nuclease activity (GO:0004518),0.33663511239911476,0.9297096222481407,0.5812064965197216,0.8694962126613118,1.0,12/52,17.39%,ENPP1;RNASE3;RNASEL;DFFB;DNASE1L1;SND1;WRN;N4BP1;RNASEH2A;RNASEH1;ISG20L2;REXO5
prerank,poly(U) RNA binding (GO:0008266),0.39365564868055686,0.9293312687896307,0.5727636849132176,0.8678397735322883,1.0,2/20,1.95%,RBMS1;ATXN1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.362302461560465,0.9281844971863554,0.5893300248138957,0.8678702529463385,1.0,9/34,21.95%,IQGAP1;STK3;INCENP;DBF4;STK4;CALM2;CAB39;RICTOR;CCNT1
prerank,calcium:sodium antiporter activity (GO:0005432),-0.37921875422009604,-0.927701030672471,0.5558659217877095,0.8102760753081352,1.0,2/10,2.00%,SLC24A3;SLC24A2
prerank,cytokine activity (GO:0005125),0.30361006193897355,0.9272685139364188,0.6276150627615062,0.8672778878385415,1.0,5/131,2.98%,GDF15;TIMP1;VEGFA;IL36G;IL6
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.3758801154862954,-0.9252120636833321,0.5507692307692308,0.8093878894251865,1.0,3/10,14.15%,ANKRD13B;IDE;ANKRD13A
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3602389965342207,0.9231241347728466,0.5819354838709677,0.8733961480755517,1.0,8/29,20.08%,MAPKAPK3;TNIP1;MAPK7;TPR;SIRT1;ACE;GCH1;DUSP10
prerank,kinase binding (GO:0019900),0.2915630513833057,0.9223885255708856,0.7517517517517518,0.8723666082490327,1.0,73/434,15.78%,IQGAP1;LYST;SASH1;TPCN2;KIF13B;GRB2;MAP3K1;CTNNB1;POLR2A;PRAM1;TFRC;PRKAG2;WWC2;PRKCD;CDKN1A;FOXO3;TOM1L2;FAS;FAM83F;EEF1A1;MAML1;SIKE1;GADD45A;DUSP3;NR3C1;IFNAR2;WDCP;GSKIP;SIK1;IRAK3;APC;ATF4;CACUL1;STAP1;MSN;RB1;CNKSR2;BLNK;RAD23A;DVL1;ACVRL1;HNRNPA0;MAVS;ESR1;GSK3B;RHOD;PAK2;CCNA2;STUB1;MIDN;TAX1BP1;FZD5;RELB;HCLS1;SYN1;ATG13;ERCC6L2;DGKQ;RELA;VDAC1;FGR;POLA1;PRKN;CEP192;SLC12A7;SHC1;SQSTM1;MAP3K2;LATS1;MAPKAP1;STK11IP;RND2;UTRN
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.34905081591132936,0.9223748711478166,0.5935162094763092,0.8699172221582036,1.0,8/33,15.83%,TOE1;EXOSC3;CNOT6L;EXOSC9;CNOT7;ERI1;CNOT6;EXOSC10
prerank,RNA polymerase core enzyme binding (GO:0043175),0.35365341636133246,0.9209424889488822,0.5789473684210527,0.8703416406258626,1.0,11/33,22.66%,WAC;GTF2B;AGO2;HNRNPU;NCOA3;SMYD2;CDC73;ELP4;RRN3;WDR43;SUPT4H1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2937539262170319,0.9204124330207204,0.7006048387096774,0.8689909226635434,1.0,68/254,25.08%,TFEC;LITAF;MITF;GRHL1;ATF3;VEZF1;E2F3;FOXO3;TFAP2B;JUN;MZF1;FOXO4;NR3C1;NR1H4;KLF5;ATF4;REL;RREB1;SOX9;IRF2;DDIT3;ESR1;FOXO1;SALL2;NFATC3;RFX5;RELA;FOXJ3;SMARCD1;ATF1;PRDM2;KLF6;MTF1;TCF12;CREB3;PLAGL2;GABPA;NFYC;CREB1;ZNF319;E2F2;HOXD8;CLOCK;STAT6;NFIC;CREB3L1;PRDM16;TCF4;HSF2;ZFP62;ZBTB16;MLXIP;HNF4G;CEBPA;NR1H2;HOXB3;STAT3;TFCP2;GMEB1;EGR2;CASZ1;TFDP1;NRF1;MYBL1;SOX4;ELF1;NFAT5;SMARCD2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.41988697410049913,0.9203693607813498,0.5843971631205673,0.8666102587012031,1.0,3/14,11.67%,TIMP1;TIMP2;BST2
prerank,RNA polymerase II complex binding (GO:0000993),0.35272474675330634,0.9182063324095974,0.5925925925925926,0.8686142850055514,1.0,11/32,22.66%,WAC;GTF2B;AGO2;HNRNPU;NCOA3;SMYD2;CDC73;ELP4;PCIF1;WDR43;SUPT4H1
prerank,gated channel activity (GO:0022836),0.4155555893658324,0.9180684224889532,0.5915915915915916,0.866477330884069,1.0,3/14,11.91%,TMEM266;PIEZO1;PIEZO2
prerank,transcription coactivator binding (GO:0001223),-0.3026675176545415,-0.917103804549092,0.5947955390334573,0.8213965522178188,1.0,8/20,18.71%,SMAD3;CIT;MED25;PGR;AR;CDK9;AHR;SMAD4
prerank,cytochrome-c oxidase activity (GO:0004129),0.40425607378745165,0.9135969050799561,0.5743740795287187,0.8732391778526059,1.0,6/15,22.51%,COX6A1;CYB5A;COX8A;COX15;COX4I1;COX5A
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.33185680353120606,0.9120809395892959,0.6108433734939759,0.8738670576987149,1.0,6/46,7.43%,B3GNT8;GCNT2;MGAT5;EXT1;HEXA;LFNG
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3129225406697239,0.9103202975914139,0.6325369738339022,0.8750842032218327,1.0,8/70,7.77%,B3GNT8;GCNT2;EXT1;HAS3;HEXA;B3GALNT2;LFNG;GXYLT2
prerank,protein phosphatase 1 binding (GO:0008157),0.38448492223195596,0.9088434865031373,0.5878284923928078,0.8756170965086306,1.0,3/21,13.66%,LILRB1;PPP1R9B;PHACTR4
prerank,mRNA methyltransferase activity (GO:0008174),-0.34847066257540915,-0.9087187885536806,0.5653495440729484,0.8343842865955928,1.0,3/12,8.59%,METTL3;CMTR1;NSUN2
prerank,DNA replication origin binding (GO:0003688),0.3708382855283171,0.9085801727442196,0.5908496732026144,0.8737110601111061,1.0,5/23,16.50%,MCM9;POLA1;ORC1;HSPD1;ORC4
prerank,receptor tyrosine kinase binding (GO:0030971),0.3255273766893954,0.9079284036358655,0.6150341685649203,0.8726020401658062,1.0,13/56,16.55%,CBLB;GAB2;DUSP3;TRAT1;STAP1;BLNK;SH2B2;GAS6;SHC1;SQSTM1;CBL;FRS2;PTPN1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.29135409130719525,-0.9077591157244906,0.6096654275092936,0.8300900279118522,1.0,4/23,4.93%,CCR5;PLCB1;CHRM3;PLCH1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3685997653857964,0.9077003022380047,0.6154822335025381,0.8706612741373074,1.0,6/25,19.63%,POR;CYP46A1;MICAL2;CYP27A1;MTRR;MICAL1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.28145218026122126,0.9052647059117402,0.849,0.8731465303796168,1.0,157/831,21.55%,EPAS1;PPARG;TFEC;LITAF;IRX3;TFEB;TRPS1;NFE2L2;ZNF3;MITF;CEBPB;ZEB2;GRHL1;FOXP3;EN2;DNMT3A;ST18;ATF3;VEZF1;RUNX2;NR1H3;E2F3;FOXO3;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;RARA;ZFP28;MZF1;FOXO4;GTF2B;BACH1;E2F1;ZBTB42;STAT5B;NR3C1;NR1H4;BHLHE40;HNRNPU;KLF5;ATF4;REL;TGIF1;ZBTB20;ETV6;ZNF177;TOP1;RREB1;POU3F1;SOX9;SNAI2;HOXA3;RB1;RBAK;ZNF148;FOXP1;IRF2;ZFAT;CARF;DACH1;CHD2;NR5A1;DDIT3;PAX8;NR2C1;ESR1;FOXK1;POU3F3;MAFB;FOXO1;MAFG;SALL2;NFATC3;PPARD;ZNF691;CUX1;ZKSCAN7;SP3;RORA;TBX6;SARS1;RELB;MAZ;RFX1;RFX5;SOX2;RELA;BBX;BCL11B;POU2F1;HBP1;ZKSCAN3;FOXJ3;PGBD1;JUNB;ATF1;GTF2A1;ZKSCAN5;PRDM2;KLF6;NHLH2;ZNF32;MTF1;MYT1;THRAP3;CCAR1;TCF12;CREB3L4;CREB3;ZBTB11;ZNF18;NKX2-1;ZBTB41;ZBTB7A;GABPA;NFYC;ZNF23;CREB1;ZBTB7B;ZNF319;E2F2;HOXD8;KLF8;SOX8;ZNF431;CLOCK;NFX1;ZBTB40;STAT6;NFIC;NR2F1;PURB;ZNF367;PRDM16;TCF4;TCF7L2;HSF2;NFE2L3;SREBF1;BCL11A;HES5;ZFP62;SP8;ZBTB16;MGA;SAFB;MLXIP;NPAS2;MYPOP;HNF4G;CEBPA;TAF1;NR1H2;ZBTB24
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.387074189500833,0.9037703756002892,0.5941011235955056,0.8738318394566471,1.0,2/20,2.57%,GPAT2;AGPAT4
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.36578751345864585,0.9030499912176193,0.5978695073235686,0.8728859401621756,1.0,5/22,11.99%,CPSF1;ZFP36L2;HNRNPA0;EXOSC9;EXOSC8
prerank,growth factor activity (GO:0008083),0.3086175935017938,0.9028180241721616,0.6396495071193866,0.8709470195541238,1.0,5/74,4.92%,VEGFA;IL6;HGF;PDGFA;OSGIN1
prerank,protein kinase binding (GO:0019901),0.28425855445689147,0.9007969707718549,0.807,0.8724222244519669,1.0,85/479,16.20%,IQGAP1;LYST;SASH1;TPCN2;KIF13B;GRB2;NEDD9;MAP3K1;MAPKAPK3;PRAM1;TFRC;PRKAG2;ADAM9;PRKCD;CDKN1A;FOXO3;TNIP1;TOM1L2;FAM83F;RARA;MAPK7;EEF1A1;MAML1;NELL2;SIKE1;DUSP3;NR3C1;IFNAR2;GSKIP;SIK1;PPEF2;IRAK3;APC;PDLIM5;ATF4;CACUL1;STAP1;MSN;SOX9;CNKSR2;SIRPA;BLNK;DVL1;ACVRL1;HNRNPA0;BMPR2;TPR;ITGB1;MAVS;ESR1;GSK3B;RHOD;SIRT1;PAK2;CCNA2;FZD5;PRKCB;STK38;RELB;APPL1;TREM2;SPAG9;HCLS1;SYN1;ATG13;ERCC6L2;RELA;VDAC1;FGR;POLA1;PRKN;CEP192;SLC12A7;PARD6A;SHC1;SQSTM1;MAP3K2;LATS1;CD247;MAPKAP1;STK11IP;RND2;UTRN;NELL1;TRAF2
prerank,tRNA binding (GO:0000049),0.3278358073548165,0.9003539127199974,0.6217494089834515,0.8710428024965298,1.0,11/43,17.02%,FARS2;EEF1A1;EIF2AK4;XPOT;NAT10;ELP1;SARS2;SARS1;ALKBH8;AIMP1;ALKBH1
prerank,GTPase activity (GO:0003924),0.2879715399511724,0.9001945275005694,0.7099080694586313,0.8690457978931198,1.0,36/192,17.06%,RAP2A;RAB8B;GNAQ;RAB20;RAB7A;RHOJ;RAB33B;GNA13;EEF1A1;RAB21;NRAS;GNA12;GBP6;RAB31;RAB1B;RAB28;ARL8B;GNG11;RAP2B;RHOD;RAB18;TBC1D24;GNGT2;RAB24;RAB43;RAB11B;ATL2;RIT1;ARL8A;RRAS;ATL1;RND2;RAB2A;RAB29;RAB22A;MTG1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.3598459561162344,0.8988916310877638,0.6023316062176166,0.8692177264398124,1.0,8/28,16.20%,RIPK1;BABAM2;TRAF1;TRAF3;TRAF5;MYD88;BID;TRAF2
prerank,cAMP response element binding (GO:0035497),0.42385920736184757,0.8966524192327581,0.6056129985228951,0.8712955598306841,1.0,3/10,19.53%,JUN;CREB1;CREB3L1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.2787947454234123,-0.896627172897745,0.6267942583732058,0.8496079717481904,1.0,9/29,17.19%,RPTOR;SPRED1;CIT;SPRED2;PKIA;PKIG;YWHAG;INCA1;PRKAR2B
prerank,enoyl-CoA hydratase activity (GO:0004300),0.43322207071566576,0.895771812646492,0.609984399375975,0.8707154787067933,1.0,3/10,15.54%,HADHA;ECHDC1;EHHADH
prerank,death receptor activity (GO:0005035),0.4368283696786097,0.8953118099232987,0.6133720930232558,0.8692213610155036,1.0,2/11,4.33%,FAS;TNFRSF1B
prerank,double-stranded DNA binding (GO:0003690),0.2807390498502642,0.8952429337340002,0.808,0.8670615004656059,1.0,90/531,21.13%,PPARG;TFEC;RBMS1;ELF2;IRX3;TFEB;CEBPB;GRHL1;FOXP3;EN2;ATF3;RUNX2;E2F3;FOXO3;TFAP2B;RUNX3;RXRA;JUN;RARA;FOXO4;E2F1;PCID2;NR3C1;BHLHE40;POLG2;HNRNPU;KLF5;ATF4;TGIF1;ZBTB20;ZNF177;TOP1;POU3F1;SOX9;SNAI2;FOXP1;IRF2;TERF1;NR5A1;XRCC5;PAX8;NR2C1;ESR1;FOXK1;MAFG;NFATC3;PPARD;CUX1;SP3;TBX6;PQBP1;CAMTA2;RFX1;RFX5;BBX;BCL11B;FOXJ3;JUNB;ETV3;MBNL2;CENPX;KLF6;NHLH2;ZNF32;MTF1;TCF12;CREB3L4;CREB3;CRY1;ZBTB7A;GABPA;ZNF23;CREB1;ZBTB7B;E2F2;HOXD8;FLI1;SOX8;CLOCK;NFIC;CREB3L1;NR2F1;TCF4;HSF2;SREBF1;MRE11;HES5;SP8;SAFB;NPAS2
prerank,mRNA binding (GO:0003729),0.28472724845142033,0.8944378225589221,0.7472306143001007,0.866313822680391,1.0,59/249,19.65%,RBMS1;HNRNPLL;SAMD4A;RBM47;CPEB4;UTP23;DDX6;HNRNPAB;CELF1;IGF2BP3;YTHDF3;AGO2;EIF3A;DDX5;RPS14;CSTF3;HNRNPU;LARP4B;RBPMS;PUM3;ETF1;MRPS7;HNRNPA0;TPR;SF1;EIF4A1;SERBP1;GRSF1;RBPMS2;PTBP3;NCBP2;THOC2;HNRNPM;PUM2;PTBP2;SNRNP35;N4BP1;RPS26;PPIE;SRBD1;SLPI;ADARB1;PCBP1;NUP98;EIF4A3;EDC3;SYNCRIP;LUC7L;RPL7;RPL26;C1QBP;EIF2S2;EIF4G3;EIF4G2;FUBP1;SECISBP2L;CPEB2;PURB;NCL
prerank,chemokine binding (GO:0019956),0.35102705367930503,0.8936501558531026,0.6369426751592356,0.8655469142910348,1.0,3/30,3.93%,CXCR4;ITGA4;XCR1
prerank,sodium:proton antiporter activity (GO:0015385),-0.3601856194104438,-0.8924502697296363,0.6045845272206304,0.8525883390900942,1.0,1/11,0.23%,SLC9A9
prerank,MHC class I protein binding (GO:0042288),0.40710097667080136,0.8901176306735387,0.6230215827338129,0.8697967978910527,1.0,2/13,10.98%,LILRB1;ATP5F1A
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.27674408153902486,0.8900903883960828,0.866,0.8675505326879694,1.0,141/732,21.55%,PPARG;TFEC;LITAF;IRX3;TFEB;NFE2L2;MITF;CEBPB;TIPARP;ZEB2;GRHL1;FOXP3;EN2;DNMT3A;ST18;ATF3;RUNX2;NR1H3;E2F3;FOXO3;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;RARA;ZFP28;MZF1;FOXO4;BACH1;E2F1;ZBTB42;STAT5B;NR3C1;NR1H4;BHLHE40;HNRNPU;KLF5;ATF4;REL;TGIF1;ZBTB20;TOP1;RREB1;POU3F1;SOX9;SNAI2;HOXA3;ZNF148;FOXP1;IRF2;ZFAT;CARF;DACH1;CHD2;NR5A1;DDIT3;PAX8;NR2C1;ESR1;FOXK1;POU3F3;MAFB;FOXO1;MAFG;SALL2;NFATC3;PPARD;ZNF691;ZKSCAN7;SP3;RORA;TBX6;SARS1;RELB;MAZ;RFX1;RFX5;SOX2;RELA;BCL11B;POU2F1;HBP1;ZKSCAN3;FOXJ3;PGBD1;JUNB;ATF1;ZKSCAN5;KLF6;NHLH2;ZNF32;MTF1;MYT1;THRAP3;CCAR1;TCF12;CREB3L4;CREB3;ZBTB11;ZNF18;NKX2-1;ZBTB41;ZBTB7A;GABPA;NFYC;ZNF23;CREB1;ZBTB7B;ZNF319;E2F2;KLF8;SOX8;ZNF431;CLOCK;ZBTB40;STAT6;NFIC;NR2F1;ZNF367;PRDM16;TCF4;TCF7L2;HSF2;NFE2L3;SREBF1;BCL11A;HES5;ZFP62;SP8;ZBTB16;MGA;SAFB;MLXIP;NPAS2;MYPOP;HNF4G;CEBPA;NR1H2;ZBTB24
prerank,organic cation transmembrane transporter activity (GO:0015101),0.39132726424042014,0.8893454879040378,0.6202898550724638,0.8667097112391083,1.0,5/16,21.63%,SLC25A42;SLC44A2;SLC7A8;SLC25A17;SLC22A5
prerank,lysophospholipase activity (GO:0004622),0.3721405309917236,0.8878731095909915,0.6126855600539811,0.8672020576560688,1.0,5/20,17.90%,MGLL;PNPLA7;ABHD4;GDE1;LYPLA2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3539617246610475,-0.8866492350829775,0.6107954545454546,0.8590706401815299,1.0,7/12,18.20%,EIF4E2;GEMIN5;DCPS;NCBP3;LARP1;CYFIP1;EIF4E3
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.3739972542401975,0.8843314935750161,0.6169088507265522,0.8715531862260358,1.0,2/21,7.20%,P2RX4;P2RX3
prerank,rRNA binding (GO:0019843),0.3256616757369456,0.8833720796596222,0.6432038834951457,0.8711220430801472,1.0,7/42,11.39%,TST;UTP23;RPS14;MRPL11;RPL23;MRPS7;ERI1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.4152012929702318,0.8833340460835168,0.6334355828220859,0.8689420624316774,1.0,5/11,22.29%,NAA10;NAA30;NAA25;NAA80;NAA15
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.2746757616106055,0.8827752691415567,0.889,0.8676441498499072,1.0,141/731,21.55%,PPARG;TFEC;LITAF;IRX3;TFEB;NFE2L2;MITF;CEBPB;ZEB2;GRHL1;FOXP3;EN2;DNMT3A;ST18;ATF3;RUNX2;NR1H3;E2F3;FOXO3;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;RARA;ZFP28;MZF1;FOXO4;BACH1;E2F1;ZBTB42;STAT5B;NR3C1;NR1H4;BHLHE40;HNRNPU;KLF5;ATF4;REL;TGIF1;ZBTB20;TOP1;RREB1;POU3F1;SOX9;SNAI2;HOXA3;ZNF148;FOXP1;IRF2;ZFAT;CARF;DACH1;CHD2;NR5A1;DDIT3;PAX8;NR2C1;ESR1;FOXK1;POU3F3;MAFB;FOXO1;MAFG;SALL2;NFATC3;PPARD;ZNF691;ZKSCAN7;SP3;RORA;TBX6;SARS1;RELB;MAZ;RFX1;RFX5;SOX2;RELA;BCL11B;POU2F1;HBP1;ZKSCAN3;FOXJ3;PGBD1;JUNB;ATF1;ZKSCAN5;KLF6;NHLH2;ZNF32;MTF1;MYT1;THRAP3;CCAR1;TCF12;CREB3L4;CREB3;ZBTB11;ZNF18;NKX2-1;ZBTB41;ZBTB7A;GABPA;NFYC;ZNF23;CREB1;ZBTB7B;ZNF319;E2F2;KLF8;SOX8;ZNF431;CLOCK;ZBTB40;STAT6;NFIC;CREB3L1;NR2F1;ZNF367;PRDM16;TCF4;TCF7L2;HSF2;NFE2L3;SREBF1;BCL11A;HES5;ZFP62;SP8;ZBTB16;MGA;SAFB;MLXIP;NPAS2;MYPOP;HNF4G;CEBPA;NR1H2;ZBTB24
prerank,NAD+ binding (GO:0070403),-0.3508657150747009,-0.8827256717645922,0.5988200589970502,0.8610746838725118,1.0,5/12,13.11%,HPGD;CRYL1;GLUD1;SIRT5;SIRT2
prerank,O-methyltransferase activity (GO:0008171),-0.35545868590670854,-0.8771670770601387,0.6184971098265896,0.8665180759416459,1.0,4/10,18.87%,COQ3;CMTR1;BCDIN3D;ASMT
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.39305653218626724,0.8765800649168346,0.6354166666666666,0.8765910474024352,1.0,5/13,17.34%,ALDH3A2;ALDH2;ALDH1A2;ALDH7A1;ALDH9A1
prerank,potassium:proton antiporter activity (GO:0015386),-0.3645910003327278,-0.8748456914845776,0.5994475138121547,0.8652779687928647,1.0,1/10,0.23%,SLC9A9
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.37656732491206635,0.8722858647094183,0.6237762237762238,0.8820217119545687,1.0,6/18,22.26%,ALDH3A2;ALDH2;ALDH18A1;ALDH1A2;ALDH9A1;HSD17B12
prerank,insulin-like growth factor binding (GO:0005520),0.38374860422878554,0.8711378711067147,0.6378299120234604,0.8816693192219894,1.0,6/15,25.45%,IGF2R;IGFALS;LRP2;ITGAV;IGFBP3;ITGB3
prerank,tropomyosin binding (GO:0005523),-0.3063342795745881,-0.8691446446556201,0.6375404530744336,0.8709732085944849,1.0,3/16,12.21%,TMOD2;PYCARD;NEBL
prerank,lipase activator activity (GO:0060229),0.41405880113619065,0.8674260435777167,0.6389728096676737,0.8858425104062683,1.0,2/10,12.78%,PDPK1;BTK
prerank,C-C chemokine receptor activity (GO:0016493),0.363736672706856,0.8664905770382313,0.6755674232309746,0.8851806519728298,1.0,2/21,3.93%,CXCR4;XCR1
prerank,poly(A) binding (GO:0008143),0.35696115557222524,0.8657910678588326,0.6344370860927152,0.8841618301744305,1.0,7/21,20.30%,RBMS1;HNRNPU;RBPMS;PPIE;EIF4A3;HNRNPDL;LARP4
prerank,general transcription initiation factor binding (GO:0140296),-0.27187894627265013,-0.8646978558551739,0.6653386454183267,0.8739778171397271,1.0,12/25,22.98%,THRA;PSMC2;YEATS2;TBP;TAF12;AR;HHEX;DRAP1;AHR;DR1;BRF2;GTF2A2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.42007808296069016,0.8634623606270003,0.6533742331288344,0.8858501253045855,1.0,4/10,16.92%,KDM4C;KDM2A;KDM7A;RIOX2
prerank,telomerase RNA binding (GO:0070034),0.35839503815595747,0.8621187083923461,0.6524633821571239,0.886024065628024,1.0,5/22,15.83%,TEP1;TENT4B;HNRNPU;DKC1;EXOSC10
prerank,RNA polymerase binding (GO:0070063),0.37222071877575497,0.8617791268061521,0.6594202898550725,0.8843819690597639,1.0,7/18,21.95%,TCERG1;ANP32B;BRCA1;PKN2;YTHDC2;TCERG1L;CCNT1
prerank,C-C chemokine binding (GO:0019957),0.35748160498968773,0.860520053207936,0.6558704453441295,0.884327505700277,1.0,2/22,3.93%,CXCR4;XCR1
prerank,G protein-coupled receptor binding (GO:0001664),0.2809808208246496,0.8602134823420108,0.7412008281573499,0.8825630285608422,1.0,29/132,23.47%,SDCBP;GNAQ;GNA13;HOMER3;ZNRF3;GNA12;HSPA1B;PDCD6IP;DVL1;FZD7;STUB1;PRKN;HSPA1A;LRP6;ARRB1;CCDC88C;GPRASP2;ACE;C1QBP;RNF43;CALCA;DNAJA1;CCL25;BBS1;HOMER2;CCRL2;CXCL12;GNAI3;FLNA
prerank,chemokine receptor activity (GO:0004950),0.34984321939790985,0.8597875489141239,0.6692307692307692,0.8810889150714655,1.0,2/24,3.93%,CXCR4;XCR1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.36042421528451984,0.8590305101195975,0.6376021798365122,0.8801642122918736,1.0,6/19,13.37%,ERCC6;ABI1;PAK2;AFAP1L2;DGKQ;GAS6
prerank,cation:chloride symporter activity (GO:0015377),-0.3596385289437066,-0.8538529888495039,0.6482558139534884,0.8901007630941844,1.0,4/10,13.22%,SLC12A2;SLC12A6;SLC6A1;SLC12A4
prerank,CARD domain binding (GO:0050700),-0.309974534593234,-0.8504897832791259,0.6732673267326733,0.8909865173088459,1.0,5/14,20.81%,CASP4;IRGM;CARD16;CARD9;NOD1
prerank,ribosomal small subunit binding (GO:0043024),0.3636373203730445,0.8494429396182887,0.6643059490084986,0.8940412491206152,1.0,2/17,5.04%,EIF1;PIM1
prerank,transcription coregulator binding (GO:0001221),0.30606256590067815,0.8490524821116632,0.713436385255648,0.8924620429976922,1.0,15/50,22.85%,CTNNB1;EED;RPL23;LCOR;ESR1;PPARD;RORA;RELA;PER3;ZBTB7A;PHF1;ZBTB16;EHMT2;MTF2;CTBP1
prerank,methyl-CpG binding (GO:0008327),-0.2740241987132062,-0.8481192292826928,0.7058823529411765,0.8891754959349764,1.0,7/22,16.33%,CXXC5;TET1;CXXC4;PRMT1;ERH;ZBTB33;ZCWPW1
prerank,insulin-like growth factor I binding (GO:0031994),-0.33124643935310427,-0.8467502947751878,0.6595744680851063,0.8856371494041525,1.0,6/13,28.92%,ITGA6;IGF1R;ITGB4;IGFBP6;IGFBP5;IGFBP2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.3443951962451832,-0.8438050934622026,0.6666666666666666,0.8853133122479514,1.0,5/11,18.18%,PRMT1;PRMT9;PRMT7;PRMT2;PRMT8
prerank,single-stranded DNA binding (GO:0003697),0.2793554116215757,0.840066177748234,0.7537960954446855,0.9053716976840057,1.0,27/93,23.57%,RBMS1;MCM9;LONP1;FAM111A;HNRNPU;TOP1;RAD23A;POLR2G;TDP2;SSBP1;POLA1;WBP11;STN1;PCBP1;TWNK;HSPD1;RADX;FUBP1;PURB;TOP3A;POLR3C;FUBP3;RAD51B;XPC;RNF138;SPRTN;ERCC4
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.4064818515770101,0.8393692626584164,0.6733436055469953,0.9042555955797352,1.0,5/10,23.59%,SUV39H2;PRDM16;ASH1L;EHMT2;SETD5
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.32453823755233313,0.8378659826099327,0.6974025974025974,0.9045507412974295,1.0,8/30,17.90%,BIRC6;TNFAIP8;XIAP;BIRC3;MT3;GAS6;UBE2O;BIRC2
prerank,neuropeptide binding (GO:0042923),-0.29974765020405053,-0.834598384440271,0.6735395189003437,0.8975698628904722,1.0,3/18,13.12%,OPRM1;GPR37;GPR149
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.31393938382909015,-0.8341979061068681,0.6879194630872483,0.8922238297512541,1.0,8/14,25.39%,EBAG9;RACK1;MAL;PYCARD;BAD;NOD1;RPS27L;ATP2A3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.4036074718411562,0.8289418487519495,0.7009345794392523,0.9169618042819708,1.0,1/10,2.43%,PRKAG2
prerank,metal ion:proton antiporter activity (GO:0051139),0.38469697770956984,0.8282173623321788,0.7034795763993948,0.9158157550238202,1.0,3/13,13.66%,SLC9A3;LETM1;SLC11A1
prerank,phosphatase activity (GO:0016791),0.28884372142062364,0.8251860244308931,0.774863387978142,0.9183730738784621,1.0,11/73,14.04%,PLPP3;LPIN3;DUSP3;PLPP6;ACP5;PLPP5;LHPP;HDHD2;PGP;OCRL;PPP1CA
prerank,phospholipase activator activity (GO:0016004),0.394925458051523,0.8251780738285975,0.7055214723926381,0.916121403914432,1.0,2/10,12.78%,PDPK1;BTK
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3379703097037445,0.8249303406843908,0.7384412153236459,0.9142785013920545,1.0,7/23,17.81%,KIF16B;SESTD1;CLVS2;SH3PXD2B;SNX14;MAPKAP1;SNX3
prerank,ribosome binding (GO:0043022),0.3021094535274634,0.8235448949336838,0.7419738406658739,0.9142715952884465,1.0,17/46,23.41%,CPEB4;YTHDF3;EIF6;ETF1;SERBP1;ERI1;NAA10;RPSA;NOMO1;C1QBP;CPEB2;EIF3C;EIF2S1;NAA15;MTIF3;TMCO1;CPEB1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.31986544624921165,0.8234845308123194,0.730423620025674,0.9121293545013672,1.0,3/29,7.51%,SLC1A5;SLC26A1;SLC38A7
prerank,microtubule binding (GO:0008017),0.2623322549160053,0.8204961160221488,0.8626262626262626,0.9145155851636182,1.0,36/222,15.13%,KIF13B;GAS2L3;FMN1;HOOK3;KIF20B;SPEF1;REEP4;CCDC69;KIF9;KIF16B;KIF27;HAUS6;SAXO2;APC;PEX14;GTSE1;KIF3A;UXT;EML3;VAPA;VASH2;TERF1;SKA2;MTCL1;ARHGEF2;CCDC66;TOGARAM1;TUBGCP4;KIF6;GAS2L1;MACF1;CLASP1;ARL3;WHAMM;NDE1;ALMS1
prerank,SH3 domain binding (GO:0017124),0.28786827314356156,0.8204487050187561,0.7452085682074409,0.9123666419417947,1.0,7/62,7.47%,CBLB;GRB2;ADAM9;ABI1;PTPN12;CYBA;SH3BP2
prerank,MHC class II protein complex binding (GO:0023026),-0.33258781997744635,-0.8202845786007966,0.6962750716332379,0.9121786023353322,1.0,2/11,4.99%,ATP1B1;HSP90AA1
prerank,anion channel activity (GO:0005253),0.28852233620029344,0.8202574358595706,0.7465753424657534,0.9104351501031254,1.0,12/61,17.01%,LRRC8D;ANO6;VDAC2;GABRE;LRRC8C;VDAC1;CLCN7;GABRA1;CLIC1;GPR89A;GPR89B;CLCN4
prerank,exonuclease activity (GO:0004527),0.29850918812169064,0.8195266230294231,0.7264038231780168,0.9094706058040254,1.0,16/46,21.59%,ENPP1;EXOSC3;EXOSC9;CNOT7;ERI1;EXOSC8;DCLRE1B;WRN;CNOT6;ISG20L2;EXOSC10;EXOSC1;REXO5;MRE11;EXOSC7;APEX2
prerank,death receptor binding (GO:0005123),-0.2981999795364024,-0.8189949560341089,0.7197452229299363,0.9082500306816024,1.0,4/15,10.95%,EDA;MADD;DAB2IP;FEM1B
prerank,bHLH transcription factor binding (GO:0043425),0.35008025353227756,0.8164892813486003,0.710334788937409,0.9121282408877585,1.0,4/19,16.56%,CREBBP;BHLHE40;SIRT1;TCF12
prerank,ion gated channel activity (GO:0022839),0.32986017980725296,0.8150890546761532,0.7265625,0.9120542096067421,1.0,2/24,2.68%,ANO6;TTYH2
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.30054610680736915,-0.8132119046095423,0.717201166180758,0.9128557312714928,1.0,4/13,17.19%,PJA2;RYR2;PKIA;PRKAR2B
prerank,tubulin binding (GO:0015631),0.2574597535331578,0.8126065378730074,0.8886659979939819,0.9135837206585999,1.0,54/295,16.29%,KIF13B;GAS2L3;FMN1;HOOK3;KIF20B;SPEF1;REEP4;CCDC69;KIF9;WASHC1;KIF16B;KIF27;HAUS6;SAXO2;DAG1;APC;PEX14;RITA1;GTSE1;KIF3A;UXT;EML3;BRCA1;DLEC1;VAPA;VASH2;TERF1;TPR;SKA2;ARL8B;MTCL1;ARHGEF2;CCDC66;BCAS3;TOGARAM1;TUBGCP4;KIF6;APPL1;GAS2L1;PRKN;CLASP1;TBCA;ARL3;ARL8A;ARL4C;WHAMM;INO80;SMC3;NDE1;ALMS1;OFD1;RABGAP1;CCDC88C;TBCEL
prerank,endopeptidase activator activity (GO:0061133),0.39080760130256786,0.8117070267524544,0.7127496159754224,0.9128300915268638,1.0,5/10,22.88%,NLRC4;PSMD14;PSME2;APH1B;PSME3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.33457262558638584,-0.8116753057138324,0.6902654867256637,0.9094138386669572,1.0,2/10,6.62%,JUP;CD200
prerank,lysine N-methyltransferase activity (GO:0016278),0.3445496990756448,0.8116632427208875,0.7081081081081081,0.9107141148883633,1.0,7/20,25.52%,ETFBKMT;SETD7;SMYD2;EHMT2;SETD3;METTL21A;SETD6
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.2242546344903255,-0.8113445791801484,0.8520408163265306,0.9038219603983098,1.0,5/38,12.40%,SPOCK1;SERPINE2;SERPINA2;SERPINI1;AGT
prerank,beta-tubulin binding (GO:0048487),0.31353202217602394,0.8111054410314484,0.7329032258064516,0.9093161666464229,1.0,8/31,14.87%,PEX14;UXT;DLEC1;ARL8B;BCAS3;APPL1;ARL8A;SMC3
prerank,phosphatase binding (GO:0019902),0.26798117608508315,0.8079018109423324,0.8184647302904564,0.9120216912817977,1.0,20/105,19.60%,LGALS3;IQGAP1;MTMR3;CTNNB1;IKBKE;KIF3A;SIRPA;CD22;STYXL1;PPP3R1;TRAF3;CEP192;JAK3;AP3B1;TRAF2;CRY1;SNX3;TRPC4AP;STAT6;TBK1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.28813831296366654,0.807774266848802,0.7608440797186401,0.9100677368790379,1.0,13/51,20.55%,SLC35D3;SLC16A10;SLC5A5;SLC35E3;SLC35D1;SLC35E2B;SLC35E2A;CLCN4;SLCO3A1;SLC35C2;SLC20A2;SLC7A8;SLC28A2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.3938987333771364,0.8068209375301081,0.7207890743550834,0.9093060591363995,1.0,7/10,29.64%,CASP12;CASP6;CASP2;CASP3;CASP8;CASP9;CFLAR
prerank,four-way junction DNA binding (GO:0000400),0.3508500420684172,0.8065449317183558,0.7189349112426036,0.9075533575188668,1.0,8/17,31.43%,XRCC2;WRN;RAD51B;FANCM;MEN1;YY1;RAD51C;HMGB1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.31798921597444596,-0.804725787497534,0.7277777777777777,0.9097776639086116,1.0,7/11,46.53%,KCNJ3;KCNQ1;KCNE3;KCNE4;KCNJ5;KCNJ8;KCNE2
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.3811086217503513,0.8044325817338248,0.7158218125960062,0.9086028250726988,1.0,2/12,8.78%,SLC9A3;LETM1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2811671898208304,0.8043575532598343,0.7649769585253456,0.9065657559267096,1.0,18/57,23.52%,UQCRFS1;NDUFS8;NDUFA10;NDUFC1;COX6A1;CYB5A;COX8A;NDUFB6;NDUFS6;NDUFS1;COX15;NDUFS3;NDUFB4;NDUFB8;COX4I1;COX5A;NDUFB9;NDUFA13
prerank,cytokine receptor activity (GO:0004896),0.2718086978285516,0.8035921913840854,0.7980132450331126,0.9056032286812852,1.0,14/83,14.13%,IL17RE;CD44;XCR1;IL10RB;IFNGR2;IFNAR2;CSF2RB;IL20RB;IL6R;IL3RA;CSF2RA;IL7R;ACKR4;IL4R
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.3005142554065525,-0.8023364276348655,0.7019230769230769,0.9080396291420864,1.0,7/14,27.27%,RPP14;TSEN34;RPP30;ELAC2;RPP38;POP5;POP7
prerank,N-methyltransferase activity (GO:0008170),0.335474899682845,0.8016689625703398,0.7165991902834008,0.9063978904136646,1.0,9/20,26.39%,GNMT;N6AMT1;TFB2M;TRMT1L;DIMT1;SETD3;ZCCHC4;FDXACB1;TRMO
prerank,thiol-dependent deubiquitinase (GO:0004843),0.2757790080646949,0.800716340353694,0.7929515418502202,0.9056282395283974,1.0,23/83,21.90%,TANK;USP42;USP12;VCPIP1;COPS5;USP40;USP26;USP48;PSMD14;USP21;USP16;TNFAIP3;USP36;BRCC3;USP8;OTUD5;USP32;USP30;STAMBP;ATXN3;USP3;USP9X;USP2
prerank,voltage-gated chloride channel activity (GO:0005247),0.39255948504154825,0.8001669217972475,0.7370892018779343,0.9043379027679306,1.0,1/10,2.36%,ANO6
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.38189189117148636,0.7995010865291325,0.7088607594936709,0.9032361699831165,1.0,2/10,6.61%,PIK3CA;PIK3C2G
prerank,alpha-tubulin binding (GO:0043014),0.3129964614711715,0.7985817248758068,0.7393483709273183,0.902402706362381,1.0,8/31,16.29%,WASHC1;DLEC1;ARL8B;ARL8A;ARL4C;INO80;OFD1;TBCEL
prerank,pyridoxal phosphate binding (GO:0030170),0.33869701321072804,0.7968879870872329,0.728021978021978,0.9028567228881461,1.0,8/20,28.77%,PYGL;PLPBP;OAT;PYGB;SHMT2;PDXK;PNPO;SRR
prerank,Notch binding (GO:0005112),0.3230253563007358,0.794605713226445,0.7317397078353254,0.9040564525924387,1.0,7/22,24.08%,CUL3;ADAM17;SNED1;DTX1;KCTD10;AAK1;CCN3
prerank,histone demethylase activity (GO:0032452),0.31483228964129534,0.794403318273974,0.756544502617801,0.9022596196132469,1.0,9/27,22.12%,KDM4C;KDM3A;JMJD1C;KDM2A;KDM7A;RIOX2;PHF2;JMJD6;KDM5C
prerank,tau-protein kinase activity (GO:0050321),0.33062817467745964,0.7928646804637882,0.7283950617283951,0.9023832261529736,1.0,4/20,10.26%,SIK3;DYRK1A;ROCK1;GSK3B
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.3570692135238702,0.7928553495752606,0.7453237410071942,0.9003271702511049,1.0,5/15,19.88%,LANCL2;SESTD1;SH3PXD2B;SNX3;SAP30L
prerank,symporter activity (GO:0015293),0.37777253956353474,0.7898817310092875,0.7171253822629969,0.9024801070643977,1.0,2/10,20.55%,SLC5A5;SLC28A2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.3490014658188952,0.789210500869358,0.7432624113475177,0.9013008651498898,1.0,6/15,26.71%,CXXC1;KMT2A;SETD3;KMT2D;SETD1B;KMT2C
prerank,GABA receptor binding (GO:0050811),0.368772120454541,0.7875952895503684,0.7507645259938838,0.9014189017589965,1.0,3/11,13.36%,JAKMIP1;ARFGEF2;PLCL2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.358863031382722,0.785522197515722,0.7334315169366715,0.9023142031418827,1.0,2/13,10.72%,ENDOV;DNASE1L1
prerank,mRNA 5'-UTR binding (GO:0048027),0.31487752954855014,0.7823822333082608,0.7519685039370079,0.9047509388604408,1.0,6/24,19.65%,UTP23;IGF2BP3;RPS14;SYNCRIP;RPL26;NCL
prerank,protein phosphatase 2A binding (GO:0051721),0.32682372988170355,0.7820268829161351,0.7676240208877284,0.9031933645881971,1.0,7/23,14.56%,ENSA;MFHAS1;STRN;BOD1;FOXO1;STRN3;ADCY8
prerank,anion transmembrane transporter activity (GO:0008509),0.36360631695586665,0.7779991976425009,0.7551319648093842,0.9066435559815859,1.0,1/12,0.43%,SLC26A11
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.27516227814386585,0.7769702997287625,0.8047945205479452,0.905973084476422,1.0,15/54,25.90%,KLK3;TGM2;SIRT6;DARS1;AGA;SIRT1;SIRT7;ACER2;ASAH1;HDAC8;NTAQ1;NADSYN1;ACER3;HDAC1;NAAA
prerank,microtubule minus-end binding (GO:0051011),-0.29818268176485657,-0.7765403278943135,0.765625,0.9446570585126184,1.0,5/13,22.59%,TUBGCP5;NUMA1;CEP290;TUBGCP6;CAMSAP1
prerank,kinase inhibitor activity (GO:0019210),0.29664504290582816,0.7757977484413036,0.7846534653465347,0.9055169532652961,1.0,7/33,20.00%,TAOK3;CDKN1A;GSKIP;DUS2;LRP6;SH3BP5;GMFB
prerank,microtubule plus-end binding (GO:0051010),-0.26104451662610745,-0.7718445130064331,0.8339622641509434,0.9461716546833663,1.0,9/20,31.01%,DST;NUMA1;KIF18A;MAPRE1;TTBK2;DCTN1;CLIP4;CLASP2;KIF2C
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.3061598454898899,-0.770742540152512,0.7359050445103857,0.9415347192945727,1.0,5/11,32.79%,PPP1R8;PPP1R14B;PPP1R1A;PPP1R14C;PPP1R2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.35414729433192305,0.7698019430243466,0.7616822429906542,0.9113452138241067,1.0,2/12,6.61%,PIK3CA;PIK3C2G
prerank,TBP-class protein binding (GO:0017025),-0.2587394031400693,-0.7696590919816495,0.8237704918032787,0.9369721710934962,1.0,10/21,22.98%,THRA;PSMC2;YEATS2;TAF12;HHEX;DRAP1;AHR;DR1;BRF2;GTF2A2
prerank,damaged DNA binding (GO:0003684),-0.21433960804195473,-0.7691186414957893,0.8988095238095238,0.9318702710268763,1.0,15/44,24.74%,DCLRE1C;SMC6;CRY2;DDB2;ERCC5;POLQ;NEIL3;FANCG;XPA;RAD1;RPA3;RPA1;DCLRE1A;ERCC2;PCNA
prerank,miRNA binding (GO:0035198),0.30099202995130725,0.764367359974651,0.7926208651399491,0.9165292984678385,1.0,6/30,13.40%,AGO2;AGO3;PUM2;SPOUT1;SOX2;RBM10
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3533282168988801,0.7635065594854343,0.7831858407079646,0.915609055522928,1.0,2/12,8.56%,APAF1;CTSH
prerank,myosin binding (GO:0017022),0.2727744006430588,0.7631806908984304,0.8321917808219178,0.9140688556891643,1.0,7/55,12.95%,CXCR4;MYL2;TRIOBP;STXBP5;MYBPC3;RAB10;RAB11B
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.29905919622105104,0.7630591218264444,0.7893432465923172,0.9121950680876243,1.0,6/31,14.16%,AQP1;TMEM38B;SLC12A3;SLC12A8;KCNK4;SLC12A7
prerank,omega peptidase activity (GO:0008242),0.25922713597995084,0.76278230513162,0.8432432432432433,0.9105015537514147,1.0,24/89,21.90%,TANK;USP42;USP12;VCPIP1;COPS5;USP40;USP26;USP48;PSMD14;USP21;USP16;TNFAIP3;USP36;BRCC3;USP8;OTUD5;USP32;APEH;USP30;STAMBP;ATXN3;USP3;USP9X;USP2
prerank,ATPase binding (GO:0051117),0.26386941628560334,0.7592448852768705,0.8344370860927153,0.9129425568614328,1.0,10/71,12.38%,ABCA1;SNX10;ATP6V1E1;TCIRG1;NUFIP1;ATP6V0A1;PPP3CA;ESR1;S100A1;TMTC4
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.33190542678474144,0.757176156364179,0.7818696883852692,0.9136027729814098,1.0,2/16,7.51%,SLC1A5;SLC38A7
prerank,chloride channel inhibitor activity (GO:0019869),0.36786043019034764,0.7565765690353545,0.7667161961367014,0.9124063838505719,1.0,2/10,5.61%,STX8;VTI1B
prerank,nucleotide diphosphatase activity (GO:0004551),0.34419946483015773,0.7556577298805631,0.7769571639586411,0.911447512258114,1.0,2/14,6.72%,ENPP1;NUDT6
prerank,MHC protein binding (GO:0042287),0.3171584232206511,0.7531016145628423,0.7800269905533064,0.9124617506374119,1.0,2/20,10.98%,LILRB1;ATP5F1A
prerank,single-stranded DNA helicase activity (GO:0017116),0.3189879307573018,0.7449013427355341,0.7873799725651578,0.9206595886084175,1.0,2/19,6.63%,RFC3;HELB
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.3204933786347847,0.7396046669529267,0.8263988522238164,0.9252143520403965,1.0,4/17,17.52%,BLVRB;PTGR2;BLVRA;DECR2
prerank,snoRNA binding (GO:0030515),0.28145796031060344,0.7294901100921798,0.8372093023255814,0.9349774766448914,1.0,5/30,10.49%,BYSL;NUFIP1;NOP14;XRCC5;DKC1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3007395106111533,0.7266029470321324,0.8143631436314364,0.9363302491718293,1.0,2/22,5.64%,MTMR3;DUSP3
prerank,death domain binding (GO:0070513),0.3440175358887494,0.7255056516141478,0.8101071975497703,0.9355928495974651,1.0,4/11,18.54%,RIPK1;BAX;MCL1;CRADD
prerank,metallocarboxypeptidase activity (GO:0004181),-0.23548515591635016,-0.7250302605629116,0.9041666666666667,0.9871117858584949,1.0,8/26,20.31%,AGBL4;AGBL5;FOLH1;AEBP1;AGBL1;AGTPBP1;VASH1;CPD
prerank,DNA secondary structure binding (GO:0000217),-0.2206661606040056,-0.7243529979148473,0.91701244813278,0.9816443452588901,1.0,2/31,2.25%,MEF2C;MAPT
prerank,insulin-like growth factor receptor binding (GO:0005159),0.3292891557934082,0.7238714826539063,0.7910216718266254,0.9354819499779505,1.0,3/12,15.15%,IGF1;SHC1;ARRB1
prerank,potassium ion leak channel activity (GO:0022841),0.32321783345795047,0.7180205927042586,0.8302425106990015,0.9399745347780379,1.0,3/15,19.13%,KCNK13;KCNK4;KCNK5
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.2905573650890488,0.716394862881426,0.8657534246575342,0.9396728873703911,1.0,6/24,20.20%,MAPKAPK3;DAPK1;PTK2B;CAMK1;MKNK2;PHKG2
prerank,endodeoxyribonuclease activity (GO:0004520),0.29431479960651064,0.7044134209391358,0.8407557354925776,0.9504636684045,1.0,3/20,11.06%,ZRANB3;ENDOV;MBD4
prerank,3'-5' exonuclease activity (GO:0008408),0.25500825719146814,0.7026684034792441,0.8607142857142858,0.9504175887969525,1.0,17/45,27.98%,TOE1;EXOSC3;CNOT6L;EXOSC9;CNOT7;ERI1;WRN;CNOT6;EXOSC10;MRE11;EXOSC7;POLD1;XRN2;EXOSC4;NOCT;POLG;DIS3L
prerank,potassium channel regulator activity (GO:0015459),0.25716610632233894,0.701947188688634,0.8898203592814371,0.9491819974025731,1.0,4/49,8.00%,SGK1;ENSA;KCNAB2;NEDD4L
prerank,MAP kinase phosphatase activity (GO:0033549),-0.2780474277820449,-0.7016647333401359,0.8562874251497006,1.0,1.0,2/12,6.52%,DUSP6;DUSP7
prerank,CCR chemokine receptor binding (GO:0048020),-0.21980239932487408,-0.7015732454115685,0.9241706161137441,0.9960265606827323,1.0,7/28,25.32%,CCL4;CCR2;NES;CCL3;CCL14;CCL5;DEFB130A
prerank,chloride transmembrane transporter activity (GO:0015108),-0.24774451685909082,-0.6980185168654722,0.9025974025974026,0.9937217377260983,1.0,5/16,19.70%,SLC4A8;SLC1A1;CLCN6;SLC26A8;SLC26A6
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.2791551122197596,0.6979473765978401,0.8793565683646113,0.9513764487758842,1.0,2/26,7.11%,B3GNT8;B3GALNT2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.22516500426953343,-0.6969270589501679,0.898876404494382,0.9825444461899697,1.0,11/21,32.15%,CDK14;CDKL3;CDK4;CDKL1;CDK10;CDK9;CDK11B;CDK19;CDK1;CDKL2;CDK20
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.22516500426953343,-0.6969270589501679,0.898876404494382,0.9825444461899697,1.0,11/21,32.15%,CDK14;CDKL3;CDK4;CDKL1;CDK10;CDK9;CDK11B;CDK19;CDK1;CDKL2;CDK20
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.311365323897977,0.6958075278454099,0.8597285067873304,0.9515644099640523,1.0,1/14,2.10%,BLVRB
prerank,ion channel inhibitor activity (GO:0008200),0.26333636283162715,0.6913519441801749,0.8702570379436965,0.954245807419419,1.0,4/35,8.00%,STX8;VTI1B;ENSA;NEDD4L
prerank,ribonuclease P RNA binding (GO:0033204),-0.29279488757427946,-0.6888875372395242,0.8567073170731707,0.9844940302869057,1.0,6/10,32.76%,RPP14;RPP30;RPP38;POP5;POP7;POP1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.28656585215498936,0.6882250435393891,0.862533692722372,0.9553018340823515,1.0,6/21,19.16%,GSKIP;AKAP1;PRRC1;ARFGEF2;AKAP7;ARFGEF1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.28507531429303407,0.6850642796351617,0.8523936170212766,0.9565095247841089,1.0,9/21,28.91%,POLH;POLL;POLA1;POLI;POLD1;POLE3;PRIMPOL;POLG;POLE
prerank,disordered domain specific binding (GO:0097718),0.28143152776687236,0.6800237083820296,0.8842530282637954,0.9595181683673967,1.0,9/23,29.11%,RB1;DFFB;NCOA3;HSPA1A;CALM2;FKBP8;CLTC;FYN;TP53
prerank,histone deacetylase binding (GO:0042826),0.22999922810600296,0.6797657132260679,0.9326818675352877,0.957719063844477,1.0,12/88,13.94%,FOXP3;NCOR1;KPNA2;HSPA1B;NIPBL;KCTD21;LCOR;PKN2;CAMTA2;RELA;PRKN;HSPA1A
prerank,cardiolipin binding (GO:1901612),-0.27759730070946886,-0.6789782174376106,0.8827160493827161,0.9881625831945023,1.0,4/10,35.20%,GSDME;UQCC3;STOML2;NME4
prerank,protein kinase regulator activity (GO:0019887),0.2287204505772939,0.6783375475359886,0.9464094319399786,0.9571360185031136,1.0,11/95,12.70%,GPRC5D;PRKAG2;TAOK3;CDKN1A;KIDINS220;GSKIP;APC;CCNA2;MT3;CNPPD1;DUS2
prerank,Wnt-activated receptor activity (GO:0042813),0.3055846759453424,0.6763478607302623,0.843609022556391,0.9569872841336737,1.0,4/15,12.68%,FZD7;FZD5;ROR1;FZD2
prerank,syntaxin-1 binding (GO:0017075),0.2773480316518393,0.6752178039860616,0.8618857901726428,0.9560829542503456,1.0,8/22,23.00%,DAPK1;STXBP5;STXBP3;VAMP3;SYPL1;STXBP2;VAMP2;SNPH
prerank,Hsp90 protein binding (GO:0051879),0.26424015634905673,0.6737932133764796,0.8857493857493858,0.955350774050254,1.0,8/33,21.13%,ERN1;NR3C1;PPEF2;STUB1;CSNK2A1;HDAC8;AHSA1;NPAS2
prerank,kinase activator activity (GO:0019209),0.26571360008385764,0.6732266619015685,0.9080310880829016,0.9538948945301429,1.0,2/30,2.43%,GPRC5D;PRKAG2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.2937647740229956,0.6715670464311388,0.8633193863319386,0.9534511106234658,1.0,1/15,5.29%,SLC26A1
prerank,"DNA binding, bending (GO:0008301)",-0.24781975718133184,-0.667995243924992,0.8975155279503105,0.9919916216427845,1.0,6/14,27.05%,TFAM;HHEX;TOP2A;FOXC1;LEF1;HMGB3
prerank,nuclear export signal receptor activity (GO:0005049),-0.25967386487020455,-0.665152353025239,0.8746438746438746,0.9885261023617653,1.0,4/11,26.24%,NUP214;RANBP17;XPO6;XPO4
prerank,regulatory RNA binding (GO:0061980),0.2501652765855758,0.664315335808857,0.9138349514563107,0.9579926548003103,1.0,6/38,13.40%,AGO2;AGO3;PUM2;SPOUT1;SOX2;RBM10
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.31771992106954683,0.6634887862723365,0.8539156626506024,0.9567515872471011,1.0,7/11,29.64%,CASP12;CASP6;CASP2;CASP3;CASP8;CASP9;CFLAR
prerank,DNA polymerase activity (GO:0034061),0.2730638360027715,0.6620682405291964,0.8839050131926122,0.9559854365569723,1.0,9/22,28.91%,POLH;POLL;POLA1;POLI;POLD1;POLE3;PRIMPOL;POLG;POLE
prerank,hydro-lyase activity (GO:0016836),0.24739944742703535,0.6617366483464301,0.9188861985472155,0.9543088475972357,1.0,8/41,19.15%,HADHA;HACD4;ENO3;CDYL;ECHDC1;EHHADH;CA2;ALAD
prerank,active ion transmembrane transporter activity (GO:0022853),0.2464458164810911,0.6585414567338658,0.9240196078431373,0.9550624081846668,1.0,7/37,17.15%,ATP13A3;UQCRFS1;COX6A1;CYB5A;COX8A;COX15;SLCO3A1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.22669520430599413,0.6577355870532899,0.9345172031076582,0.9537517542837946,1.0,5/73,10.73%,APLNR;EDNRA;VIPR1;PTH2R;GRPR
prerank,translation elongation factor activity (GO:0003746),0.2933053092490394,0.6544499615111438,0.8986975397973951,0.9546507159312881,1.0,2/14,11.60%,EEF1A1;GTPBP2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.28938677707440574,0.6489419966314797,0.8899858956276445,0.9573125461228031,1.0,2/15,7.51%,SLC1A5;SLC38A7
prerank,methyltransferase activity (GO:0008168),0.23373520094641603,0.6460562056762572,0.9357907253269917,0.9576373826586386,1.0,17/46,26.81%,NSUN3;COMTD1;N6AMT1;MEPCE;MRM2;DNMT1;RRP8;NDUFAF7;AS3MT;CARNMT1;MGMT;COMT;GCSH;AMT;NSUN4;FTSJ1;METTL4
prerank,protein kinase C binding (GO:0005080),0.23631732347781426,0.6449077013405199,0.9251207729468599,0.9566131828024075,1.0,10/43,20.20%,ADAM9;NELL2;PDLIM5;PRKCB;PARD6A;SQSTM1;NELL1;CAVIN3;CAVIN2;ITGAV
prerank,fibroblast growth factor binding (GO:0017134),0.2656600075463181,0.639698815520023,0.9142461964038727,0.9587116689823524,1.0,2/21,5.58%,FGFR4;THBS1
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.2600176972260043,-0.633378160784776,0.9154518950437318,1.0,1.0,4/11,22.35%,CTC1;RAD50;HNRNPA2B1;RPA1
prerank,histone deacetylase activity (GO:0004407),0.26595403453374505,0.631788471079906,0.9226441631504922,0.9627075916961104,1.0,5/19,19.36%,SIRT6;SIRT1;SIRT7;SIRT3;HDAC8
prerank,phosphatase activator activity (GO:0019211),-0.23495884006296106,-0.6310565047875151,0.9467084639498433,1.0,1.0,6/14,24.68%,B3GAT3;PPP2R5D;GTF2F1;PPP2R5A;PPP2R5B;CALM3
prerank,BMP binding (GO:0036122),0.2910161834802603,0.6208317543007231,0.8873873873873874,0.968675976161896,1.0,2/11,21.66%,BMPR2;GREM2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.21595836784033626,-0.6204273437636498,0.9290540540540541,1.0,1.0,11/18,47.53%,HSD17B7;HSD17B10;HSD17B1;HSD11B1;HSD3B7;DHRS9;SRD5A2;HSD3B2;HSD17B14;AKR1C1;HSD17B3
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.23234366482804827,0.6156132996785298,0.942643391521197,0.9682532530375397,1.0,11/34,23.52%,NDUFS8;NDUFA10;NDUFC1;NDUFB6;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFB8;NDUFB9;NDUFA13
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.23234366482804827,0.6156132996785298,0.942643391521197,0.9682532530375397,1.0,11/34,23.52%,NDUFS8;NDUFA10;NDUFC1;NDUFB6;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFB8;NDUFB9;NDUFA13
prerank,RNA stem-loop binding (GO:0035613),-0.24346785727572273,-0.6125631750358768,0.9345794392523364,1.0,1.0,3/12,17.82%,FMR1;MYH10;CPEB3
prerank,U6 snRNA binding (GO:0017070),0.2724510697096795,0.6087692206394573,0.9184549356223176,0.9708605086122223,1.0,8/14,30.97%,PRPF8;LARP7;RBM22;EIF5A;LSM8;LSM4;METTL16;TUT1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.27956809100112906,0.6034857114313472,0.9264705882352942,0.9723041321120752,1.0,4/12,23.08%,CDK7;CDK8;CDK13;CDK6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.29525317061309314,0.6000252396516695,0.9252336448598131,0.9723652333210085,1.0,3/10,23.27%,CRMP1;OPLAH;DPYSL3
prerank,chemokine activity (GO:0008009),0.23015223773807017,0.5974240493389601,0.9576923076923077,0.9719324669014939,1.0,5/31,22.86%,CKLF;CX3CL1;CCL7;CCL25;CXCL12
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.2376602604440337,-0.5923521766238192,0.9314285714285714,1.0,1.0,4/11,17.87%,APLF;NEIL2;NEIL3;HMCES
prerank,ankyrin binding (GO:0030506),0.25736093691719353,0.5905846098292201,0.9386084583901774,0.9737493311688297,1.0,3/19,21.02%,SLC8A1;PLEC;PTPRC
prerank,titin binding (GO:0031432),0.262971080324182,0.5708658002709105,0.9351032448377581,0.9819408144175393,1.0,3/13,19.04%,MYBPC3;MYBPC1;CALM2
prerank,hormone activity (GO:0005179),0.20401539485065118,0.5693200855038587,0.9835487661574618,0.9806415967935855,1.0,3/54,9.15%,IGF1;METRNL;TRH
prerank,steroid hydroxylase activity (GO:0008395),-0.20184644132308743,-0.5673743480034011,0.976027397260274,1.0,1.0,6/16,38.38%,CYP7B1;CH25H;CYP2U1;CYP1A1;CYP2R1;CYP1B1
prerank,CXCR chemokine receptor binding (GO:0045236),-0.22873642583641954,-0.5670148979411258,0.9575070821529745,1.0,1.0,11/11,77.15%,YARS1;CXCL10;CXCL9;CXCL1;CXCL13;CXCL2;CXCL5;PPBP;ITCH;PF4;CXCL12
prerank,leak channel activity (GO:0022840),0.24626983447971357,0.5663060933002513,0.9579242636746143,0.9801322205063248,1.0,2/18,12.56%,KCNK13;KCNK4
prerank,nucleosomal DNA binding (GO:0031492),0.23492187980808554,0.5611941837387846,0.955585464333782,0.9804849597069509,1.0,9/21,28.74%,SMARCC1;SMARCB1;MBD2;SMARCE1;SMARCD2;ACTB;HDAC1;SMARCA4;HNRNPC
prerank,pseudouridine synthase activity (GO:0009982),-0.2143944017563134,-0.5535717714171318,0.9281437125748503,1.0,1.0,3/13,18.37%,PUS7;TRUB2;RPUSD4
prerank,calcium channel inhibitor activity (GO:0019855),0.26196649664986266,0.5489742068928015,0.9443585780525502,0.9834211015248093,1.0,3/11,22.25%,CALM2;SLC30A1;FKBP1A
prerank,nucleoside-diphosphatase activity (GO:0017110),0.24782017308847704,0.5480226695555335,0.9540740740740741,0.9818877270502531,1.0,2/12,14.46%,ENTPD1;SLC25A42
prerank,ATPase activator activity (GO:0001671),0.23235070323872808,0.5463342228968218,0.9648173207036536,0.9805975759163956,1.0,2/20,8.15%,DNAJB6;MYBPC3
prerank,protein phosphatase activator activity (GO:0072542),-0.2088400755240742,-0.5429319914765757,0.9692307692307692,1.0,1.0,5/13,24.68%,B3GAT3;PPP2R5D;PPP2R5A;PPP2R5B;CALM3
prerank,adenylate cyclase binding (GO:0008179),-0.22273204503273503,-0.5408952231592,0.9650145772594753,0.9981720243793796,1.0,4/10,24.68%,AKAP12;AKAP5;ADCY2;CALM3
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.20593927924629862,-0.5408659265515904,0.9692307692307692,0.9925387975640465,1.0,3/14,13.23%,NFU1;ACO2;NUBPL
prerank,mechanosensitive ion channel activity (GO:0008381),0.25018170401270734,0.5382726820451142,0.9488721804511279,0.9814716137104093,1.0,2/12,11.91%,PIEZO1;PIEZO2
prerank,ribonuclease P activity (GO:0004526),-0.21193615117535358,-0.5169114576974788,0.9841269841269841,0.9931464221171539,1.0,5/11,27.27%,RPP14;RPP30;RPP38;POP5;POP7
prerank,SUMO binding (GO:0032183),0.22673958679840972,0.4889631892533045,0.9831288343558282,0.9925755508082014,1.0,3/13,18.34%,SERBP1;USPL1;SIMC1
prerank,hormone receptor binding (GO:0051427),-0.18533400301356104,-0.4859285171702971,0.993485342019544,0.9932536200087758,1.0,14/14,81.49%,ADCYAP1;CCK;JAK1;PTHLH;VIP;NPPA;GHRH;GPHA2;NPPB;TYK2;NPPC;SOCS2;JAK2;NCOA6
prerank,phosphate ion binding (GO:0042301),0.22296458686895626,0.4701666810207427,0.9812792511700468,0.9938791028325461,1.0,3/10,25.06%,RELA;ADSS1;ADSS2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.21591774577699602,0.46183579173553885,0.9909638554216867,0.9931335782825216,1.0,2/11,21.63%,SLC25A20;SLC22A5
